id	sid	tid	token	lemma	pos
ejde-885	1	1	third	third	ADJ
ejde-885	1	2	international	international	ADJ
ejde-885	1	3	conference	conference	NOUN
ejde-885	1	4	on	on	ADP
ejde-885	1	5	applications	application	NOUN
ejde-885	1	6	of	of	ADP
ejde-885	1	7	mathematics	mathematic	NOUN
ejde-885	1	8	to	to	ADP
ejde-885	1	9	nonlinear	nonlinear	ADJ
ejde-885	1	10	sciences	science	NOUN
ejde-885	1	11	,	,	PUNCT
ejde-885	1	12	electronic	electronic	ADJ
ejde-885	1	13	journal	journal	NOUN
ejde-885	1	14	of	of	ADP
ejde-885	1	15	differential	differential	ADJ
ejde-885	1	16	equations	equation	NOUN
ejde-885	1	17	,	,	PUNCT
ejde-885	1	18	conference	conference	NOUN
ejde-885	1	19	27	27	NUM
ejde-885	1	20	(	(	PUNCT
ejde-885	1	21	2024	2024	NUM
ejde-885	1	22	)	)	PUNCT
ejde-885	1	23	,	,	PUNCT
ejde-885	1	24	pp	pp	PROPN
ejde-885	1	25	.	.	PUNCT
ejde-885	2	1	1–12	1–12	NOUN
ejde-885	2	2	.	.	PUNCT
ejde-885	3	1	issn	issn	PROPN
ejde-885	3	2	:	:	PUNCT
ejde-885	3	3	1072	1072	NUM
ejde-885	3	4	-	-	SYM
ejde-885	3	5	6691	6691	NUM
ejde-885	3	6	.	.	PUNCT
ejde-885	4	1	url	url	PROPN
ejde-885	4	2	:	:	PUNCT
ejde-885	4	3	https://ejde.math.txstate.edu	https://ejde.math.txstate.edu	PROPN
ejde-885	4	4	,	,	PUNCT
ejde-885	4	5	https://ejde.math.unt.edu	https://ejde.math.unt.edu	PROPN
ejde-885	4	6	doi	doi	PROPN
ejde-885	4	7	:	:	PUNCT
ejde-885	4	8	10.58997	10.58997	NUM
ejde-885	4	9	/	/	SYM
ejde-885	4	10	ejde.conf.27.g1	ejde.conf.27.g1	PRON
ejde-885	4	11	respiratory	respiratory	ADJ
ejde-885	4	12	illness	illness	NOUN
ejde-885	4	13	clinical	clinical	ADJ
ejde-885	4	14	trial	trial	NOUN
ejde-885	4	15	modeling	model	VERB
ejde-885	4	16	david	david	PROPN
ejde-885	4	17	gerberry	gerberry	PROPN
ejde-885	4	18	,	,	PUNCT
ejde-885	4	19	hem	hem	PROPN
ejde-885	4	20	joshi	joshi	PROPN
ejde-885	4	21	,	,	PUNCT
ejde-885	4	22	mac	mac	PROPN
ejde-885	4	23	peloquin	peloquin	NOUN
ejde-885	4	24	,	,	PUNCT
ejde-885	4	25	sonia	sonia	PROPN
ejde-885	4	26	vargas	vargas	PROPN
ejde-885	4	27	abstract	abstract	NOUN
ejde-885	4	28	.	.	PUNCT
ejde-885	5	1	respiratory	respiratory	ADJ
ejde-885	5	2	illnesses	illness	NOUN
ejde-885	5	3	pose	pose	VERB
ejde-885	5	4	a	a	DET
ejde-885	5	5	significant	significant	ADJ
ejde-885	5	6	burden	burden	NOUN
ejde-885	5	7	on	on	ADP
ejde-885	5	8	public	public	ADJ
ejde-885	5	9	health	health	NOUN
ejde-885	5	10	,	,	PUNCT
ejde-885	5	11	causing	cause	VERB
ejde-885	5	12	numerous	numerous	ADJ
ejde-885	5	13	fatalities	fatality	NOUN
ejde-885	5	14	annually	annually	ADV
ejde-885	5	15	.	.	PUNCT
ejde-885	6	1	using	use	VERB
ejde-885	6	2	the	the	DET
ejde-885	6	3	classical	classical	ADJ
ejde-885	6	4	seir	seir	ADJ
ejde-885	6	5	framework	framework	NOUN
ejde-885	6	6	,	,	PUNCT
ejde-885	6	7	we	we	PRON
ejde-885	6	8	model	model	VERB
ejde-885	6	9	a	a	DET
ejde-885	6	10	general	general	ADJ
ejde-885	6	11	respiratory	respiratory	ADJ
ejde-885	6	12	infection	infection	NOUN
ejde-885	6	13	to	to	PART
ejde-885	6	14	investigate	investigate	VERB
ejde-885	6	15	the	the	DET
ejde-885	6	16	interaction	interaction	NOUN
ejde-885	6	17	between	between	ADP
ejde-885	6	18	the	the	DET
ejde-885	6	19	disease	disease	NOUN
ejde-885	6	20	’s	’s	PART
ejde-885	6	21	epidemiological	epidemiological	ADJ
ejde-885	6	22	dynamics	dynamic	NOUN
ejde-885	6	23	and	and	CCONJ
ejde-885	6	24	the	the	DET
ejde-885	6	25	dynamics	dynamic	NOUN
ejde-885	6	26	of	of	ADP
ejde-885	6	27	a	a	DET
ejde-885	6	28	vaccine	vaccine	NOUN
ejde-885	6	29	clinical	clinical	ADJ
ejde-885	6	30	trial	trial	NOUN
ejde-885	6	31	.	.	PUNCT
ejde-885	7	1	we	we	PRON
ejde-885	7	2	develop	develop	VERB
ejde-885	7	3	a	a	DET
ejde-885	7	4	system	system	NOUN
ejde-885	7	5	to	to	PART
ejde-885	7	6	describe	describe	VERB
ejde-885	7	7	clinical	clinical	ADJ
ejde-885	7	8	trials	trial	NOUN
ejde-885	7	9	for	for	ADP
ejde-885	7	10	a	a	DET
ejde-885	7	11	vaccine	vaccine	NOUN
ejde-885	7	12	targeting	target	VERB
ejde-885	7	13	a	a	DET
ejde-885	7	14	new	new	ADJ
ejde-885	7	15	respiratory	respiratory	ADJ
ejde-885	7	16	infection	infection	NOUN
ejde-885	7	17	.	.	PUNCT
ejde-885	8	1	we	we	PRON
ejde-885	8	2	model	model	VERB
ejde-885	8	3	the	the	DET
ejde-885	8	4	interplay	interplay	NOUN
ejde-885	8	5	between	between	ADP
ejde-885	8	6	epidemiological	epidemiological	ADJ
ejde-885	8	7	dynamics	dynamic	NOUN
ejde-885	8	8	and	and	CCONJ
ejde-885	8	9	clinical	clinical	ADJ
ejde-885	8	10	trials	trial	NOUN
ejde-885	8	11	,	,	PUNCT
ejde-885	8	12	establishing	establish	VERB
ejde-885	8	13	the	the	DET
ejde-885	8	14	relationship	relationship	NOUN
ejde-885	8	15	between	between	ADP
ejde-885	8	16	these	these	DET
ejde-885	8	17	two	two	NUM
ejde-885	8	18	systems	system	NOUN
ejde-885	8	19	.	.	PUNCT
ejde-885	9	1	we	we	PRON
ejde-885	9	2	also	also	ADV
ejde-885	9	3	explore	explore	VERB
ejde-885	9	4	the	the	DET
ejde-885	9	5	impact	impact	NOUN
ejde-885	9	6	of	of	ADP
ejde-885	9	7	vaccines	vaccine	NOUN
ejde-885	9	8	becoming	become	VERB
ejde-885	9	9	available	available	ADJ
ejde-885	9	10	to	to	ADP
ejde-885	9	11	adults	adult	NOUN
ejde-885	9	12	and	and	CCONJ
ejde-885	9	13	children	child	NOUN
ejde-885	9	14	at	at	ADP
ejde-885	9	15	different	different	ADJ
ejde-885	9	16	times	time	NOUN
ejde-885	9	17	by	by	ADP
ejde-885	9	18	dividing	divide	VERB
ejde-885	9	19	each	each	DET
ejde-885	9	20	epidemiological	epidemiological	ADJ
ejde-885	9	21	compartment	compartment	NOUN
ejde-885	9	22	into	into	ADP
ejde-885	9	23	two	two	NUM
ejde-885	9	24	age	age	NOUN
ejde-885	9	25	-	-	PUNCT
ejde-885	9	26	based	base	VERB
ejde-885	9	27	categories	category	NOUN
ejde-885	9	28	:	:	PUNCT
ejde-885	9	29	adults	adult	NOUN
ejde-885	9	30	and	and	CCONJ
ejde-885	9	31	children	child	NOUN
ejde-885	9	32	.	.	PUNCT
ejde-885	10	1	we	we	PRON
ejde-885	10	2	calculate	calculate	VERB
ejde-885	10	3	the	the	DET
ejde-885	10	4	basic	basic	ADJ
ejde-885	10	5	reproductive	reproductive	ADJ
ejde-885	10	6	number	number	NOUN
ejde-885	10	7	for	for	ADP
ejde-885	10	8	the	the	DET
ejde-885	10	9	epidemiological	epidemiological	ADJ
ejde-885	10	10	model	model	NOUN
ejde-885	10	11	for	for	ADP
ejde-885	10	12	each	each	DET
ejde-885	10	13	transmission	transmission	NOUN
ejde-885	10	14	category	category	NOUN
ejde-885	10	15	(	(	PUNCT
ejde-885	10	16	adults	adult	NOUN
ejde-885	10	17	and	and	CCONJ
ejde-885	10	18	children	child	NOUN
ejde-885	10	19	)	)	PUNCT
ejde-885	10	20	and	and	CCONJ
ejde-885	10	21	then	then	ADV
ejde-885	10	22	determine	determine	VERB
ejde-885	10	23	an	an	DET
ejde-885	10	24	overall	overall	ADJ
ejde-885	10	25	reproductive	reproductive	ADJ
ejde-885	10	26	number	number	NOUN
ejde-885	10	27	for	for	ADP
ejde-885	10	28	the	the	DET
ejde-885	10	29	entire	entire	ADJ
ejde-885	10	30	population	population	NOUN
ejde-885	10	31	.	.	PUNCT
ejde-885	11	1	additionally	additionally	ADV
ejde-885	11	2	,	,	PUNCT
ejde-885	11	3	we	we	PRON
ejde-885	11	4	conduct	conduct	VERB
ejde-885	11	5	numerical	numerical	ADJ
ejde-885	11	6	simulations	simulation	NOUN
ejde-885	11	7	under	under	ADP
ejde-885	11	8	various	various	ADJ
ejde-885	11	9	assumptions	assumption	NOUN
ejde-885	11	10	and	and	CCONJ
ejde-885	11	11	present	present	VERB
ejde-885	11	12	our	our	PRON
ejde-885	11	13	findings	finding	NOUN
ejde-885	11	14	.	.	PUNCT
ejde-885	12	1	1	1	X
ejde-885	12	2	.	.	X
ejde-885	12	3	introduction	introduction	NOUN
ejde-885	12	4	mathematical	mathematical	ADJ
ejde-885	12	5	modeling	modeling	NOUN
ejde-885	12	6	is	be	AUX
ejde-885	12	7	a	a	DET
ejde-885	12	8	powerful	powerful	ADJ
ejde-885	12	9	tool	tool	NOUN
ejde-885	12	10	used	use	VERB
ejde-885	12	11	for	for	ADP
ejde-885	12	12	understanding	understand	VERB
ejde-885	12	13	complex	complex	ADJ
ejde-885	12	14	systems	system	NOUN
ejde-885	12	15	including	include	VERB
ejde-885	12	16	the	the	DET
ejde-885	12	17	spread	spread	NOUN
ejde-885	12	18	of	of	ADP
ejde-885	12	19	infectious	infectious	ADJ
ejde-885	12	20	diseases	disease	NOUN
ejde-885	12	21	.	.	PUNCT
ejde-885	13	1	doing	do	VERB
ejde-885	13	2	so	so	ADV
ejde-885	13	3	involves	involve	VERB
ejde-885	13	4	creating	create	VERB
ejde-885	13	5	mathematical	mathematical	ADJ
ejde-885	13	6	equations	equation	NOUN
ejde-885	13	7	and	and	CCONJ
ejde-885	13	8	simulations	simulation	NOUN
ejde-885	13	9	that	that	PRON
ejde-885	13	10	capture	capture	VERB
ejde-885	13	11	the	the	DET
ejde-885	13	12	dynamics	dynamic	NOUN
ejde-885	13	13	of	of	ADP
ejde-885	13	14	disease	disease	NOUN
ejde-885	13	15	transmission	transmission	NOUN
ejde-885	13	16	and	and	CCONJ
ejde-885	13	17	their	their	PRON
ejde-885	13	18	impact	impact	NOUN
ejde-885	13	19	on	on	ADP
ejde-885	13	20	populations	population	NOUN
ejde-885	13	21	.	.	PUNCT
ejde-885	14	1	by	by	ADP
ejde-885	14	2	incorporating	incorporate	VERB
ejde-885	14	3	factors	factor	NOUN
ejde-885	14	4	such	such	ADJ
ejde-885	14	5	as	as	ADP
ejde-885	14	6	population	population	NOUN
ejde-885	14	7	size	size	NOUN
ejde-885	14	8	,	,	PUNCT
ejde-885	14	9	contact	contact	NOUN
ejde-885	14	10	rates	rate	NOUN
ejde-885	14	11	,	,	PUNCT
ejde-885	14	12	disease	disease	NOUN
ejde-885	14	13	parameters	parameter	NOUN
ejde-885	14	14	,	,	PUNCT
ejde-885	14	15	and	and	CCONJ
ejde-885	14	16	intervention	intervention	NOUN
ejde-885	14	17	strategies	strategy	NOUN
ejde-885	14	18	,	,	PUNCT
ejde-885	14	19	mathematical	mathematical	ADJ
ejde-885	14	20	modeling	modeling	NOUN
ejde-885	14	21	can	can	AUX
ejde-885	14	22	investigate	investigate	VERB
ejde-885	14	23	potential	potential	ADJ
ejde-885	14	24	scenarios	scenario	NOUN
ejde-885	14	25	to	to	PART
ejde-885	14	26	help	help	VERB
ejde-885	14	27	inform	inform	VERB
ejde-885	14	28	public	public	ADJ
ejde-885	14	29	health	health	NOUN
ejde-885	14	30	decisions	decision	NOUN
ejde-885	14	31	.	.	PUNCT
ejde-885	15	1	these	these	DET
ejde-885	15	2	models	model	NOUN
ejde-885	15	3	can	can	AUX
ejde-885	15	4	estimate	estimate	VERB
ejde-885	15	5	the	the	DET
ejde-885	15	6	future	future	ADJ
ejde-885	15	7	course	course	NOUN
ejde-885	15	8	of	of	ADP
ejde-885	15	9	an	an	DET
ejde-885	15	10	outbreak	outbreak	NOUN
ejde-885	15	11	,	,	PUNCT
ejde-885	15	12	evaluate	evaluate	VERB
ejde-885	15	13	the	the	DET
ejde-885	15	14	effectiveness	effectiveness	NOUN
ejde-885	15	15	of	of	ADP
ejde-885	15	16	various	various	ADJ
ejde-885	15	17	interventions	intervention	NOUN
ejde-885	15	18	,	,	PUNCT
ejde-885	15	19	and	and	CCONJ
ejde-885	15	20	assess	assess	VERB
ejde-885	15	21	the	the	DET
ejde-885	15	22	potential	potential	ADJ
ejde-885	15	23	impact	impact	NOUN
ejde-885	15	24	of	of	ADP
ejde-885	15	25	policy	policy	NOUN
ejde-885	15	26	measures	measure	NOUN
ejde-885	15	27	.	.	PUNCT
ejde-885	16	1	they	they	PRON
ejde-885	16	2	allow	allow	VERB
ejde-885	16	3	researchers	researcher	NOUN
ejde-885	16	4	and	and	CCONJ
ejde-885	16	5	policymakers	policymaker	NOUN
ejde-885	16	6	to	to	PART
ejde-885	16	7	explore	explore	VERB
ejde-885	16	8	different	different	ADJ
ejde-885	16	9	strategies	strategy	NOUN
ejde-885	16	10	and	and	CCONJ
ejde-885	16	11	make	make	VERB
ejde-885	16	12	evidence	evidence	NOUN
ejde-885	16	13	-	-	PUNCT
ejde-885	16	14	based	base	VERB
ejde-885	16	15	decisions	decision	NOUN
ejde-885	16	16	to	to	PART
ejde-885	16	17	control	control	VERB
ejde-885	16	18	and	and	CCONJ
ejde-885	16	19	mitigate	mitigate	VERB
ejde-885	16	20	the	the	DET
ejde-885	16	21	spread	spread	NOUN
ejde-885	16	22	of	of	ADP
ejde-885	16	23	infectious	infectious	ADJ
ejde-885	16	24	diseases	disease	NOUN
ejde-885	16	25	,	,	PUNCT
ejde-885	16	26	ultimately	ultimately	ADV
ejde-885	16	27	helping	help	VERB
ejde-885	16	28	to	to	PART
ejde-885	16	29	save	save	VERB
ejde-885	16	30	lives	life	NOUN
ejde-885	16	31	and	and	CCONJ
ejde-885	16	32	reduce	reduce	VERB
ejde-885	16	33	the	the	DET
ejde-885	16	34	burden	burden	NOUN
ejde-885	16	35	on	on	ADP
ejde-885	16	36	health	health	NOUN
ejde-885	16	37	care	care	NOUN
ejde-885	16	38	systems	system	NOUN
ejde-885	16	39	[	[	X
ejde-885	16	40	1	1	NUM
ejde-885	16	41	]	]	PUNCT
ejde-885	16	42	.	.	PUNCT
ejde-885	17	1	respiratory	respiratory	ADJ
ejde-885	17	2	illnesses	illness	NOUN
ejde-885	17	3	are	be	AUX
ejde-885	17	4	a	a	DET
ejde-885	17	5	significant	significant	ADJ
ejde-885	17	6	burden	burden	NOUN
ejde-885	17	7	to	to	ADP
ejde-885	17	8	modern	modern	ADJ
ejde-885	17	9	life	life	NOUN
ejde-885	17	10	and	and	CCONJ
ejde-885	17	11	a	a	DET
ejde-885	17	12	large	large	ADJ
ejde-885	17	13	cause	cause	NOUN
ejde-885	17	14	of	of	ADP
ejde-885	17	15	human	human	ADJ
ejde-885	17	16	death	death	NOUN
ejde-885	17	17	and	and	CCONJ
ejde-885	17	18	suffering	suffer	VERB
ejde-885	17	19	each	each	DET
ejde-885	17	20	year	year	NOUN
ejde-885	17	21	.	.	PUNCT
ejde-885	18	1	the	the	DET
ejde-885	18	2	covid-19	covid-19	PROPN
ejde-885	18	3	pandemic	pandemic	NOUN
ejde-885	18	4	proved	prove	VERB
ejde-885	18	5	that	that	SCONJ
ejde-885	18	6	these	these	DET
ejde-885	18	7	types	type	NOUN
ejde-885	18	8	of	of	ADP
ejde-885	18	9	illnesses	illness	NOUN
ejde-885	18	10	can	can	AUX
ejde-885	18	11	change	change	VERB
ejde-885	18	12	the	the	DET
ejde-885	18	13	way	way	NOUN
ejde-885	18	14	a	a	DET
ejde-885	18	15	society	society	NOUN
ejde-885	18	16	functions	function	NOUN
ejde-885	18	17	.	.	PUNCT
ejde-885	19	1	to	to	PART
ejde-885	19	2	stop	stop	VERB
ejde-885	19	3	the	the	DET
ejde-885	19	4	spread	spread	NOUN
ejde-885	19	5	and	and	CCONJ
ejde-885	19	6	deaths	death	NOUN
ejde-885	19	7	caused	cause	VERB
ejde-885	19	8	by	by	ADP
ejde-885	19	9	these	these	DET
ejde-885	19	10	diseases	disease	NOUN
ejde-885	19	11	,	,	PUNCT
ejde-885	19	12	efforts	effort	NOUN
ejde-885	19	13	to	to	PART
ejde-885	19	14	quickly	quickly	ADV
ejde-885	19	15	design	design	VERB
ejde-885	19	16	vaccines	vaccine	NOUN
ejde-885	19	17	for	for	ADP
ejde-885	19	18	these	these	DET
ejde-885	19	19	respiratory	respiratory	ADJ
ejde-885	19	20	illnesses	illness	NOUN
ejde-885	19	21	are	be	AUX
ejde-885	19	22	paramount	paramount	ADJ
ejde-885	19	23	.	.	PUNCT
ejde-885	20	1	as	as	SCONJ
ejde-885	20	2	shown	show	VERB
ejde-885	20	3	during	during	ADP
ejde-885	20	4	the	the	DET
ejde-885	20	5	response	response	NOUN
ejde-885	20	6	to	to	ADP
ejde-885	20	7	the	the	DET
ejde-885	20	8	covid-19	covid-19	PROPN
ejde-885	20	9	2020	2020	NUM
ejde-885	20	10	mathematics	mathematic	NOUN
ejde-885	20	11	subject	subject	ADJ
ejde-885	20	12	classification	classification	NOUN
ejde-885	20	13	.	.	PUNCT
ejde-885	21	1	34	34	NUM
ejde-885	21	2	-	-	SYM
ejde-885	21	3	11	11	NUM
ejde-885	21	4	,	,	PUNCT
ejde-885	21	5	00a71	00a71	NUM
ejde-885	21	6	,	,	PUNCT
ejde-885	21	7	92	92	NUM
ejde-885	21	8	-	-	SYM
ejde-885	21	9	10	10	NUM
ejde-885	21	10	.	.	PUNCT
ejde-885	22	1	key	key	ADJ
ejde-885	22	2	words	word	NOUN
ejde-885	22	3	and	and	CCONJ
ejde-885	22	4	phrases	phrase	NOUN
ejde-885	22	5	.	.	PUNCT
ejde-885	23	1	modeling	modeling	NOUN
ejde-885	23	2	;	;	PUNCT
ejde-885	23	3	clinical	clinical	ADJ
ejde-885	23	4	trials	trial	NOUN
ejde-885	23	5	;	;	PUNCT
ejde-885	23	6	vaccine	vaccine	NOUN
ejde-885	23	7	efficacy	efficacy	NOUN
ejde-885	23	8	;	;	PUNCT
ejde-885	23	9	reproductive	reproductive	ADJ
ejde-885	23	10	number	number	NOUN
ejde-885	23	11	.	.	PUNCT
ejde-885	24	1	©	©	ADP
ejde-885	24	2	2024	2024	NUM
ejde-885	24	3	this	this	DET
ejde-885	24	4	work	work	NOUN
ejde-885	24	5	is	be	AUX
ejde-885	24	6	licensed	license	VERB
ejde-885	24	7	under	under	ADP
ejde-885	24	8	a	a	DET
ejde-885	24	9	cc	cc	NOUN
ejde-885	24	10	by	by	ADP
ejde-885	24	11	4.0	4.0	NUM
ejde-885	24	12	license	license	NOUN
ejde-885	24	13	.	.	PUNCT
ejde-885	25	1	published	publish	VERB
ejde-885	25	2	august	august	PROPN
ejde-885	25	3	20	20	NUM
ejde-885	25	4	,	,	PUNCT
ejde-885	25	5	2024	2024	NUM
ejde-885	25	6	.	.	PUNCT
ejde-885	25	7	1	1	NUM
ejde-885	25	8	2	2	NUM
ejde-885	25	9	d.	d.	NOUN
ejde-885	25	10	gerberry	gerberry	NOUN
ejde-885	25	11	,	,	PUNCT
ejde-885	25	12	h.	h.	PROPN
ejde-885	25	13	joshi	joshi	PROPN
ejde-885	25	14	,	,	PUNCT
ejde-885	25	15	m.	m.	NOUN
ejde-885	25	16	peloquin	peloquin	NOUN
ejde-885	25	17	,	,	PUNCT
ejde-885	25	18	s.	s.	PROPN
ejde-885	25	19	vargas	vargas	PROPN
ejde-885	25	20	ejde-2022	ejde-2022	NOUN
ejde-885	25	21	/	/	SYM
ejde-885	25	22	conf/26	conf/26	NOUN
ejde-885	25	23	pandemic	pandemic	ADJ
ejde-885	25	24	,	,	PUNCT
ejde-885	25	25	the	the	DET
ejde-885	25	26	emergence	emergence	NOUN
ejde-885	25	27	of	of	ADP
ejde-885	25	28	mrna	mrna	PROPN
ejde-885	25	29	technology	technology	PROPN
ejde-885	25	30	allows	allow	VERB
ejde-885	25	31	for	for	SCONJ
ejde-885	25	32	vaccines	vaccine	NOUN
ejde-885	25	33	to	to	PART
ejde-885	25	34	be	be	AUX
ejde-885	25	35	formulated	formulate	VERB
ejde-885	25	36	much	much	ADV
ejde-885	25	37	faster	fast	ADV
ejde-885	25	38	than	than	ADP
ejde-885	25	39	ever	ever	ADV
ejde-885	25	40	before	before	ADP
ejde-885	25	41	[	[	X
ejde-885	25	42	2	2	NUM
ejde-885	25	43	,	,	PUNCT
ejde-885	25	44	3	3	NUM
ejde-885	25	45	,	,	PUNCT
ejde-885	25	46	4	4	NUM
ejde-885	25	47	,	,	PUNCT
ejde-885	25	48	5	5	NUM
ejde-885	25	49	,	,	PUNCT
ejde-885	25	50	6	6	NUM
ejde-885	25	51	]	]	PUNCT
ejde-885	25	52	.	.	PUNCT
ejde-885	26	1	with	with	ADP
ejde-885	26	2	the	the	DET
ejde-885	26	3	new	new	ADJ
ejde-885	26	4	found	find	VERB
ejde-885	26	5	ability	ability	NOUN
ejde-885	26	6	to	to	PART
ejde-885	26	7	develop	develop	VERB
ejde-885	26	8	vaccines	vaccine	NOUN
ejde-885	26	9	so	so	ADV
ejde-885	26	10	quickly	quickly	ADV
ejde-885	26	11	,	,	PUNCT
ejde-885	26	12	the	the	DET
ejde-885	26	13	time	time	NOUN
ejde-885	26	14	it	it	PRON
ejde-885	26	15	takes	take	VERB
ejde-885	26	16	to	to	PART
ejde-885	26	17	test	test	VERB
ejde-885	26	18	new	new	ADJ
ejde-885	26	19	vaccines	vaccine	NOUN
ejde-885	26	20	(	(	PUNCT
ejde-885	26	21	i.e.	i.e.	X
ejde-885	26	22	clinical	clinical	ADJ
ejde-885	26	23	trials	trial	NOUN
ejde-885	26	24	)	)	PUNCT
ejde-885	26	25	represents	represent	VERB
ejde-885	26	26	the	the	DET
ejde-885	26	27	major	major	ADJ
ejde-885	26	28	limitation	limitation	NOUN
ejde-885	26	29	to	to	ADP
ejde-885	26	30	the	the	DET
ejde-885	26	31	speed	speed	NOUN
ejde-885	26	32	with	with	ADP
ejde-885	26	33	which	which	PRON
ejde-885	26	34	society	society	NOUN
ejde-885	26	35	can	can	AUX
ejde-885	26	36	begin	begin	VERB
ejde-885	26	37	to	to	PART
ejde-885	26	38	immunize	immunize	VERB
ejde-885	26	39	its	its	PRON
ejde-885	26	40	population	population	NOUN
ejde-885	26	41	and	and	CCONJ
ejde-885	26	42	ultimately	ultimately	ADV
ejde-885	26	43	change	change	VERB
ejde-885	26	44	the	the	DET
ejde-885	26	45	course	course	NOUN
ejde-885	26	46	of	of	ADP
ejde-885	26	47	the	the	DET
ejde-885	26	48	next	next	ADJ
ejde-885	26	49	pandemic	pandemic	ADJ
ejde-885	26	50	[	[	X
ejde-885	26	51	7	7	NUM
ejde-885	26	52	,	,	PUNCT
ejde-885	26	53	8	8	NUM
ejde-885	26	54	,	,	PUNCT
ejde-885	26	55	9	9	NUM
ejde-885	26	56	,	,	PUNCT
ejde-885	26	57	10	10	NUM
ejde-885	26	58	]	]	PUNCT
ejde-885	26	59	.	.	PUNCT
ejde-885	27	1	of	of	ADP
ejde-885	27	2	course	course	ADV
ejde-885	27	3	,	,	PUNCT
ejde-885	27	4	it	it	PRON
ejde-885	27	5	is	be	AUX
ejde-885	27	6	important	important	ADJ
ejde-885	27	7	to	to	PART
ejde-885	27	8	note	note	VERB
ejde-885	27	9	that	that	PRON
ejde-885	27	10	vaccine	vaccine	NOUN
ejde-885	27	11	clinical	clinical	ADJ
ejde-885	27	12	trials	trial	NOUN
ejde-885	27	13	do	do	AUX
ejde-885	27	14	not	not	PART
ejde-885	27	15	occur	occur	VERB
ejde-885	27	16	in	in	ADP
ejde-885	27	17	a	a	DET
ejde-885	27	18	vacuum	vacuum	NOUN
ejde-885	27	19	but	but	CCONJ
ejde-885	27	20	rather	rather	ADV
ejde-885	27	21	involve	involve	VERB
ejde-885	27	22	individuals	individual	NOUN
ejde-885	27	23	(	(	PUNCT
ejde-885	27	24	both	both	CCONJ
ejde-885	27	25	in	in	ADP
ejde-885	27	26	the	the	DET
ejde-885	27	27	control	control	NOUN
ejde-885	27	28	and	and	CCONJ
ejde-885	27	29	treatment	treatment	NOUN
ejde-885	27	30	arms	arm	NOUN
ejde-885	27	31	of	of	ADP
ejde-885	27	32	the	the	DET
ejde-885	27	33	clinical	clinical	ADJ
ejde-885	27	34	trial	trial	NOUN
ejde-885	27	35	)	)	PUNCT
ejde-885	27	36	interacting	interact	VERB
ejde-885	27	37	with	with	ADP
ejde-885	27	38	the	the	DET
ejde-885	27	39	general	general	ADJ
ejde-885	27	40	population	population	NOUN
ejde-885	27	41	under	under	ADP
ejde-885	27	42	the	the	DET
ejde-885	27	43	current	current	ADJ
ejde-885	27	44	conditions	condition	NOUN
ejde-885	27	45	of	of	ADP
ejde-885	27	46	the	the	DET
ejde-885	27	47	epidemic	epidemic	NOUN
ejde-885	27	48	.	.	PUNCT
ejde-885	28	1	therefore	therefore	ADV
ejde-885	28	2	,	,	PUNCT
ejde-885	28	3	the	the	DET
ejde-885	28	4	conditions	condition	NOUN
ejde-885	28	5	of	of	ADP
ejde-885	28	6	the	the	DET
ejde-885	28	7	epidemic	epidemic	NOUN
ejde-885	28	8	will	will	AUX
ejde-885	28	9	always	always	ADV
ejde-885	28	10	impact	impact	VERB
ejde-885	28	11	the	the	DET
ejde-885	28	12	clinical	clinical	ADJ
ejde-885	28	13	trial	trial	NOUN
ejde-885	28	14	.	.	PUNCT
ejde-885	29	1	for	for	ADP
ejde-885	29	2	example	example	NOUN
ejde-885	29	3	,	,	PUNCT
ejde-885	29	4	a	a	DET
ejde-885	29	5	clinical	clinical	ADJ
ejde-885	29	6	trial	trial	NOUN
ejde-885	29	7	will	will	AUX
ejde-885	29	8	require	require	VERB
ejde-885	29	9	a	a	DET
ejde-885	29	10	longer	long	ADJ
ejde-885	29	11	period	period	NOUN
ejde-885	29	12	to	to	PART
ejde-885	29	13	demonstrate	demonstrate	VERB
ejde-885	29	14	a	a	DET
ejde-885	29	15	statistically	statistically	ADV
ejde-885	29	16	significant	significant	ADJ
ejde-885	29	17	protective	protective	ADJ
ejde-885	29	18	effect	effect	NOUN
ejde-885	29	19	if	if	SCONJ
ejde-885	29	20	conditions	condition	NOUN
ejde-885	29	21	are	be	AUX
ejde-885	29	22	such	such	ADJ
ejde-885	29	23	that	that	DET
ejde-885	29	24	disease	disease	NOUN
ejde-885	29	25	incidence	incidence	NOUN
ejde-885	29	26	is	be	AUX
ejde-885	29	27	very	very	ADV
ejde-885	29	28	low	low	ADJ
ejde-885	29	29	in	in	ADP
ejde-885	29	30	the	the	DET
ejde-885	29	31	general	general	ADJ
ejde-885	29	32	population	population	NOUN
ejde-885	29	33	.	.	PUNCT
ejde-885	30	1	if	if	SCONJ
ejde-885	30	2	a	a	DET
ejde-885	30	3	clinical	clinical	ADJ
ejde-885	30	4	trial	trial	NOUN
ejde-885	30	5	is	be	AUX
ejde-885	30	6	conducted	conduct	VERB
ejde-885	30	7	while	while	SCONJ
ejde-885	30	8	disease	disease	NOUN
ejde-885	30	9	incidence	incidence	NOUN
ejde-885	30	10	is	be	AUX
ejde-885	30	11	very	very	ADV
ejde-885	30	12	high	high	ADJ
ejde-885	30	13	,	,	PUNCT
ejde-885	30	14	a	a	DET
ejde-885	30	15	shorter	short	ADJ
ejde-885	30	16	period	period	NOUN
ejde-885	30	17	of	of	ADP
ejde-885	30	18	time	time	NOUN
ejde-885	30	19	will	will	AUX
ejde-885	30	20	be	be	AUX
ejde-885	30	21	needed	need	VERB
ejde-885	30	22	to	to	PART
ejde-885	30	23	establish	establish	VERB
ejde-885	30	24	protection	protection	NOUN
ejde-885	30	25	.	.	PUNCT
ejde-885	31	1	complicating	complicate	VERB
ejde-885	31	2	matters	matter	NOUN
ejde-885	31	3	further	far	ADV
ejde-885	31	4	,	,	PUNCT
ejde-885	31	5	vaccination	vaccination	NOUN
ejde-885	31	6	is	be	AUX
ejde-885	31	7	typically	typically	ADV
ejde-885	31	8	not	not	PART
ejde-885	31	9	tested	test	VERB
ejde-885	31	10	and	and	CCONJ
ejde-885	31	11	rolled	roll	VERB
ejde-885	31	12	out	out	ADP
ejde-885	31	13	for	for	ADP
ejde-885	31	14	the	the	DET
ejde-885	31	15	entire	entire	ADJ
ejde-885	31	16	population	population	NOUN
ejde-885	31	17	at	at	ADP
ejde-885	31	18	the	the	DET
ejde-885	31	19	same	same	ADJ
ejde-885	31	20	time	time	NOUN
ejde-885	31	21	.	.	PUNCT
ejde-885	32	1	with	with	ADP
ejde-885	32	2	covid	covid	PROPN
ejde-885	32	3	vaccines	vaccine	NOUN
ejde-885	32	4	for	for	ADP
ejde-885	32	5	example	example	NOUN
ejde-885	32	6	,	,	PUNCT
ejde-885	32	7	clinical	clinical	ADJ
ejde-885	32	8	trials	trial	NOUN
ejde-885	32	9	for	for	ADP
ejde-885	32	10	adults	adult	NOUN
ejde-885	32	11	were	be	AUX
ejde-885	32	12	conducted	conduct	VERB
ejde-885	32	13	first	first	ADV
ejde-885	32	14	followed	follow	VERB
ejde-885	32	15	by	by	ADP
ejde-885	32	16	children	child	NOUN
ejde-885	32	17	.	.	PUNCT
ejde-885	33	1	therefore	therefore	ADV
ejde-885	33	2	,	,	PUNCT
ejde-885	33	3	the	the	DET
ejde-885	33	4	clinical	clinical	ADJ
ejde-885	33	5	trial	trial	NOUN
ejde-885	33	6	for	for	ADP
ejde-885	33	7	vaccines	vaccine	NOUN
ejde-885	33	8	in	in	ADP
ejde-885	33	9	children	child	NOUN
ejde-885	33	10	occurred	occur	VERB
ejde-885	33	11	at	at	ADP
ejde-885	33	12	the	the	DET
ejde-885	33	13	same	same	ADJ
ejde-885	33	14	time	time	NOUN
ejde-885	33	15	that	that	PRON
ejde-885	33	16	vaccination	vaccination	NOUN
ejde-885	33	17	was	be	AUX
ejde-885	33	18	available	available	ADJ
ejde-885	33	19	to	to	ADP
ejde-885	33	20	adults	adult	NOUN
ejde-885	33	21	in	in	ADP
ejde-885	33	22	the	the	DET
ejde-885	33	23	general	general	ADJ
ejde-885	33	24	population	population	NOUN
ejde-885	33	25	[	[	X
ejde-885	33	26	11	11	NUM
ejde-885	33	27	,	,	PUNCT
ejde-885	33	28	12	12	NUM
ejde-885	33	29	]	]	PUNCT
ejde-885	33	30	.	.	PUNCT
ejde-885	34	1	in	in	ADP
ejde-885	34	2	this	this	DET
ejde-885	34	3	modeling	modeling	NOUN
ejde-885	34	4	work	work	NOUN
ejde-885	34	5	,	,	PUNCT
ejde-885	34	6	our	our	PRON
ejde-885	34	7	goal	goal	NOUN
ejde-885	34	8	is	be	AUX
ejde-885	34	9	to	to	PART
ejde-885	34	10	examine	examine	VERB
ejde-885	34	11	the	the	DET
ejde-885	34	12	interaction	interaction	NOUN
ejde-885	34	13	between	between	ADP
ejde-885	34	14	the	the	DET
ejde-885	34	15	epidemiological	epidemiological	ADJ
ejde-885	34	16	dynamics	dynamic	NOUN
ejde-885	34	17	of	of	ADP
ejde-885	34	18	a	a	DET
ejde-885	34	19	disease	disease	NOUN
ejde-885	34	20	and	and	CCONJ
ejde-885	34	21	the	the	DET
ejde-885	34	22	dynamics	dynamic	NOUN
ejde-885	34	23	of	of	ADP
ejde-885	34	24	a	a	DET
ejde-885	34	25	vaccine	vaccine	NOUN
ejde-885	34	26	clinical	clinical	ADJ
ejde-885	34	27	trial	trial	NOUN
ejde-885	34	28	.	.	PUNCT
ejde-885	35	1	while	while	SCONJ
ejde-885	35	2	motivated	motivate	VERB
ejde-885	35	3	by	by	ADP
ejde-885	35	4	the	the	DET
ejde-885	35	5	covid-19	covid-19	PROPN
ejde-885	35	6	pandemic	pandemic	NOUN
ejde-885	35	7	,	,	PUNCT
ejde-885	35	8	our	our	PRON
ejde-885	35	9	work	work	NOUN
ejde-885	35	10	generalizes	generalize	VERB
ejde-885	35	11	to	to	PART
ejde-885	35	12	study	study	VERB
ejde-885	35	13	a	a	DET
ejde-885	35	14	pandemic	pandemic	NOUN
ejde-885	35	15	of	of	ADP
ejde-885	35	16	a	a	DET
ejde-885	35	17	general	general	ADJ
ejde-885	35	18	respiratory	respiratory	ADJ
ejde-885	35	19	disease	disease	NOUN
ejde-885	35	20	;	;	PUNCT
ejde-885	35	21	as	as	SCONJ
ejde-885	35	22	respiratory	respiratory	ADJ
ejde-885	35	23	infections	infection	NOUN
ejde-885	35	24	(	(	PUNCT
ejde-885	35	25	other	other	ADJ
ejde-885	35	26	corona	corona	NOUN
ejde-885	35	27	viruses	virus	NOUN
ejde-885	35	28	,	,	PUNCT
ejde-885	35	29	avian	avian	ADJ
ejde-885	35	30	influenza	influenza	NOUN
ejde-885	35	31	,	,	PUNCT
ejde-885	35	32	h1n5	h1n5	PROPN
ejde-885	35	33	,	,	PUNCT
ejde-885	35	34	sars	sar	NOUN
ejde-885	35	35	,	,	PUNCT
ejde-885	35	36	etc	etc	X
ejde-885	35	37	.	.	X
ejde-885	35	38	)	)	PUNCT
ejde-885	35	39	share	share	VERB
ejde-885	35	40	many	many	ADJ
ejde-885	35	41	characteristics	characteristic	NOUN
ejde-885	35	42	and	and	CCONJ
ejde-885	35	43	all	all	PRON
ejde-885	35	44	have	have	VERB
ejde-885	35	45	the	the	DET
ejde-885	35	46	potential	potential	NOUN
ejde-885	35	47	for	for	ADP
ejde-885	35	48	causing	cause	VERB
ejde-885	35	49	future	future	ADJ
ejde-885	35	50	pandemics	pandemic	NOUN
ejde-885	35	51	.	.	PUNCT
ejde-885	36	1	2	2	X
ejde-885	36	2	.	.	X
ejde-885	36	3	epidemiological	epidemiological	ADJ
ejde-885	36	4	model	model	NOUN
ejde-885	36	5	we	we	PRON
ejde-885	36	6	use	use	VERB
ejde-885	36	7	the	the	DET
ejde-885	36	8	classical	classical	ADJ
ejde-885	36	9	seir	seir	NOUN
ejde-885	36	10	framework	framework	NOUN
ejde-885	36	11	to	to	PART
ejde-885	36	12	model	model	VERB
ejde-885	36	13	a	a	DET
ejde-885	36	14	general	general	ADJ
ejde-885	36	15	respiratory	respiratory	ADJ
ejde-885	36	16	infection	infection	NOUN
ejde-885	36	17	,	,	PUNCT
ejde-885	36	18	where	where	SCONJ
ejde-885	36	19	individuals	individual	NOUN
ejde-885	36	20	progress	progress	VERB
ejde-885	36	21	from	from	ADP
ejde-885	36	22	being	be	AUX
ejde-885	36	23	susceptible	susceptible	ADJ
ejde-885	36	24	(	(	PUNCT
ejde-885	36	25	s	s	NOUN
ejde-885	36	26	)	)	PUNCT
ejde-885	36	27	,	,	PUNCT
ejde-885	36	28	exposed	expose	VERB
ejde-885	36	29	(	(	PUNCT
ejde-885	36	30	e	e	NOUN
ejde-885	36	31	)	)	PUNCT
ejde-885	36	32	in	in	ADP
ejde-885	36	33	which	which	PRON
ejde-885	36	34	individuals	individual	NOUN
ejde-885	36	35	have	have	AUX
ejde-885	36	36	contracted	contract	VERB
ejde-885	36	37	the	the	DET
ejde-885	36	38	disease	disease	NOUN
ejde-885	36	39	but	but	CCONJ
ejde-885	36	40	are	be	AUX
ejde-885	36	41	not	not	PART
ejde-885	36	42	yet	yet	ADV
ejde-885	36	43	able	able	ADJ
ejde-885	36	44	to	to	PART
ejde-885	36	45	transmit	transmit	VERB
ejde-885	36	46	it	it	PRON
ejde-885	36	47	,	,	PUNCT
ejde-885	36	48	infectious	infectious	ADJ
ejde-885	36	49	(	(	PUNCT
ejde-885	36	50	i	i	NOUN
ejde-885	36	51	)	)	PUNCT
ejde-885	36	52	,	,	PUNCT
ejde-885	36	53	and	and	CCONJ
ejde-885	36	54	recovered	recover	VERB
ejde-885	36	55	(	(	PUNCT
ejde-885	36	56	r	r	NOUN
ejde-885	36	57	)	)	PUNCT
ejde-885	36	58	.	.	PUNCT
ejde-885	37	1	for	for	ADP
ejde-885	37	2	simplicity	simplicity	NOUN
ejde-885	37	3	,	,	PUNCT
ejde-885	37	4	we	we	PRON
ejde-885	37	5	assume	assume	VERB
ejde-885	37	6	permanent	permanent	ADJ
ejde-885	37	7	immunity	immunity	NOUN
ejde-885	37	8	after	after	ADP
ejde-885	37	9	recovery	recovery	NOUN
ejde-885	37	10	.	.	PUNCT
ejde-885	38	1	as	as	SCONJ
ejde-885	38	2	we	we	PRON
ejde-885	38	3	look	look	VERB
ejde-885	38	4	to	to	PART
ejde-885	38	5	examine	examine	VERB
ejde-885	38	6	the	the	DET
ejde-885	38	7	effect	effect	NOUN
ejde-885	38	8	of	of	ADP
ejde-885	38	9	vaccines	vaccine	NOUN
ejde-885	38	10	being	be	AUX
ejde-885	38	11	available	available	ADJ
ejde-885	38	12	to	to	ADP
ejde-885	38	13	adults	adult	NOUN
ejde-885	38	14	and	and	CCONJ
ejde-885	38	15	children	child	NOUN
ejde-885	38	16	at	at	ADP
ejde-885	38	17	different	different	ADJ
ejde-885	38	18	times	time	NOUN
ejde-885	38	19	,	,	PUNCT
ejde-885	38	20	we	we	PRON
ejde-885	38	21	separate	separate	VERB
ejde-885	38	22	each	each	DET
ejde-885	38	23	epidemiological	epidemiological	ADJ
ejde-885	38	24	compartment	compartment	NOUN
ejde-885	38	25	into	into	ADP
ejde-885	38	26	two	two	NUM
ejde-885	38	27	classes	class	NOUN
ejde-885	38	28	based	base	VERB
ejde-885	38	29	on	on	ADP
ejde-885	38	30	age	age	NOUN
ejde-885	38	31	(	(	PUNCT
ejde-885	38	32	a	a	PRON
ejde-885	38	33	for	for	ADP
ejde-885	38	34	adults	adult	NOUN
ejde-885	38	35	,	,	PUNCT
ejde-885	38	36	k	k	X
ejde-885	38	37	for	for	ADP
ejde-885	38	38	children	child	NOUN
ejde-885	38	39	or	or	CCONJ
ejde-885	38	40	“	"	PUNCT
ejde-885	38	41	kids	kid	NOUN
ejde-885	38	42	”	"	PUNCT
ejde-885	38	43	)	)	PUNCT
ejde-885	38	44	.	.	PUNCT
ejde-885	39	1	therefore	therefore	ADV
ejde-885	39	2	,	,	PUNCT
ejde-885	39	3	the	the	DET
ejde-885	39	4	model	model	NOUN
ejde-885	39	5	consists	consist	VERB
ejde-885	39	6	of	of	ADP
ejde-885	39	7	the	the	DET
ejde-885	39	8	state	state	NOUN
ejde-885	39	9	variables	variable	NOUN
ejde-885	39	10	sa	sa	PROPN
ejde-885	39	11	,	,	PUNCT
ejde-885	39	12	ea	ea	PROPN
ejde-885	39	13	,	,	PUNCT
ejde-885	39	14	ia	ia	PROPN
ejde-885	39	15	,	,	PUNCT
ejde-885	39	16	and	and	CCONJ
ejde-885	39	17	ra	ra	PROPN
ejde-885	39	18	for	for	ADP
ejde-885	39	19	susceptible	susceptible	ADJ
ejde-885	39	20	,	,	PUNCT
ejde-885	39	21	exposed	expose	VERB
ejde-885	39	22	,	,	PUNCT
ejde-885	39	23	infectious	infectious	ADJ
ejde-885	39	24	,	,	PUNCT
ejde-885	39	25	and	and	CCONJ
ejde-885	39	26	recovered	recover	VERB
ejde-885	39	27	adults	adult	NOUN
ejde-885	39	28	;	;	PUNCT
ejde-885	39	29	sk	sk	INTJ
ejde-885	39	30	,	,	PUNCT
ejde-885	39	31	ek	ek	PROPN
ejde-885	39	32	,	,	PUNCT
ejde-885	39	33	ik	ik	PROPN
ejde-885	39	34	,	,	PUNCT
ejde-885	39	35	and	and	CCONJ
ejde-885	39	36	rk	rk	NOUN
ejde-885	39	37	for	for	ADP
ejde-885	39	38	susceptible	susceptible	ADJ
ejde-885	39	39	,	,	PUNCT
ejde-885	39	40	exposed	expose	VERB
ejde-885	39	41	,	,	PUNCT
ejde-885	39	42	infectious	infectious	ADJ
ejde-885	39	43	,	,	PUNCT
ejde-885	39	44	and	and	CCONJ
ejde-885	39	45	recovered	recovered	ADJ
ejde-885	39	46	kids	kid	NOUN
ejde-885	39	47	;	;	PUNCT
ejde-885	39	48	and	and	CCONJ
ejde-885	39	49	is	be	AUX
ejde-885	39	50	given	give	VERB
ejde-885	39	51	by	by	ADP
ejde-885	39	52	the	the	DET
ejde-885	39	53	equations	equation	NOUN
ejde-885	39	54	s′	s′	VERB
ejde-885	39	55	a	a	DET
ejde-885	39	56	=	=	PUNCT
ejde-885	39	57	−sa	−sa	PROPN
ejde-885	39	58	(	(	PUNCT
ejde-885	39	59	pβaa	pβaa	NOUN
ejde-885	39	60	ia	ia	PROPN
ejde-885	39	61	na	na	ADP
ejde-885	39	62	+	+	CCONJ
ejde-885	39	63	pβka	pβka	X
ejde-885	39	64	ik	ik	PROPN
ejde-885	39	65	nk	nk	PROPN
ejde-885	39	66	)	)	PUNCT
ejde-885	39	67	,	,	PUNCT
ejde-885	39	68	(	(	PUNCT
ejde-885	39	69	2.1	2.1	NUM
ejde-885	39	70	)	)	PUNCT
ejde-885	39	71	e′	e′	NOUN
ejde-885	39	72	a	a	DET
ejde-885	39	73	=	=	X
ejde-885	39	74	sa	sa	PROPN
ejde-885	39	75	(	(	PUNCT
ejde-885	39	76	pβaa	pβaa	NOUN
ejde-885	39	77	ia	ia	PROPN
ejde-885	39	78	na	na	ADP
ejde-885	39	79	+	+	CCONJ
ejde-885	39	80	pβka	pβka	X
ejde-885	39	81	ik	ik	PROPN
ejde-885	39	82	nk	nk	PROPN
ejde-885	39	83	)	)	PUNCT
ejde-885	39	84	−	−	PROPN
ejde-885	39	85	γ1ea	γ1ea	PROPN
ejde-885	39	86	,	,	PUNCT
ejde-885	39	87	(	(	PUNCT
ejde-885	39	88	2.2	2.2	NUM
ejde-885	39	89	)	)	PUNCT
ejde-885	40	1	i	i	PRON
ejde-885	40	2	′a	′a	ADV
ejde-885	40	3	=	=	PUNCT
ejde-885	40	4	γ1ea	γ1ea	PUNCT
ejde-885	40	5	−	−	PROPN
ejde-885	40	6	ρ1ia	ρ1ia	PUNCT
ejde-885	40	7	−	−	PROPN
ejde-885	40	8	δ1ia	δ1ia	NOUN
ejde-885	40	9	,	,	PUNCT
ejde-885	40	10	(	(	PUNCT
ejde-885	40	11	2.3	2.3	NUM
ejde-885	40	12	)	)	PUNCT
ejde-885	40	13	r′	r′	NOUN
ejde-885	40	14	a	a	DET
ejde-885	40	15	=	=	NOUN
ejde-885	40	16	ρ1ia	ρ1ia	NOUN
ejde-885	40	17	,	,	PUNCT
ejde-885	40	18	(	(	PUNCT
ejde-885	40	19	2.4	2.4	NUM
ejde-885	40	20	)	)	PUNCT
ejde-885	40	21	s′	s′	VERB
ejde-885	40	22	k	k	PROPN
ejde-885	40	23	=	=	SYM
ejde-885	40	24	−sk	−sk	PROPN
ejde-885	40	25	(	(	PUNCT
ejde-885	40	26	pβkk	pβkk	VERB
ejde-885	40	27	ik	ik	PROPN
ejde-885	40	28	nk	nk	PROPN
ejde-885	40	29	+	+	PROPN
ejde-885	40	30	pβak	pβak	PROPN
ejde-885	40	31	ia	ia	PROPN
ejde-885	40	32	na	na	PROPN
ejde-885	40	33	)	)	PUNCT
ejde-885	40	34	,	,	PUNCT
ejde-885	40	35	(	(	PUNCT
ejde-885	40	36	2.5	2.5	NUM
ejde-885	40	37	)	)	PUNCT
ejde-885	40	38	e′	e′	X
ejde-885	41	1	k	k	X
ejde-885	41	2	=	=	PRON
ejde-885	41	3	sk	sk	INTJ
ejde-885	41	4	(	(	PUNCT
ejde-885	41	5	pβkk	pβkk	PROPN
ejde-885	41	6	ik	ik	PROPN
ejde-885	41	7	nk	nk	PROPN
ejde-885	41	8	+	+	PROPN
ejde-885	41	9	pβak	pβak	PROPN
ejde-885	41	10	ia	ia	PROPN
ejde-885	41	11	na	na	INTJ
ejde-885	41	12	)	)	PUNCT
ejde-885	41	13	−	−	PRON
ejde-885	41	14	γ2ek	γ2ek	PUNCT
ejde-885	41	15	,	,	PUNCT
ejde-885	41	16	(	(	PUNCT
ejde-885	41	17	2.6	2.6	NUM
ejde-885	41	18	)	)	PUNCT
ejde-885	41	19	i	i	PRON
ejde-885	41	20	′k	′k	ADV
ejde-885	41	21	=	=	PUNCT
ejde-885	41	22	γ2ek	γ2ek	PUNCT
ejde-885	41	23	−	−	X
ejde-885	41	24	ρ2ik	ρ2ik	SYM
ejde-885	41	25	−	−	PROPN
ejde-885	41	26	δ2ik	δ2ik	PUNCT
ejde-885	41	27	,	,	PUNCT
ejde-885	41	28	(	(	PUNCT
ejde-885	41	29	2.7	2.7	NUM
ejde-885	41	30	)	)	PUNCT
ejde-885	41	31	ejde-2024	ejde-2024	ADJ
ejde-885	41	32	/	/	SYM
ejde-885	41	33	conf/27	conf/27	NOUN
ejde-885	41	34	clinical	clinical	ADJ
ejde-885	41	35	trial	trial	NOUN
ejde-885	41	36	modeling	model	VERB
ejde-885	41	37	3	3	NUM
ejde-885	41	38	r′	r′	NOUN
ejde-885	41	39	k	k	X
ejde-885	41	40	=	=	PUNCT
ejde-885	41	41	ρ2ik	ρ2ik	PROPN
ejde-885	41	42	,	,	PUNCT
ejde-885	41	43	(	(	PUNCT
ejde-885	41	44	2.8	2.8	NUM
ejde-885	41	45	)	)	PUNCT
ejde-885	41	46	where	where	SCONJ
ejde-885	41	47	na	na	ADP
ejde-885	41	48	=	=	SYM
ejde-885	41	49	sa	sa	PROPN
ejde-885	41	50	+	+	PROPN
ejde-885	41	51	ea	ea	PROPN
ejde-885	41	52	+	+	CCONJ
ejde-885	41	53	ia	ia	PROPN
ejde-885	41	54	+	+	CCONJ
ejde-885	41	55	ra	ra	PROPN
ejde-885	41	56	is	be	AUX
ejde-885	41	57	the	the	DET
ejde-885	41	58	total	total	ADJ
ejde-885	41	59	population	population	NOUN
ejde-885	41	60	of	of	ADP
ejde-885	41	61	adults	adult	NOUN
ejde-885	41	62	and	and	CCONJ
ejde-885	41	63	nk	nk	NOUN
ejde-885	41	64	=	=	NOUN
ejde-885	41	65	sk	sk	PROPN
ejde-885	41	66	+	+	CCONJ
ejde-885	41	67	ek	ek	PROPN
ejde-885	41	68	+	+	CCONJ
ejde-885	41	69	ik	ik	PROPN
ejde-885	42	1	+	+	CCONJ
ejde-885	42	2	rk	rk	NOUN
ejde-885	42	3	is	be	AUX
ejde-885	42	4	the	the	DET
ejde-885	42	5	total	total	ADJ
ejde-885	42	6	population	population	NOUN
ejde-885	42	7	of	of	ADP
ejde-885	42	8	kids	kid	NOUN
ejde-885	42	9	.	.	PUNCT
ejde-885	43	1	exposed	expose	VERB
ejde-885	43	2	adults	adult	NOUN
ejde-885	43	3	and	and	CCONJ
ejde-885	43	4	kids	kid	NOUN
ejde-885	43	5	progress	progress	VERB
ejde-885	43	6	to	to	PART
ejde-885	43	7	become	become	VERB
ejde-885	43	8	infectious	infectious	ADJ
ejde-885	43	9	at	at	ADP
ejde-885	43	10	rates	rate	NOUN
ejde-885	43	11	γ1	γ1	NOUN
ejde-885	43	12	and	and	CCONJ
ejde-885	43	13	γ2	γ2	NOUN
ejde-885	43	14	,	,	PUNCT
ejde-885	43	15	respectively	respectively	ADV
ejde-885	43	16	,	,	PUNCT
ejde-885	43	17	and	and	CCONJ
ejde-885	43	18	recover	recover	VERB
ejde-885	43	19	from	from	ADP
ejde-885	43	20	infection	infection	NOUN
ejde-885	43	21	at	at	ADP
ejde-885	43	22	rates	rate	NOUN
ejde-885	43	23	ρ1	ρ1	NOUN
ejde-885	43	24	and	and	CCONJ
ejde-885	43	25	ρ2	ρ2	NOUN
ejde-885	43	26	,	,	PUNCT
ejde-885	43	27	respectively	respectively	ADV
ejde-885	43	28	.	.	PUNCT
ejde-885	44	1	disease	disease	NOUN
ejde-885	44	2	-	-	PUNCT
ejde-885	44	3	induced	induce	VERB
ejde-885	44	4	mortality	mortality	NOUN
ejde-885	44	5	occurs	occur	VERB
ejde-885	44	6	at	at	ADP
ejde-885	44	7	rates	rate	NOUN
ejde-885	44	8	δ1	δ1	NOUN
ejde-885	44	9	and	and	CCONJ
ejde-885	44	10	δ2	δ2	VERB
ejde-885	44	11	for	for	ADP
ejde-885	44	12	adults	adult	NOUN
ejde-885	44	13	and	and	CCONJ
ejde-885	44	14	children	child	NOUN
ejde-885	44	15	,	,	PUNCT
ejde-885	44	16	respectively	respectively	ADV
ejde-885	44	17	.	.	PUNCT
ejde-885	45	1	as	as	SCONJ
ejde-885	45	2	we	we	PRON
ejde-885	45	3	are	be	AUX
ejde-885	45	4	modeling	model	VERB
ejde-885	45	5	respiratory	respiratory	ADJ
ejde-885	45	6	diseases	disease	NOUN
ejde-885	45	7	with	with	ADP
ejde-885	45	8	fast	fast	ADJ
ejde-885	45	9	epidemiological	epidemiological	ADJ
ejde-885	45	10	dynamics	dynamic	NOUN
ejde-885	45	11	(	(	PUNCT
ejde-885	45	12	on	on	ADP
ejde-885	45	13	the	the	DET
ejde-885	45	14	order	order	NOUN
ejde-885	45	15	of	of	ADP
ejde-885	45	16	weeks	week	NOUN
ejde-885	45	17	or	or	CCONJ
ejde-885	45	18	months	month	NOUN
ejde-885	45	19	)	)	PUNCT
ejde-885	45	20	,	,	PUNCT
ejde-885	45	21	we	we	PRON
ejde-885	45	22	ignore	ignore	VERB
ejde-885	45	23	demographics	demographic	NOUN
ejde-885	45	24	and	and	CCONJ
ejde-885	45	25	assume	assume	VERB
ejde-885	45	26	a	a	DET
ejde-885	45	27	fixed	fixed	ADJ
ejde-885	45	28	population	population	NOUN
ejde-885	45	29	.	.	PUNCT
ejde-885	46	1	in	in	ADP
ejde-885	46	2	other	other	ADJ
ejde-885	46	3	words	word	NOUN
ejde-885	46	4	,	,	PUNCT
ejde-885	46	5	we	we	PRON
ejde-885	46	6	do	do	AUX
ejde-885	46	7	not	not	PART
ejde-885	46	8	consider	consider	VERB
ejde-885	46	9	birth	birth	NOUN
ejde-885	46	10	/	/	SYM
ejde-885	46	11	recruitment	recruitment	NOUN
ejde-885	46	12	rates	rate	NOUN
ejde-885	46	13	into	into	ADP
ejde-885	46	14	the	the	DET
ejde-885	46	15	population	population	NOUN
ejde-885	46	16	or	or	CCONJ
ejde-885	46	17	background	background	NOUN
ejde-885	46	18	mortality	mortality	NOUN
ejde-885	46	19	rates	rate	NOUN
ejde-885	46	20	.	.	PUNCT
ejde-885	47	1	transmission	transmission	NOUN
ejde-885	47	2	occurs	occur	VERB
ejde-885	47	3	both	both	CCONJ
ejde-885	47	4	within	within	ADP
ejde-885	47	5	and	and	CCONJ
ejde-885	47	6	outside	outside	ADJ
ejde-885	47	7	age	age	NOUN
ejde-885	47	8	groups	group	NOUN
ejde-885	47	9	at	at	ADP
ejde-885	47	10	contact	contact	NOUN
ejde-885	47	11	rates	rate	NOUN
ejde-885	47	12	of	of	ADP
ejde-885	47	13	βaa	βaa	NOUN
ejde-885	47	14	between	between	ADP
ejde-885	47	15	infected	infected	ADJ
ejde-885	47	16	adults	adult	NOUN
ejde-885	47	17	and	and	CCONJ
ejde-885	47	18	susceptible	susceptible	ADJ
ejde-885	47	19	adults	adult	NOUN
ejde-885	47	20	,	,	PUNCT
ejde-885	47	21	βka	βka	INTJ
ejde-885	47	22	between	between	ADP
ejde-885	47	23	infected	infect	VERB
ejde-885	47	24	kids	kid	NOUN
ejde-885	47	25	and	and	CCONJ
ejde-885	47	26	susceptible	susceptible	ADJ
ejde-885	47	27	adults	adult	NOUN
ejde-885	47	28	,	,	PUNCT
ejde-885	47	29	βkk	βkk	NOUN
ejde-885	47	30	between	between	ADP
ejde-885	47	31	infected	infected	ADJ
ejde-885	47	32	kids	kid	NOUN
ejde-885	47	33	and	and	CCONJ
ejde-885	47	34	susceptible	susceptible	ADJ
ejde-885	47	35	kids	kid	NOUN
ejde-885	47	36	,	,	PUNCT
ejde-885	47	37	and	and	CCONJ
ejde-885	47	38	βak	βak	VERB
ejde-885	47	39	between	between	ADP
ejde-885	47	40	infected	infect	VERB
ejde-885	47	41	adults	adult	NOUN
ejde-885	47	42	and	and	CCONJ
ejde-885	47	43	susceptible	susceptible	ADJ
ejde-885	47	44	kids	kid	NOUN
ejde-885	47	45	.	.	PUNCT
ejde-885	48	1	for	for	ADP
ejde-885	48	2	consistency	consistency	NOUN
ejde-885	48	3	with	with	ADP
ejde-885	48	4	[	[	X
ejde-885	48	5	13	13	NUM
ejde-885	48	6	]	]	PUNCT
ejde-885	48	7	,	,	PUNCT
ejde-885	48	8	we	we	PRON
ejde-885	48	9	consider	consider	VERB
ejde-885	48	10	these	these	PRON
ejde-885	48	11	as	as	ADP
ejde-885	48	12	contact	contact	NOUN
ejde-885	48	13	rates	rate	NOUN
ejde-885	48	14	sufficient	sufficient	ADJ
ejde-885	48	15	to	to	PART
ejde-885	48	16	pass	pass	VERB
ejde-885	48	17	the	the	DET
ejde-885	48	18	disease	disease	NOUN
ejde-885	48	19	and	and	CCONJ
ejde-885	48	20	multiply	multiply	ADV
ejde-885	48	21	by	by	ADP
ejde-885	48	22	the	the	DET
ejde-885	48	23	probability	probability	NOUN
ejde-885	48	24	p	p	NOUN
ejde-885	48	25	of	of	ADP
ejde-885	48	26	infection	infection	NOUN
ejde-885	48	27	actually	actually	ADV
ejde-885	48	28	being	be	AUX
ejde-885	48	29	transmitted	transmit	VERB
ejde-885	48	30	in	in	ADP
ejde-885	48	31	such	such	ADJ
ejde-885	48	32	contacts	contact	NOUN
ejde-885	48	33	.	.	PUNCT
ejde-885	49	1	2.1	2.1	NUM
ejde-885	49	2	.	.	PUNCT
ejde-885	49	3	basic	basic	ADJ
ejde-885	49	4	reproductive	reproductive	ADJ
ejde-885	49	5	number	number	NOUN
ejde-885	49	6	for	for	ADP
ejde-885	49	7	epidemiological	epidemiological	ADJ
ejde-885	49	8	model	model	NOUN
ejde-885	49	9	.	.	PUNCT
ejde-885	50	1	in	in	ADP
ejde-885	50	2	disease	disease	NOUN
ejde-885	50	3	modeling	modeling	NOUN
ejde-885	50	4	,	,	PUNCT
ejde-885	50	5	the	the	DET
ejde-885	50	6	basic	basic	ADJ
ejde-885	50	7	reproductive	reproductive	ADJ
ejde-885	50	8	number	number	NOUN
ejde-885	50	9	is	be	AUX
ejde-885	50	10	defined	define	VERB
ejde-885	50	11	as	as	ADP
ejde-885	50	12	the	the	DET
ejde-885	50	13	number	number	NOUN
ejde-885	50	14	of	of	ADP
ejde-885	50	15	new	new	ADJ
ejde-885	50	16	infections	infection	NOUN
ejde-885	50	17	caused	cause	VERB
ejde-885	50	18	by	by	ADP
ejde-885	50	19	a	a	DET
ejde-885	50	20	single	single	ADJ
ejde-885	50	21	infected	infected	ADJ
ejde-885	50	22	person	person	NOUN
ejde-885	50	23	introduced	introduce	VERB
ejde-885	50	24	into	into	ADP
ejde-885	50	25	a	a	DET
ejde-885	50	26	completely	completely	ADV
ejde-885	50	27	susceptible	susceptible	ADJ
ejde-885	50	28	population	population	NOUN
ejde-885	50	29	.	.	PUNCT
ejde-885	51	1	thus	thus	ADV
ejde-885	51	2	a	a	DET
ejde-885	51	3	reproductive	reproductive	ADJ
ejde-885	51	4	number	number	NOUN
ejde-885	51	5	greater	great	ADJ
ejde-885	51	6	than	than	ADP
ejde-885	51	7	one	one	NUM
ejde-885	51	8	means	mean	VERB
ejde-885	51	9	that	that	SCONJ
ejde-885	51	10	the	the	DET
ejde-885	51	11	disease	disease	NOUN
ejde-885	51	12	will	will	AUX
ejde-885	51	13	continue	continue	VERB
ejde-885	51	14	to	to	PART
ejde-885	51	15	grow	grow	VERB
ejde-885	51	16	and	and	CCONJ
ejde-885	51	17	spread	spread	VERB
ejde-885	51	18	with	with	ADP
ejde-885	51	19	time	time	NOUN
ejde-885	51	20	,	,	PUNCT
ejde-885	51	21	while	while	SCONJ
ejde-885	51	22	a	a	DET
ejde-885	51	23	reproductive	reproductive	ADJ
ejde-885	51	24	number	number	NOUN
ejde-885	51	25	less	less	ADJ
ejde-885	51	26	than	than	ADP
ejde-885	51	27	one	one	NUM
ejde-885	51	28	means	mean	VERB
ejde-885	51	29	the	the	DET
ejde-885	51	30	disease	disease	NOUN
ejde-885	51	31	will	will	AUX
ejde-885	51	32	dwindle	dwindle	VERB
ejde-885	51	33	and	and	CCONJ
ejde-885	51	34	eventually	eventually	ADV
ejde-885	51	35	die	die	VERB
ejde-885	51	36	out	out	ADP
ejde-885	51	37	[	[	X
ejde-885	51	38	14	14	NUM
ejde-885	51	39	]	]	PUNCT
ejde-885	51	40	.	.	PUNCT
ejde-885	52	1	first	first	ADV
ejde-885	52	2	,	,	PUNCT
ejde-885	52	3	we	we	PRON
ejde-885	52	4	calculated	calculate	VERB
ejde-885	52	5	a	a	DET
ejde-885	52	6	reproductive	reproductive	ADJ
ejde-885	52	7	number	number	NOUN
ejde-885	52	8	for	for	ADP
ejde-885	52	9	each	each	DET
ejde-885	52	10	transmission	transmission	NOUN
ejde-885	52	11	category	category	NOUN
ejde-885	52	12	.	.	PUNCT
ejde-885	53	1	these	these	DET
ejde-885	53	2	calculations	calculation	NOUN
ejde-885	53	3	are	be	AUX
ejde-885	53	4	as	as	SCONJ
ejde-885	53	5	follows	follow	VERB
ejde-885	53	6	:	:	PUNCT
ejde-885	53	7	raa	raa	NOUN
ejde-885	53	8	0	0	NUM
ejde-885	53	9	=	=	SYM
ejde-885	53	10	baa	baa	NOUN
ejde-885	53	11	δ1	δ1	NOUN
ejde-885	53	12	+	+	CCONJ
ejde-885	53	13	ρ1	ρ1	NOUN
ejde-885	53	14	,	,	PUNCT
ejde-885	53	15	rak	rak	PROPN
ejde-885	53	16	0	0	PUNCT
ejde-885	54	1	=	=	SYM
ejde-885	54	2	bak	bak	PROPN
ejde-885	54	3	δ1	δ1	NOUN
ejde-885	54	4	+	+	CCONJ
ejde-885	54	5	ρ1	ρ1	NOUN
ejde-885	54	6	,	,	PUNCT
ejde-885	54	7	rka	rka	PROPN
ejde-885	54	8	0	0	X
ejde-885	54	9	=	=	SYM
ejde-885	54	10	bka	bka	PROPN
ejde-885	54	11	δ2	δ2	VERB
ejde-885	54	12	+	+	CCONJ
ejde-885	54	13	ρ2	ρ2	NOUN
ejde-885	54	14	,	,	PUNCT
ejde-885	54	15	rkk	rkk	NOUN
ejde-885	54	16	0	0	NUM
ejde-885	54	17	=	=	SYM
ejde-885	54	18	bkk	bkk	PROPN
ejde-885	54	19	δ2	δ2	VERB
ejde-885	54	20	+	+	CCONJ
ejde-885	54	21	ρ2	ρ2	NOUN
ejde-885	54	22	.	.	PUNCT
ejde-885	55	1	we	we	PRON
ejde-885	55	2	then	then	ADV
ejde-885	55	3	used	use	VERB
ejde-885	55	4	these	these	DET
ejde-885	55	5	individual	individual	ADJ
ejde-885	55	6	reproductive	reproductive	ADJ
ejde-885	55	7	numbers	number	NOUN
ejde-885	55	8	to	to	PART
ejde-885	55	9	find	find	VERB
ejde-885	55	10	an	an	DET
ejde-885	55	11	overall	overall	ADJ
ejde-885	55	12	reproductive	reproductive	ADJ
ejde-885	55	13	number	number	NOUN
ejde-885	55	14	for	for	ADP
ejde-885	55	15	the	the	DET
ejde-885	55	16	entire	entire	ADJ
ejde-885	55	17	population	population	NOUN
ejde-885	55	18	.	.	PUNCT
ejde-885	56	1	this	this	PRON
ejde-885	56	2	was	be	AUX
ejde-885	56	3	found	find	VERB
ejde-885	56	4	by	by	ADP
ejde-885	56	5	finding	find	VERB
ejde-885	56	6	the	the	DET
ejde-885	56	7	next	next	ADJ
ejde-885	56	8	-	-	PUNCT
ejde-885	56	9	generation	generation	NOUN
ejde-885	56	10	matrix	matrix	NOUN
ejde-885	56	11	and	and	CCONJ
ejde-885	56	12	evaluating	evaluate	VERB
ejde-885	56	13	its	its	PRON
ejde-885	56	14	eigenvalues	eigenvalue	NOUN
ejde-885	56	15	at	at	ADP
ejde-885	56	16	the	the	DET
ejde-885	56	17	disease	disease	NOUN
ejde-885	56	18	-	-	PUNCT
ejde-885	56	19	free	free	ADJ
ejde-885	56	20	equilibrium	equilibrium	NOUN
ejde-885	56	21	.	.	PUNCT
ejde-885	57	1	the	the	DET
ejde-885	57	2	overall	overall	ADJ
ejde-885	57	3	reproductive	reproductive	ADJ
ejde-885	57	4	number	number	NOUN
ejde-885	57	5	is	be	AUX
ejde-885	57	6	r0	r0	NOUN
ejde-885	57	7	=	=	PUNCT
ejde-885	57	8	(	(	PUNCT
ejde-885	57	9	baa	baa	PROPN
ejde-885	57	10	δ1+ρ1	δ1+ρ1	PROPN
ejde-885	57	11	+	+	PROPN
ejde-885	57	12	bkk	bkk	PROPN
ejde-885	57	13	δ2+ρ2	δ2+ρ2	PROPN
ejde-885	57	14	+	+	CCONJ
ejde-885	57	15	√	√	PROPN
ejde-885	57	16	(	(	PUNCT
ejde-885	57	17	baa	baa	PROPN
ejde-885	57	18	δ1+ρ1	δ1+ρ1	PROPN
ejde-885	57	19	+	+	PROPN
ejde-885	57	20	bkk	bkk	PROPN
ejde-885	57	21	δ2+ρ2	δ2+ρ2	PROPN
ejde-885	57	22	)	)	PUNCT
ejde-885	57	23	2	2	NUM
ejde-885	57	24	−	−	NOUN
ejde-885	57	25	4	4	NUM
ejde-885	57	26	(	(	PUNCT
ejde-885	57	27	baa	baa	PROPN
ejde-885	57	28	δ1+ρ1	δ1+ρ1	PROPN
ejde-885	57	29	bkk	bkk	PROPN
ejde-885	57	30	δ2+ρ2	δ2+ρ2	PROPN
ejde-885	57	31	−	−	PROPN
ejde-885	57	32	bak	bak	PROPN
ejde-885	57	33	δ1+ρ1	δ1+ρ1	PROPN
ejde-885	57	34	bka	bka	PROPN
ejde-885	57	35	δ2+ρ2	δ2+ρ2	PROPN
ejde-885	57	36	)	)	PUNCT
ejde-885	57	37	)	)	PUNCT
ejde-885	58	1	2	2	NUM
ejde-885	58	2	.	.	X
ejde-885	59	1	3	3	X
ejde-885	59	2	.	.	X
ejde-885	59	3	clinical	clinical	ADJ
ejde-885	59	4	trial	trial	NOUN
ejde-885	59	5	modeling	modeling	NOUN
ejde-885	59	6	with	with	ADP
ejde-885	59	7	the	the	DET
ejde-885	59	8	epidemiological	epidemiological	ADJ
ejde-885	59	9	model	model	NOUN
ejde-885	59	10	complete	complete	ADJ
ejde-885	59	11	,	,	PUNCT
ejde-885	59	12	we	we	PRON
ejde-885	59	13	proceed	proceed	VERB
ejde-885	59	14	to	to	PART
ejde-885	59	15	establish	establish	VERB
ejde-885	59	16	the	the	DET
ejde-885	59	17	system	system	NOUN
ejde-885	59	18	to	to	PART
ejde-885	59	19	describe	describe	VERB
ejde-885	59	20	clinical	clinical	ADJ
ejde-885	59	21	trials	trial	NOUN
ejde-885	59	22	for	for	ADP
ejde-885	59	23	a	a	DET
ejde-885	59	24	vaccine	vaccine	NOUN
ejde-885	59	25	for	for	ADP
ejde-885	59	26	a	a	DET
ejde-885	59	27	new	new	ADJ
ejde-885	59	28	respiratory	respiratory	ADJ
ejde-885	59	29	infection	infection	NOUN
ejde-885	59	30	.	.	PUNCT
ejde-885	60	1	at	at	ADP
ejde-885	60	2	this	this	DET
ejde-885	60	3	point	point	NOUN
ejde-885	60	4	,	,	PUNCT
ejde-885	60	5	it	it	PRON
ejde-885	60	6	is	be	AUX
ejde-885	60	7	important	important	ADJ
ejde-885	60	8	to	to	PART
ejde-885	60	9	express	express	VERB
ejde-885	60	10	the	the	DET
ejde-885	60	11	principal	principal	ADJ
ejde-885	60	12	aspects	aspect	NOUN
ejde-885	60	13	of	of	ADP
ejde-885	60	14	the	the	DET
ejde-885	60	15	clinical	clinical	ADJ
ejde-885	60	16	trial	trial	NOUN
ejde-885	60	17	process	process	NOUN
ejde-885	60	18	that	that	PRON
ejde-885	60	19	our	our	PRON
ejde-885	60	20	model	model	NOUN
ejde-885	60	21	will	will	AUX
ejde-885	60	22	consider	consider	VERB
ejde-885	60	23	and	and	CCONJ
ejde-885	60	24	those	those	PRON
ejde-885	60	25	it	it	PRON
ejde-885	60	26	does	do	VERB
ejde-885	60	27	not	not	PART
ejde-885	60	28	.	.	PUNCT
ejde-885	61	1	clinical	clinical	ADJ
ejde-885	61	2	trials	trial	NOUN
ejde-885	61	3	for	for	ADP
ejde-885	61	4	new	new	ADJ
ejde-885	61	5	vaccines	vaccine	NOUN
ejde-885	61	6	typically	typically	ADV
ejde-885	61	7	involve	involve	VERB
ejde-885	61	8	three	three	NUM
ejde-885	61	9	separate	separate	ADJ
ejde-885	61	10	phases	phase	NOUN
ejde-885	61	11	.	.	PUNCT
ejde-885	62	1	phase	phase	NOUN
ejde-885	62	2	1	1	NUM
ejde-885	62	3	involves	involve	VERB
ejde-885	62	4	a	a	DET
ejde-885	62	5	small	small	ADJ
ejde-885	62	6	group	group	NOUN
ejde-885	62	7	of	of	ADP
ejde-885	62	8	healthy	healthy	ADJ
ejde-885	62	9	volunteers	volunteer	NOUN
ejde-885	62	10	to	to	PART
ejde-885	62	11	study	study	VERB
ejde-885	62	12	dosage	dosage	NOUN
ejde-885	62	13	,	,	PUNCT
ejde-885	62	14	safety	safety	NOUN
ejde-885	62	15	,	,	PUNCT
ejde-885	62	16	and	and	CCONJ
ejde-885	62	17	immune	immune	ADJ
ejde-885	62	18	response	response	NOUN
ejde-885	62	19	.	.	PUNCT
ejde-885	63	1	phase	phase	NOUN
ejde-885	63	2	2	2	NUM
ejde-885	63	3	trials	trial	NOUN
ejde-885	63	4	expand	expand	VERB
ejde-885	63	5	the	the	DET
ejde-885	63	6	study	study	NOUN
ejde-885	63	7	population	population	NOUN
ejde-885	63	8	and	and	CCONJ
ejde-885	63	9	further	far	ADV
ejde-885	63	10	evaluate	evaluate	VERB
ejde-885	63	11	safety	safety	NOUN
ejde-885	63	12	and	and	CCONJ
ejde-885	63	13	immunogenicity	immunogenicity	NOUN
ejde-885	63	14	while	while	SCONJ
ejde-885	63	15	also	also	ADV
ejde-885	63	16	exploring	explore	VERB
ejde-885	63	17	factors	factor	NOUN
ejde-885	63	18	like	like	ADP
ejde-885	63	19	age	age	NOUN
ejde-885	63	20	and	and	CCONJ
ejde-885	63	21	underlying	underlying	ADJ
ejde-885	63	22	health	health	NOUN
ejde-885	63	23	conditions	condition	NOUN
ejde-885	63	24	.	.	PUNCT
ejde-885	64	1	phase	phase	NOUN
ejde-885	64	2	3	3	NUM
ejde-885	64	3	trials	trial	NOUN
ejde-885	64	4	,	,	PUNCT
ejde-885	64	5	the	the	DET
ejde-885	64	6	largest	large	ADJ
ejde-885	64	7	phase	phase	NOUN
ejde-885	64	8	,	,	PUNCT
ejde-885	64	9	involve	involve	VERB
ejde-885	64	10	thousands	thousand	NOUN
ejde-885	64	11	of	of	ADP
ejde-885	64	12	participants	participant	NOUN
ejde-885	64	13	and	and	CCONJ
ejde-885	64	14	assess	assess	VERB
ejde-885	64	15	vaccine	vaccine	NOUN
ejde-885	64	16	efficacy	efficacy	NOUN
ejde-885	64	17	by	by	ADP
ejde-885	64	18	comparing	compare	VERB
ejde-885	64	19	vaccinated	vaccinate	VERB
ejde-885	64	20	individuals	individual	NOUN
ejde-885	64	21	to	to	ADP
ejde-885	64	22	a	a	DET
ejde-885	64	23	control	control	NOUN
ejde-885	64	24	group	group	NOUN
ejde-885	64	25	receiving	receive	VERB
ejde-885	64	26	a	a	DET
ejde-885	64	27	placebo	placebo	NOUN
ejde-885	64	28	or	or	CCONJ
ejde-885	64	29	alternative	alternative	NOUN
ejde-885	64	30	.	.	PUNCT
ejde-885	65	1	these	these	DET
ejde-885	65	2	trials	trial	NOUN
ejde-885	65	3	closely	closely	ADV
ejde-885	65	4	monitor	monitor	VERB
ejde-885	65	5	participants	participant	NOUN
ejde-885	65	6	for	for	ADP
ejde-885	65	7	the	the	DET
ejde-885	65	8	4	4	NUM
ejde-885	65	9	d.	d.	NOUN
ejde-885	65	10	gerberry	gerberry	NOUN
ejde-885	65	11	,	,	PUNCT
ejde-885	65	12	h.	h.	PROPN
ejde-885	65	13	joshi	joshi	PROPN
ejde-885	65	14	,	,	PUNCT
ejde-885	65	15	m.	m.	NOUN
ejde-885	65	16	peloquin	peloquin	NOUN
ejde-885	65	17	,	,	PUNCT
ejde-885	65	18	s.	s.	PROPN
ejde-885	65	19	vargas	vargas	PROPN
ejde-885	65	20	ejde-2022	ejde-2022	NOUN
ejde-885	65	21	/	/	SYM
ejde-885	65	22	conf/26	conf/26	NOUN
ejde-885	65	23	given	give	VERB
ejde-885	65	24	respiratory	respiratory	ADJ
ejde-885	65	25	infection	infection	NOUN
ejde-885	65	26	,	,	PUNCT
ejde-885	65	27	aiming	aim	VERB
ejde-885	65	28	to	to	PART
ejde-885	65	29	determine	determine	VERB
ejde-885	65	30	if	if	SCONJ
ejde-885	65	31	the	the	DET
ejde-885	65	32	vaccine	vaccine	NOUN
ejde-885	65	33	prevents	prevent	VERB
ejde-885	65	34	or	or	CCONJ
ejde-885	65	35	reduces	reduce	VERB
ejde-885	65	36	the	the	DET
ejde-885	65	37	severity	severity	NOUN
ejde-885	65	38	of	of	ADP
ejde-885	65	39	the	the	DET
ejde-885	65	40	disease	disease	NOUN
ejde-885	65	41	.	.	PUNCT
ejde-885	66	1	importantly	importantly	ADV
ejde-885	66	2	,	,	PUNCT
ejde-885	66	3	given	give	VERB
ejde-885	66	4	the	the	DET
ejde-885	66	5	logistical	logistical	ADJ
ejde-885	66	6	challenge	challenge	NOUN
ejde-885	66	7	and	and	CCONJ
ejde-885	66	8	size	size	NOUN
ejde-885	66	9	of	of	ADP
ejde-885	66	10	phase	phase	NOUN
ejde-885	66	11	3	3	NUM
ejde-885	66	12	trials	trial	NOUN
ejde-885	66	13	,	,	PUNCT
ejde-885	66	14	trial	trial	NOUN
ejde-885	66	15	participants	participant	NOUN
ejde-885	66	16	are	be	AUX
ejde-885	66	17	not	not	PART
ejde-885	66	18	monitored	monitor	VERB
ejde-885	66	19	for	for	ADP
ejde-885	66	20	infection	infection	NOUN
ejde-885	66	21	continuously	continuously	ADV
ejde-885	66	22	but	but	CCONJ
ejde-885	66	23	rather	rather	ADV
ejde-885	66	24	a	a	DET
ejde-885	66	25	fixed	fix	VERB
ejde-885	66	26	periods	period	NOUN
ejde-885	66	27	(	(	PUNCT
ejde-885	66	28	e.g.	e.g.	ADV
ejde-885	66	29	weekly	weekly	ADJ
ejde-885	66	30	,	,	PUNCT
ejde-885	66	31	biweekly	biweekly	ADJ
ejde-885	66	32	,	,	PUNCT
ejde-885	66	33	etc	etc	X
ejde-885	66	34	.	.	X
ejde-885	66	35	)	)	PUNCT
ejde-885	66	36	.	.	PUNCT
ejde-885	67	1	the	the	DET
ejde-885	67	2	end	end	NOUN
ejde-885	67	3	of	of	ADP
ejde-885	67	4	a	a	DET
ejde-885	67	5	phase	phase	NOUN
ejde-885	67	6	3	3	NUM
ejde-885	67	7	trial	trial	NOUN
ejde-885	67	8	can	can	AUX
ejde-885	67	9	be	be	AUX
ejde-885	67	10	determined	determine	VERB
ejde-885	67	11	in	in	ADP
ejde-885	67	12	a	a	DET
ejde-885	67	13	few	few	ADJ
ejde-885	67	14	different	different	ADJ
ejde-885	67	15	ways	way	NOUN
ejde-885	67	16	.	.	PUNCT
ejde-885	68	1	first	first	ADJ
ejde-885	68	2	,	,	PUNCT
ejde-885	68	3	statistical	statistical	ADJ
ejde-885	68	4	significance	significance	NOUN
ejde-885	68	5	can	can	AUX
ejde-885	68	6	be	be	AUX
ejde-885	68	7	used	use	VERB
ejde-885	68	8	to	to	PART
ejde-885	68	9	indicate	indicate	VERB
ejde-885	68	10	the	the	DET
ejde-885	68	11	successful	successful	ADJ
ejde-885	68	12	completion	completion	NOUN
ejde-885	68	13	of	of	ADP
ejde-885	68	14	a	a	DET
ejde-885	68	15	trial	trial	NOUN
ejde-885	68	16	.	.	PUNCT
ejde-885	69	1	this	this	PRON
ejde-885	69	2	occurs	occur	VERB
ejde-885	69	3	when	when	SCONJ
ejde-885	69	4	the	the	DET
ejde-885	69	5	vaccine	vaccine	NOUN
ejde-885	69	6	’s	’s	PART
ejde-885	69	7	performance	performance	NOUN
ejde-885	69	8	is	be	AUX
ejde-885	69	9	statistically	statistically	ADV
ejde-885	69	10	significant	significant	ADJ
ejde-885	69	11	enough	enough	ADV
ejde-885	69	12	to	to	PART
ejde-885	69	13	support	support	VERB
ejde-885	69	14	the	the	DET
ejde-885	69	15	vaccine	vaccine	NOUN
ejde-885	69	16	’s	’s	PART
ejde-885	69	17	approval	approval	NOUN
ejde-885	69	18	.	.	PUNCT
ejde-885	70	1	the	the	DET
ejde-885	70	2	analysis	analysis	NOUN
ejde-885	70	3	must	must	AUX
ejde-885	70	4	determine	determine	VERB
ejde-885	70	5	whether	whether	SCONJ
ejde-885	70	6	the	the	DET
ejde-885	70	7	observed	observed	ADJ
ejde-885	70	8	results	result	NOUN
ejde-885	70	9	are	be	AUX
ejde-885	70	10	due	due	ADJ
ejde-885	70	11	to	to	ADP
ejde-885	70	12	the	the	DET
ejde-885	70	13	effectiveness	effectiveness	NOUN
ejde-885	70	14	of	of	ADP
ejde-885	70	15	the	the	DET
ejde-885	70	16	vaccine	vaccine	NOUN
ejde-885	70	17	and	and	CCONJ
ejde-885	70	18	not	not	PART
ejde-885	70	19	random	random	ADJ
ejde-885	70	20	chance	chance	NOUN
ejde-885	70	21	[	[	X
ejde-885	70	22	15	15	NUM
ejde-885	70	23	]	]	PUNCT
ejde-885	70	24	.	.	PUNCT
ejde-885	71	1	in	in	ADP
ejde-885	71	2	another	another	DET
ejde-885	71	3	method	method	NOUN
ejde-885	71	4	,	,	PUNCT
ejde-885	71	5	clinical	clinical	ADJ
ejde-885	71	6	trials	trial	NOUN
ejde-885	71	7	follow	follow	VERB
ejde-885	71	8	a	a	DET
ejde-885	71	9	predetermined	predetermine	VERB
ejde-885	71	10	protocol	protocol	NOUN
ejde-885	71	11	that	that	PRON
ejde-885	71	12	outlines	outline	VERB
ejde-885	71	13	specific	specific	ADJ
ejde-885	71	14	endpoints	endpoint	NOUN
ejde-885	71	15	and	and	CCONJ
ejde-885	71	16	goals	goal	NOUN
ejde-885	71	17	,	,	PUNCT
ejde-885	71	18	and	and	CCONJ
ejde-885	71	19	the	the	DET
ejde-885	71	20	trials	trial	NOUN
ejde-885	71	21	need	need	VERB
ejde-885	71	22	to	to	PART
ejde-885	71	23	collect	collect	VERB
ejde-885	71	24	enough	enough	ADJ
ejde-885	71	25	data	datum	NOUN
ejde-885	71	26	to	to	PART
ejde-885	71	27	reach	reach	VERB
ejde-885	71	28	these	these	DET
ejde-885	71	29	goals	goal	NOUN
ejde-885	71	30	.	.	PUNCT
ejde-885	72	1	the	the	DET
ejde-885	72	2	extensive	extensive	ADJ
ejde-885	72	3	and	and	CCONJ
ejde-885	72	4	complicated	complicated	ADJ
ejde-885	72	5	details	detail	NOUN
ejde-885	72	6	of	of	ADP
ejde-885	72	7	clinical	clinical	ADJ
ejde-885	72	8	trial	trial	NOUN
ejde-885	72	9	design	design	NOUN
ejde-885	72	10	,	,	PUNCT
ejde-885	72	11	execution	execution	NOUN
ejde-885	72	12	,	,	PUNCT
ejde-885	72	13	and	and	CCONJ
ejde-885	72	14	regulation	regulation	NOUN
ejde-885	72	15	are	be	AUX
ejde-885	72	16	beyond	beyond	ADP
ejde-885	72	17	the	the	DET
ejde-885	72	18	scope	scope	NOUN
ejde-885	72	19	of	of	ADP
ejde-885	72	20	this	this	DET
ejde-885	72	21	modeling	modeling	NOUN
ejde-885	72	22	work	work	NOUN
ejde-885	72	23	[	[	X
ejde-885	72	24	16	16	NUM
ejde-885	72	25	]	]	PUNCT
ejde-885	72	26	,	,	PUNCT
ejde-885	72	27	so	so	SCONJ
ejde-885	72	28	we	we	PRON
ejde-885	72	29	focus	focus	VERB
ejde-885	72	30	on	on	ADP
ejde-885	72	31	the	the	DET
ejde-885	72	32	central	central	ADJ
ejde-885	72	33	characteristics	characteristic	NOUN
ejde-885	72	34	related	relate	VERB
ejde-885	72	35	to	to	ADP
ejde-885	72	36	epidemiological	epidemiological	ADJ
ejde-885	72	37	dynamics	dynamic	NOUN
ejde-885	72	38	.	.	PUNCT
ejde-885	73	1	one	one	NUM
ejde-885	73	2	last	last	ADJ
ejde-885	73	3	feature	feature	NOUN
ejde-885	73	4	of	of	ADP
ejde-885	73	5	clinical	clinical	ADJ
ejde-885	73	6	trials	trial	NOUN
ejde-885	73	7	that	that	PRON
ejde-885	73	8	is	be	AUX
ejde-885	73	9	central	central	ADJ
ejde-885	73	10	to	to	ADP
ejde-885	73	11	our	our	PRON
ejde-885	73	12	modeling	modeling	NOUN
ejde-885	73	13	work	work	NOUN
ejde-885	73	14	is	be	AUX
ejde-885	73	15	that	that	SCONJ
ejde-885	73	16	clinical	clinical	ADJ
ejde-885	73	17	trials	trial	NOUN
ejde-885	73	18	of	of	ADP
ejde-885	73	19	new	new	ADJ
ejde-885	73	20	vaccines	vaccine	NOUN
ejde-885	73	21	are	be	AUX
ejde-885	73	22	typically	typically	ADV
ejde-885	73	23	conducted	conduct	VERB
ejde-885	73	24	for	for	ADP
ejde-885	73	25	adults	adult	NOUN
ejde-885	73	26	before	before	ADP
ejde-885	73	27	subsequent	subsequent	ADJ
ejde-885	73	28	clinical	clinical	ADJ
ejde-885	73	29	trials	trial	NOUN
ejde-885	73	30	for	for	ADP
ejde-885	73	31	the	the	DET
ejde-885	73	32	vaccine	vaccine	NOUN
ejde-885	73	33	in	in	ADP
ejde-885	73	34	kids	kid	NOUN
ejde-885	73	35	.	.	PUNCT
ejde-885	74	1	this	this	PRON
ejde-885	74	2	occurs	occur	VERB
ejde-885	74	3	for	for	ADP
ejde-885	74	4	multiple	multiple	ADJ
ejde-885	74	5	reasons	reason	NOUN
ejde-885	74	6	[	[	X
ejde-885	74	7	17	17	NUM
ejde-885	74	8	]	]	PUNCT
ejde-885	74	9	.	.	PUNCT
ejde-885	75	1	first	first	ADV
ejde-885	75	2	,	,	PUNCT
ejde-885	75	3	it	it	PRON
ejde-885	75	4	is	be	AUX
ejde-885	75	5	obvious	obvious	ADJ
ejde-885	75	6	that	that	SCONJ
ejde-885	75	7	adults	adult	NOUN
ejde-885	75	8	are	be	AUX
ejde-885	75	9	in	in	ADP
ejde-885	75	10	the	the	DET
ejde-885	75	11	workforce	workforce	NOUN
ejde-885	75	12	,	,	PUNCT
ejde-885	75	13	and	and	CCONJ
ejde-885	75	14	interact	interact	VERB
ejde-885	75	15	with	with	ADP
ejde-885	75	16	others	other	NOUN
ejde-885	75	17	much	much	ADV
ejde-885	75	18	more	more	ADJ
ejde-885	75	19	than	than	ADP
ejde-885	75	20	children	child	NOUN
ejde-885	75	21	.	.	PUNCT
ejde-885	76	1	thus	thus	ADV
ejde-885	76	2	,	,	PUNCT
ejde-885	76	3	curbing	curb	VERB
ejde-885	76	4	the	the	DET
ejde-885	76	5	spread	spread	NOUN
ejde-885	76	6	starts	start	VERB
ejde-885	76	7	with	with	ADP
ejde-885	76	8	them	they	PRON
ejde-885	76	9	since	since	SCONJ
ejde-885	76	10	they	they	PRON
ejde-885	76	11	come	come	VERB
ejde-885	76	12	in	in	ADP
ejde-885	76	13	contact	contact	NOUN
ejde-885	76	14	with	with	ADP
ejde-885	76	15	both	both	DET
ejde-885	76	16	adults	adult	NOUN
ejde-885	76	17	and	and	CCONJ
ejde-885	76	18	children	child	NOUN
ejde-885	76	19	alike	alike	ADV
ejde-885	76	20	.	.	PUNCT
ejde-885	77	1	children	child	NOUN
ejde-885	77	2	are	be	AUX
ejde-885	77	3	often	often	ADV
ejde-885	77	4	only	only	ADV
ejde-885	77	5	in	in	ADP
ejde-885	77	6	contact	contact	NOUN
ejde-885	77	7	with	with	ADP
ejde-885	77	8	other	other	ADJ
ejde-885	77	9	children	child	NOUN
ejde-885	77	10	,	,	PUNCT
ejde-885	77	11	and	and	CCONJ
ejde-885	77	12	their	their	PRON
ejde-885	77	13	parents	parent	NOUN
ejde-885	77	14	,	,	PUNCT
ejde-885	77	15	whom	whom	PRON
ejde-885	77	16	they	they	PRON
ejde-885	77	17	rely	rely	VERB
ejde-885	77	18	on	on	ADP
ejde-885	77	19	for	for	ADP
ejde-885	77	20	basic	basic	ADJ
ejde-885	77	21	needs	need	NOUN
ejde-885	77	22	.	.	PUNCT
ejde-885	78	1	furthermore	furthermore	ADV
ejde-885	78	2	,	,	PUNCT
ejde-885	78	3	it	it	PRON
ejde-885	78	4	is	be	AUX
ejde-885	78	5	important	important	ADJ
ejde-885	78	6	to	to	PART
ejde-885	78	7	test	test	VERB
ejde-885	78	8	adults	adult	NOUN
ejde-885	78	9	first	first	ADV
ejde-885	78	10	to	to	PART
ejde-885	78	11	verify	verify	VERB
ejde-885	78	12	safety	safety	NOUN
ejde-885	78	13	and	and	CCONJ
ejde-885	78	14	will	will	AUX
ejde-885	78	15	not	not	PART
ejde-885	78	16	have	have	VERB
ejde-885	78	17	adverse	adverse	ADJ
ejde-885	78	18	effects	effect	NOUN
ejde-885	78	19	that	that	PRON
ejde-885	78	20	could	could	AUX
ejde-885	78	21	affect	affect	VERB
ejde-885	78	22	their	their	PRON
ejde-885	78	23	development	development	NOUN
ejde-885	78	24	.	.	PUNCT
ejde-885	79	1	overall	overall	ADV
ejde-885	79	2	,	,	PUNCT
ejde-885	79	3	parents	parent	NOUN
ejde-885	79	4	are	be	AUX
ejde-885	79	5	also	also	ADV
ejde-885	79	6	very	very	ADV
ejde-885	79	7	weary	weary	ADJ
ejde-885	79	8	of	of	ADP
ejde-885	79	9	giving	give	VERB
ejde-885	79	10	something	something	PRON
ejde-885	79	11	to	to	ADP
ejde-885	79	12	their	their	PRON
ejde-885	79	13	kids	kid	NOUN
ejde-885	79	14	that	that	PRON
ejde-885	79	15	has	have	AUX
ejde-885	79	16	not	not	PART
ejde-885	79	17	been	be	AUX
ejde-885	79	18	proven	prove	VERB
ejde-885	79	19	safe	safe	ADJ
ejde-885	79	20	[	[	X
ejde-885	79	21	17	17	NUM
ejde-885	79	22	]	]	PUNCT
ejde-885	79	23	.	.	PUNCT
ejde-885	80	1	for	for	ADP
ejde-885	80	2	our	our	PRON
ejde-885	80	3	mathematical	mathematical	ADJ
ejde-885	80	4	model	model	NOUN
ejde-885	80	5	,	,	PUNCT
ejde-885	80	6	we	we	PRON
ejde-885	80	7	focus	focus	VERB
ejde-885	80	8	only	only	ADV
ejde-885	80	9	on	on	ADP
ejde-885	80	10	phase	phase	NOUN
ejde-885	80	11	3	3	NUM
ejde-885	80	12	,	,	PUNCT
ejde-885	80	13	the	the	DET
ejde-885	80	14	large	large	ADJ
ejde-885	80	15	-	-	PUNCT
ejde-885	80	16	scale	scale	NOUN
ejde-885	80	17	trial	trial	NOUN
ejde-885	80	18	that	that	PRON
ejde-885	80	19	happens	happen	VERB
ejde-885	80	20	at	at	ADP
ejde-885	80	21	the	the	DET
ejde-885	80	22	end	end	NOUN
ejde-885	80	23	of	of	ADP
ejde-885	80	24	the	the	DET
ejde-885	80	25	testing	testing	NOUN
ejde-885	80	26	process	process	NOUN
ejde-885	80	27	.	.	PUNCT
ejde-885	81	1	we	we	PRON
ejde-885	81	2	use	use	VERB
ejde-885	81	3	a	a	DET
ejde-885	81	4	discrete	discrete	ADJ
ejde-885	81	5	-	-	PUNCT
ejde-885	81	6	time	time	NOUN
ejde-885	81	7	model	model	NOUN
ejde-885	81	8	(	(	PUNCT
ejde-885	81	9	i.e.	i.e.	X
ejde-885	81	10	difference	difference	NOUN
ejde-885	81	11	equation	equation	NOUN
ejde-885	81	12	)	)	PUNCT
ejde-885	81	13	to	to	PART
ejde-885	81	14	track	track	VERB
ejde-885	81	15	the	the	DET
ejde-885	81	16	number	number	NOUN
ejde-885	81	17	of	of	ADP
ejde-885	81	18	infections	infection	NOUN
ejde-885	81	19	in	in	ADP
ejde-885	81	20	the	the	DET
ejde-885	81	21	control	control	NOUN
ejde-885	81	22	and	and	CCONJ
ejde-885	81	23	treatment	treatment	NOUN
ejde-885	81	24	arms	arm	NOUN
ejde-885	81	25	due	due	ADP
ejde-885	81	26	to	to	ADP
ejde-885	81	27	the	the	DET
ejde-885	81	28	fact	fact	NOUN
ejde-885	81	29	that	that	SCONJ
ejde-885	81	30	trial	trial	NOUN
ejde-885	81	31	participants	participant	NOUN
ejde-885	81	32	are	be	AUX
ejde-885	81	33	monitored	monitor	VERB
ejde-885	81	34	for	for	ADP
ejde-885	81	35	new	new	ADJ
ejde-885	81	36	infection	infection	NOUN
ejde-885	81	37	a	a	DET
ejde-885	81	38	fixed	fix	VERB
ejde-885	81	39	time	time	NOUN
ejde-885	81	40	periods	period	NOUN
ejde-885	81	41	(	(	PUNCT
ejde-885	81	42	e.g.	e.g.	ADV
ejde-885	81	43	weekly	weekly	ADJ
ejde-885	81	44	,	,	PUNCT
ejde-885	81	45	biweekly	biweekly	ADJ
ejde-885	81	46	,	,	PUNCT
ejde-885	81	47	etc	etc	X
ejde-885	81	48	.	.	X
ejde-885	81	49	)	)	PUNCT
ejde-885	81	50	.	.	PUNCT
ejde-885	82	1	the	the	DET
ejde-885	82	2	clinical	clinical	ADJ
ejde-885	82	3	trial	trial	NOUN
ejde-885	82	4	model	model	NOUN
ejde-885	82	5	tracks	track	VERB
ejde-885	82	6	the	the	DET
ejde-885	82	7	number	number	NOUN
ejde-885	82	8	of	of	ADP
ejde-885	82	9	cumulative	cumulative	ADJ
ejde-885	82	10	infections	infection	NOUN
ejde-885	82	11	in	in	ADP
ejde-885	82	12	the	the	DET
ejde-885	82	13	control	control	NOUN
ejde-885	82	14	arms	arm	NOUN
ejde-885	82	15	,	,	PUNCT
ejde-885	82	16	c	c	NOUN
ejde-885	82	17	,	,	PUNCT
ejde-885	82	18	and	and	CCONJ
ejde-885	82	19	treatment	treatment	NOUN
ejde-885	82	20	or	or	CCONJ
ejde-885	82	21	vaccinated	vaccinated	ADJ
ejde-885	82	22	arms	arm	NOUN
ejde-885	82	23	,	,	PUNCT
ejde-885	82	24	v	v	NOUN
ejde-885	82	25	,	,	PUNCT
ejde-885	82	26	of	of	ADP
ejde-885	82	27	the	the	DET
ejde-885	82	28	clinical	clinical	ADJ
ejde-885	82	29	trial	trial	NOUN
ejde-885	82	30	and	and	CCONJ
ejde-885	82	31	e	e	NOUN
ejde-885	82	32	is	be	AUX
ejde-885	82	33	the	the	DET
ejde-885	82	34	vaccine	vaccine	NOUN
ejde-885	82	35	efficacy	efficacy	NOUN
ejde-885	82	36	.	.	PUNCT
ejde-885	83	1	subscripts	subscript	NOUN
ejde-885	83	2	u	u	NOUN
ejde-885	83	3	and	and	CCONJ
ejde-885	83	4	i	i	PRON
ejde-885	83	5	refer	refer	VERB
ejde-885	83	6	to	to	ADP
ejde-885	83	7	the	the	DET
ejde-885	83	8	numbers	number	NOUN
ejde-885	83	9	of	of	ADP
ejde-885	83	10	uninfected	uninfected	ADJ
ejde-885	83	11	and	and	CCONJ
ejde-885	83	12	infected	infected	ADJ
ejde-885	83	13	individuals	individual	NOUN
ejde-885	83	14	in	in	ADP
ejde-885	83	15	each	each	DET
ejde-885	83	16	clinical	clinical	ADJ
ejde-885	83	17	trial	trial	NOUN
ejde-885	83	18	arm	arm	NOUN
ejde-885	83	19	,	,	PUNCT
ejde-885	83	20	respectively	respectively	ADV
ejde-885	83	21	.	.	PUNCT
ejde-885	84	1	the	the	DET
ejde-885	84	2	equations	equation	NOUN
ejde-885	84	3	for	for	ADP
ejde-885	84	4	the	the	DET
ejde-885	84	5	clinical	clinical	ADJ
ejde-885	84	6	trial	trial	NOUN
ejde-885	84	7	model	model	NOUN
ejde-885	84	8	are	be	AUX
ejde-885	84	9	as	as	SCONJ
ejde-885	84	10	follows	follow	VERB
ejde-885	84	11	:	:	PUNCT
ejde-885	84	12	vi[j	vi[j	VERB
ejde-885	84	13	+	+	CCONJ
ejde-885	84	14	1	1	X
ejde-885	84	15	]	]	X
ejde-885	84	16	=	=	PUNCT
ejde-885	84	17	vi[j	vi[j	NOUN
ejde-885	84	18	]	]	PUNCT
ejde-885	85	1	+	+	CCONJ
ejde-885	85	2	vu[j](1−	vu[j](1−	X
ejde-885	85	3	e)(probability	e)(probability	ADP
ejde-885	85	4	of	of	ADP
ejde-885	85	5	infection	infection	NOUN
ejde-885	85	6	for	for	ADP
ejde-885	85	7	time	time	NOUN
ejde-885	85	8	step	step	NOUN
ejde-885	85	9	j	j	PROPN
ejde-885	85	10	+	+	CCONJ
ejde-885	85	11	1	1	NUM
ejde-885	85	12	)	)	PUNCT
ejde-885	85	13	,	,	PUNCT
ejde-885	85	14	(	(	PUNCT
ejde-885	85	15	3.1	3.1	NUM
ejde-885	85	16	)	)	PUNCT
ejde-885	85	17	vu[j	vu[j	NOUN
ejde-885	85	18	+	+	CCONJ
ejde-885	85	19	1	1	NUM
ejde-885	85	20	]	]	X
ejde-885	85	21	=	=	SYM
ejde-885	85	22	vu[j]−	vu[j]−	NOUN
ejde-885	85	23	vu[j](1−	vu[j](1−	VERB
ejde-885	85	24	e)(probability	e)(probability	ADP
ejde-885	85	25	of	of	ADP
ejde-885	85	26	infection	infection	NOUN
ejde-885	85	27	for	for	ADP
ejde-885	85	28	time	time	NOUN
ejde-885	85	29	step	step	NOUN
ejde-885	85	30	j	j	PROPN
ejde-885	85	31	+	+	CCONJ
ejde-885	85	32	1	1	NUM
ejde-885	85	33	)	)	PUNCT
ejde-885	85	34	,	,	PUNCT
ejde-885	85	35	(	(	PUNCT
ejde-885	85	36	3.2	3.2	NUM
ejde-885	85	37	)	)	PUNCT
ejde-885	85	38	ci[j	ci[j	NOUN
ejde-885	85	39	+	+	CCONJ
ejde-885	85	40	1	1	X
ejde-885	85	41	]	]	X
ejde-885	85	42	=	=	PUNCT
ejde-885	85	43	ci[j	ci[j	NOUN
ejde-885	85	44	]	]	X
ejde-885	86	1	+	+	NUM
ejde-885	86	2	cu[j](probability	cu[j](probability	NOUN
ejde-885	86	3	of	of	ADP
ejde-885	86	4	infection	infection	NOUN
ejde-885	86	5	for	for	ADP
ejde-885	86	6	time	time	NOUN
ejde-885	86	7	step	step	NOUN
ejde-885	86	8	j	j	PROPN
ejde-885	86	9	+	+	CCONJ
ejde-885	86	10	1	1	NUM
ejde-885	86	11	)	)	PUNCT
ejde-885	86	12	,	,	PUNCT
ejde-885	86	13	(	(	PUNCT
ejde-885	86	14	3.3	3.3	NUM
ejde-885	86	15	)	)	PUNCT
ejde-885	86	16	cu[j	cu[j	NOUN
ejde-885	86	17	+	+	CCONJ
ejde-885	86	18	1	1	X
ejde-885	86	19	]	]	X
ejde-885	86	20	=	=	PUNCT
ejde-885	86	21	cu[j]−	cu[j]−	PROPN
ejde-885	86	22	cu[j](probability	cu[j](probability	NOUN
ejde-885	86	23	of	of	ADP
ejde-885	86	24	infection	infection	NOUN
ejde-885	86	25	for	for	ADP
ejde-885	86	26	time	time	NOUN
ejde-885	86	27	step	step	NOUN
ejde-885	86	28	j	j	PROPN
ejde-885	86	29	+	+	CCONJ
ejde-885	86	30	1	1	NUM
ejde-885	86	31	)	)	PUNCT
ejde-885	86	32	.	.	PUNCT
ejde-885	87	1	(	(	PUNCT
ejde-885	87	2	3.4	3.4	NUM
ejde-885	87	3	)	)	PUNCT
ejde-885	87	4	importantly	importantly	ADV
ejde-885	87	5	,	,	PUNCT
ejde-885	87	6	the	the	DET
ejde-885	87	7	probability	probability	NOUN
ejde-885	87	8	of	of	ADP
ejde-885	87	9	infection	infection	NOUN
ejde-885	87	10	in	in	ADP
ejde-885	87	11	a	a	DET
ejde-885	87	12	given	give	VERB
ejde-885	87	13	time	time	NOUN
ejde-885	87	14	step	step	NOUN
ejde-885	87	15	(	(	PUNCT
ejde-885	87	16	e.g.	e.g.	ADV
ejde-885	87	17	2	2	NUM
ejde-885	87	18	weeks	week	NOUN
ejde-885	87	19	)	)	PUNCT
ejde-885	87	20	is	be	AUX
ejde-885	87	21	determined	determine	VERB
ejde-885	87	22	by	by	ADP
ejde-885	87	23	the	the	DET
ejde-885	87	24	rate	rate	NOUN
ejde-885	87	25	of	of	ADP
ejde-885	87	26	new	new	ADJ
ejde-885	87	27	infections	infection	NOUN
ejde-885	87	28	over	over	ADP
ejde-885	87	29	that	that	DET
ejde-885	87	30	period	period	NOUN
ejde-885	87	31	in	in	ADP
ejde-885	87	32	the	the	DET
ejde-885	87	33	general	general	ADJ
ejde-885	87	34	population	population	NOUN
ejde-885	87	35	which	which	PRON
ejde-885	87	36	,	,	PUNCT
ejde-885	87	37	in	in	ADP
ejde-885	87	38	our	our	PRON
ejde-885	87	39	modeling	modeling	NOUN
ejde-885	87	40	framework	framework	NOUN
ejde-885	87	41	,	,	PUNCT
ejde-885	87	42	is	be	AUX
ejde-885	87	43	governed	govern	VERB
ejde-885	87	44	by	by	ADP
ejde-885	87	45	the	the	DET
ejde-885	87	46	solution	solution	NOUN
ejde-885	87	47	to	to	ADP
ejde-885	87	48	the	the	DET
ejde-885	87	49	epidemiological	epidemiological	ADJ
ejde-885	87	50	component	component	NOUN
ejde-885	87	51	of	of	ADP
ejde-885	87	52	the	the	DET
ejde-885	87	53	model	model	NOUN
ejde-885	87	54	.	.	PUNCT
ejde-885	88	1	3.1	3.1	NUM
ejde-885	88	2	.	.	PUNCT
ejde-885	89	1	coupling	couple	VERB
ejde-885	89	2	the	the	DET
ejde-885	89	3	epidemiological	epidemiological	ADJ
ejde-885	89	4	and	and	CCONJ
ejde-885	89	5	clinical	clinical	ADJ
ejde-885	89	6	trial	trial	NOUN
ejde-885	89	7	models	model	NOUN
ejde-885	89	8	.	.	PUNCT
ejde-885	90	1	as	as	SCONJ
ejde-885	90	2	our	our	PRON
ejde-885	90	3	goal	goal	NOUN
ejde-885	90	4	is	be	AUX
ejde-885	90	5	to	to	PART
ejde-885	90	6	model	model	VERB
ejde-885	90	7	the	the	DET
ejde-885	90	8	interplay	interplay	NOUN
ejde-885	90	9	between	between	ADP
ejde-885	90	10	epidemiological	epidemiological	ADJ
ejde-885	90	11	dynamics	dynamic	NOUN
ejde-885	90	12	and	and	CCONJ
ejde-885	90	13	clinical	clinical	ADJ
ejde-885	90	14	trials	trial	NOUN
ejde-885	90	15	for	for	ADP
ejde-885	90	16	new	new	ADJ
ejde-885	90	17	vaccines	vaccine	NOUN
ejde-885	90	18	,	,	PUNCT
ejde-885	90	19	it	it	PRON
ejde-885	90	20	is	be	AUX
ejde-885	90	21	essential	essential	ADJ
ejde-885	90	22	to	to	PART
ejde-885	90	23	formulate	formulate	VERB
ejde-885	90	24	the	the	DET
ejde-885	90	25	relationship	relationship	NOUN
ejde-885	90	26	between	between	ADP
ejde-885	90	27	the	the	DET
ejde-885	90	28	two	two	NUM
ejde-885	90	29	systems	system	NOUN
ejde-885	90	30	.	.	PUNCT
ejde-885	91	1	fortunately	fortunately	ADV
ejde-885	91	2	,	,	PUNCT
ejde-885	91	3	the	the	DET
ejde-885	91	4	relatively	relatively	ADV
ejde-885	91	5	small	small	ADJ
ejde-885	91	6	size	size	NOUN
ejde-885	91	7	of	of	ADP
ejde-885	91	8	a	a	DET
ejde-885	91	9	clinical	clinical	ADJ
ejde-885	91	10	trial	trial	NOUN
ejde-885	91	11	population	population	NOUN
ejde-885	91	12	compared	compare	VERB
ejde-885	91	13	to	to	ADP
ejde-885	91	14	ejde-2024	ejde-2024	ADJ
ejde-885	91	15	/	/	SYM
ejde-885	91	16	conf/27	conf/27	NOUN
ejde-885	91	17	clinical	clinical	ADJ
ejde-885	91	18	trial	trial	NOUN
ejde-885	91	19	modeling	model	VERB
ejde-885	91	20	5	5	NUM
ejde-885	91	21	the	the	DET
ejde-885	91	22	much	much	ADV
ejde-885	91	23	larger	large	ADJ
ejde-885	91	24	size	size	NOUN
ejde-885	91	25	of	of	ADP
ejde-885	91	26	the	the	DET
ejde-885	91	27	general	general	ADJ
ejde-885	91	28	population	population	NOUN
ejde-885	91	29	simplifies	simplify	VERB
ejde-885	91	30	the	the	DET
ejde-885	91	31	process	process	NOUN
ejde-885	91	32	.	.	PUNCT
ejde-885	92	1	while	while	SCONJ
ejde-885	92	2	the	the	DET
ejde-885	92	3	dynamics	dynamic	NOUN
ejde-885	92	4	of	of	ADP
ejde-885	92	5	the	the	DET
ejde-885	92	6	ongoing	ongoing	ADJ
ejde-885	92	7	epidemic	epidemic	NOUN
ejde-885	92	8	certainly	certainly	ADV
ejde-885	92	9	affect	affect	VERB
ejde-885	92	10	infection	infection	NOUN
ejde-885	92	11	rates	rate	NOUN
ejde-885	92	12	experienced	experience	VERB
ejde-885	92	13	by	by	ADP
ejde-885	92	14	the	the	DET
ejde-885	92	15	clinical	clinical	ADJ
ejde-885	92	16	trial	trial	NOUN
ejde-885	92	17	population	population	NOUN
ejde-885	92	18	,	,	PUNCT
ejde-885	92	19	we	we	PRON
ejde-885	92	20	can	can	AUX
ejde-885	92	21	ignore	ignore	VERB
ejde-885	92	22	any	any	DET
ejde-885	92	23	impact	impact	NOUN
ejde-885	92	24	that	that	PRON
ejde-885	92	25	the	the	DET
ejde-885	92	26	clinical	clinical	ADJ
ejde-885	92	27	trial	trial	NOUN
ejde-885	92	28	population	population	NOUN
ejde-885	92	29	will	will	AUX
ejde-885	92	30	have	have	VERB
ejde-885	92	31	on	on	ADP
ejde-885	92	32	the	the	DET
ejde-885	92	33	trajectory	trajectory	NOUN
ejde-885	92	34	of	of	ADP
ejde-885	92	35	the	the	DET
ejde-885	92	36	epidemic	epidemic	NOUN
ejde-885	92	37	in	in	ADP
ejde-885	92	38	the	the	DET
ejde-885	92	39	overall	overall	ADJ
ejde-885	92	40	population	population	NOUN
ejde-885	92	41	.	.	PUNCT
ejde-885	93	1	clinical	clinical	ADJ
ejde-885	93	2	trials	trial	NOUN
ejde-885	93	3	can	can	AUX
ejde-885	93	4	be	be	AUX
ejde-885	93	5	large	large	ADJ
ejde-885	93	6	and	and	CCONJ
ejde-885	93	7	include	include	VERB
ejde-885	93	8	thousands	thousand	NOUN
ejde-885	93	9	of	of	ADP
ejde-885	93	10	individuals	individual	NOUN
ejde-885	93	11	.	.	PUNCT
ejde-885	94	1	however	however	ADV
ejde-885	94	2	,	,	PUNCT
ejde-885	94	3	the	the	DET
ejde-885	94	4	protective	protective	ADJ
ejde-885	94	5	effect	effect	NOUN
ejde-885	94	6	experienced	experience	VERB
ejde-885	94	7	by	by	ADP
ejde-885	94	8	those	those	DET
ejde-885	94	9	individuals	individual	NOUN
ejde-885	94	10	will	will	AUX
ejde-885	94	11	not	not	PART
ejde-885	94	12	change	change	VERB
ejde-885	94	13	the	the	DET
ejde-885	94	14	experience	experience	NOUN
ejde-885	94	15	of	of	ADP
ejde-885	94	16	the	the	DET
ejde-885	94	17	millions	million	NOUN
ejde-885	94	18	of	of	ADP
ejde-885	94	19	individuals	individual	NOUN
ejde-885	94	20	in	in	ADP
ejde-885	94	21	the	the	DET
ejde-885	94	22	general	general	ADJ
ejde-885	94	23	population	population	NOUN
ejde-885	94	24	.	.	PUNCT
ejde-885	95	1	to	to	PART
ejde-885	95	2	couple	couple	VERB
ejde-885	95	3	the	the	DET
ejde-885	95	4	two	two	NUM
ejde-885	95	5	models	model	NOUN
ejde-885	95	6	,	,	PUNCT
ejde-885	95	7	we	we	PRON
ejde-885	95	8	must	must	AUX
ejde-885	95	9	express	express	VERB
ejde-885	95	10	the	the	DET
ejde-885	95	11	probability	probability	NOUN
ejde-885	95	12	of	of	ADP
ejde-885	95	13	infection	infection	NOUN
ejde-885	95	14	for	for	ADP
ejde-885	95	15	a	a	DET
ejde-885	95	16	given	give	VERB
ejde-885	95	17	time	time	NOUN
ejde-885	95	18	step	step	NOUN
ejde-885	95	19	in	in	ADP
ejde-885	95	20	the	the	DET
ejde-885	95	21	discrete	discrete	ADJ
ejde-885	95	22	model	model	NOUN
ejde-885	95	23	in	in	ADP
ejde-885	95	24	terms	term	NOUN
ejde-885	95	25	of	of	ADP
ejde-885	95	26	the	the	DET
ejde-885	95	27	disease	disease	NOUN
ejde-885	95	28	incidence	incidence	NOUN
ejde-885	95	29	resulting	result	VERB
ejde-885	95	30	from	from	ADP
ejde-885	95	31	the	the	DET
ejde-885	95	32	continuous	continuous	ADJ
ejde-885	95	33	epidemiological	epidemiological	ADJ
ejde-885	95	34	model	model	NOUN
ejde-885	95	35	.	.	PUNCT
ejde-885	96	1	we	we	PRON
ejde-885	96	2	do	do	VERB
ejde-885	96	3	so	so	ADV
ejde-885	96	4	using	use	VERB
ejde-885	96	5	the	the	DET
ejde-885	96	6	formula	formula	NOUN
ejde-885	96	7	probability	probability	NOUN
ejde-885	96	8	of	of	ADP
ejde-885	96	9	infection	infection	NOUN
ejde-885	96	10	for	for	ADP
ejde-885	96	11	time	time	NOUN
ejde-885	96	12	step	step	NOUN
ejde-885	96	13	=	=	PUNCT
ejde-885	96	14	new	new	ADJ
ejde-885	96	15	infections	infection	NOUN
ejde-885	96	16	for	for	ADP
ejde-885	96	17	time	time	NOUN
ejde-885	96	18	step	step	NOUN
ejde-885	96	19	number	number	NOUN
ejde-885	96	20	of	of	ADP
ejde-885	96	21	uninfectious	uninfectious	ADJ
ejde-885	96	22	individuals	individual	NOUN
ejde-885	96	23	at	at	ADP
ejde-885	96	24	the	the	DET
ejde-885	96	25	beginning	beginning	NOUN
ejde-885	96	26	of	of	ADP
ejde-885	96	27	the	the	DET
ejde-885	96	28	time	time	NOUN
ejde-885	96	29	step	step	NOUN
ejde-885	96	30	=	=	SYM
ejde-885	96	31	∫	∫	PROPN
ejde-885	96	32	t0+∆t	t0+∆t	PROPN
ejde-885	96	33	t0	t0	PROPN
ejde-885	96	34	γe(t	γe(t	PUNCT
ejde-885	96	35	)	)	PUNCT
ejde-885	96	36	dt	dt	PROPN
ejde-885	96	37	s(t0	s(t0	PROPN
ejde-885	96	38	)	)	PUNCT
ejde-885	97	1	+	+	CCONJ
ejde-885	97	2	e(t0	e(t0	NOUN
ejde-885	97	3	)	)	PUNCT
ejde-885	98	1	+	+	NOUN
ejde-885	98	2	r(t0	r(t0	NOUN
ejde-885	98	3	)	)	PUNCT
ejde-885	98	4	,	,	PUNCT
ejde-885	98	5	where	where	SCONJ
ejde-885	98	6	the	the	DET
ejde-885	98	7	time	time	NOUN
ejde-885	98	8	step	step	NOUN
ejde-885	98	9	j	j	PROPN
ejde-885	98	10	+	+	CCONJ
ejde-885	98	11	1	1	NUM
ejde-885	98	12	in	in	ADP
ejde-885	98	13	the	the	DET
ejde-885	98	14	clinical	clinical	ADJ
ejde-885	98	15	trial	trial	NOUN
ejde-885	98	16	model	model	NOUN
ejde-885	98	17	corresponds	correspond	VERB
ejde-885	98	18	to	to	ADP
ejde-885	98	19	the	the	DET
ejde-885	98	20	interval	interval	NOUN
ejde-885	98	21	(	(	PUNCT
ejde-885	98	22	t0	t0	PROPN
ejde-885	98	23	,	,	PUNCT
ejde-885	98	24	t0	t0	PROPN
ejde-885	98	25	+	+	CCONJ
ejde-885	98	26	∆t	∆t	PROPN
ejde-885	98	27	)	)	PUNCT
ejde-885	98	28	in	in	ADP
ejde-885	98	29	the	the	DET
ejde-885	98	30	epidemiological	epidemiological	ADJ
ejde-885	98	31	model	model	NOUN
ejde-885	98	32	.	.	PUNCT
ejde-885	99	1	in	in	ADP
ejde-885	99	2	all	all	PRON
ejde-885	99	3	of	of	ADP
ejde-885	99	4	our	our	PRON
ejde-885	99	5	simulations	simulation	NOUN
ejde-885	99	6	,	,	PUNCT
ejde-885	99	7	we	we	PRON
ejde-885	99	8	use	use	VERB
ejde-885	99	9	a	a	DET
ejde-885	99	10	clinical	clinical	ADJ
ejde-885	99	11	trial	trial	NOUN
ejde-885	99	12	timestep	timestep	NOUN
ejde-885	99	13	of	of	ADP
ejde-885	99	14	∆t	∆t	PROPN
ejde-885	99	15	=	=	SYM
ejde-885	99	16	14	14	NUM
ejde-885	99	17	days	day	NOUN
ejde-885	99	18	.	.	PUNCT
ejde-885	100	1	with	with	ADP
ejde-885	100	2	the	the	DET
ejde-885	100	3	linked	link	VERB
ejde-885	100	4	epidemiological	epidemiological	ADJ
ejde-885	100	5	and	and	CCONJ
ejde-885	100	6	clinical	clinical	ADJ
ejde-885	100	7	trial	trial	NOUN
ejde-885	100	8	models	model	NOUN
ejde-885	100	9	,	,	PUNCT
ejde-885	100	10	we	we	PRON
ejde-885	100	11	can	can	AUX
ejde-885	100	12	state	state	VERB
ejde-885	100	13	the	the	DET
ejde-885	100	14	plan	plan	NOUN
ejde-885	100	15	for	for	ADP
ejde-885	100	16	our	our	PRON
ejde-885	100	17	general	general	ADJ
ejde-885	100	18	simulation	simulation	NOUN
ejde-885	100	19	as	as	SCONJ
ejde-885	100	20	illustrated	illustrate	VERB
ejde-885	100	21	in	in	ADP
ejde-885	100	22	figure	figure	NOUN
ejde-885	100	23	1	1	NUM
ejde-885	100	24	.	.	PUNCT
ejde-885	100	25	figure	figure	NOUN
ejde-885	100	26	1	1	NUM
ejde-885	100	27	.	.	PUNCT
ejde-885	100	28	general	general	ADJ
ejde-885	100	29	simulation	simulation	NOUN
ejde-885	100	30	linking	link	VERB
ejde-885	100	31	epidemiological	epidemiological	ADJ
ejde-885	100	32	dynamics	dynamic	NOUN
ejde-885	100	33	to	to	ADP
ejde-885	100	34	those	those	PRON
ejde-885	100	35	of	of	ADP
ejde-885	100	36	vaccine	vaccine	NOUN
ejde-885	100	37	clinical	clinical	ADJ
ejde-885	100	38	trials	trial	NOUN
ejde-885	100	39	in	in	ADP
ejde-885	100	40	adults	adult	NOUN
ejde-885	100	41	and	and	CCONJ
ejde-885	100	42	children	child	NOUN
ejde-885	100	43	.	.	PUNCT
ejde-885	101	1	for	for	ADP
ejde-885	101	2	simplicity	simplicity	NOUN
ejde-885	101	3	,	,	PUNCT
ejde-885	101	4	we	we	PRON
ejde-885	101	5	assume	assume	VERB
ejde-885	101	6	that	that	SCONJ
ejde-885	101	7	the	the	DET
ejde-885	101	8	respiratory	respiratory	ADJ
ejde-885	101	9	infection	infection	NOUN
ejde-885	101	10	of	of	ADP
ejde-885	101	11	interest	interest	NOUN
ejde-885	101	12	is	be	AUX
ejde-885	101	13	transmitted	transmit	VERB
ejde-885	101	14	in	in	ADP
ejde-885	101	15	waves	wave	NOUN
ejde-885	101	16	(	(	PUNCT
ejde-885	101	17	as	as	SCONJ
ejde-885	101	18	was	be	AUX
ejde-885	101	19	true	true	ADJ
ejde-885	101	20	with	with	ADP
ejde-885	101	21	covid	covid	PROPN
ejde-885	101	22	and	and	CCONJ
ejde-885	101	23	for	for	ADP
ejde-885	101	24	seasonal	seasonal	ADJ
ejde-885	101	25	respiratory	respiratory	ADJ
ejde-885	101	26	infections	infection	NOUN
ejde-885	101	27	)	)	PUNCT
ejde-885	101	28	.	.	PUNCT
ejde-885	102	1	for	for	ADP
ejde-885	102	2	a	a	DET
ejde-885	102	3	clear	clear	ADJ
ejde-885	102	4	comparison	comparison	NOUN
ejde-885	102	5	,	,	PUNCT
ejde-885	102	6	we	we	PRON
ejde-885	102	7	will	will	AUX
ejde-885	102	8	also	also	ADV
ejde-885	102	9	assume	assume	VERB
ejde-885	102	10	that	that	SCONJ
ejde-885	102	11	these	these	DET
ejde-885	102	12	waves	wave	NOUN
ejde-885	102	13	occur	occur	VERB
ejde-885	102	14	a	a	DET
ejde-885	102	15	year	year	NOUN
ejde-885	102	16	apart	apart	ADV
ejde-885	102	17	and	and	CCONJ
ejde-885	102	18	are	be	AUX
ejde-885	102	19	identical	identical	ADJ
ejde-885	102	20	except	except	SCONJ
ejde-885	102	21	for	for	ADP
ejde-885	102	22	the	the	DET
ejde-885	102	23	aspects	aspect	NOUN
ejde-885	102	24	that	that	PRON
ejde-885	102	25	are	be	AUX
ejde-885	102	26	the	the	DET
ejde-885	102	27	focal	focal	ADJ
ejde-885	102	28	point	point	NOUN
ejde-885	102	29	of	of	ADP
ejde-885	102	30	this	this	DET
ejde-885	102	31	study	study	NOUN
ejde-885	102	32	.	.	PUNCT
ejde-885	103	1	we	we	PRON
ejde-885	103	2	assume	assume	VERB
ejde-885	103	3	that	that	SCONJ
ejde-885	103	4	a	a	DET
ejde-885	103	5	phase	phase	NOUN
ejde-885	103	6	3	3	NUM
ejde-885	103	7	vaccine	vaccine	NOUN
ejde-885	103	8	clinical	clinical	ADJ
ejde-885	103	9	trial	trial	NOUN
ejde-885	103	10	begins	begin	VERB
ejde-885	103	11	on	on	ADP
ejde-885	103	12	the	the	DET
ejde-885	103	13	100th	100th	ADJ
ejde-885	103	14	day	day	NOUN
ejde-885	103	15	of	of	ADP
ejde-885	103	16	the	the	DET
ejde-885	103	17	first	first	ADJ
ejde-885	103	18	wave	wave	NOUN
ejde-885	103	19	of	of	ADP
ejde-885	103	20	the	the	DET
ejde-885	103	21	epidemic	epidemic	NOUN
ejde-885	103	22	.	.	PUNCT
ejde-885	104	1	this	this	DET
ejde-885	104	2	first	first	ADJ
ejde-885	104	3	clinical	clinical	ADJ
ejde-885	104	4	trial	trial	NOUN
ejde-885	104	5	is	be	AUX
ejde-885	104	6	conducted	conduct	VERB
ejde-885	104	7	to	to	PART
ejde-885	104	8	measure	measure	VERB
ejde-885	104	9	vaccine	vaccine	NOUN
ejde-885	104	10	efficacy	efficacy	NOUN
ejde-885	104	11	in	in	ADP
ejde-885	104	12	adults	adult	NOUN
ejde-885	104	13	and	and	CCONJ
ejde-885	104	14	infection	infection	NOUN
ejde-885	104	15	rates	rate	NOUN
ejde-885	104	16	of	of	ADP
ejde-885	104	17	the	the	DET
ejde-885	104	18	clinical	clinical	ADJ
ejde-885	104	19	trial	trial	NOUN
ejde-885	104	20	population	population	NOUN
ejde-885	104	21	(	(	PUNCT
ejde-885	104	22	both	both	CCONJ
ejde-885	104	23	experimental	experimental	ADJ
ejde-885	104	24	and	and	CCONJ
ejde-885	104	25	control	control	NOUN
ejde-885	104	26	groups	group	NOUN
ejde-885	104	27	)	)	PUNCT
ejde-885	104	28	are	be	AUX
ejde-885	104	29	governed	govern	VERB
ejde-885	104	30	by	by	ADP
ejde-885	104	31	the	the	DET
ejde-885	104	32	state	state	NOUN
ejde-885	104	33	of	of	ADP
ejde-885	104	34	the	the	DET
ejde-885	104	35	ongoing	ongoing	ADJ
ejde-885	104	36	epidemic	epidemic	NOUN
ejde-885	104	37	in	in	ADP
ejde-885	104	38	the	the	DET
ejde-885	104	39	general	general	ADJ
ejde-885	104	40	population	population	NOUN
ejde-885	104	41	at	at	ADP
ejde-885	104	42	large	large	ADJ
ejde-885	104	43	.	.	PUNCT
ejde-885	105	1	these	these	DET
ejde-885	105	2	infection	infection	NOUN
ejde-885	105	3	rates	rate	NOUN
ejde-885	105	4	in	in	ADP
ejde-885	105	5	the	the	DET
ejde-885	105	6	adult	adult	NOUN
ejde-885	105	7	clinical	clinical	ADJ
ejde-885	105	8	trial	trial	NOUN
ejde-885	105	9	are	be	AUX
ejde-885	105	10	tracked	track	VERB
ejde-885	105	11	by	by	ADP
ejde-885	105	12	the	the	DET
ejde-885	105	13	model	model	NOUN
ejde-885	105	14	in	in	ADP
ejde-885	105	15	equations	equation	NOUN
ejde-885	105	16	3.1	3.1	NUM
ejde-885	105	17	-	-	SYM
ejde-885	105	18	3.4	3.4	NUM
ejde-885	105	19	.	.	PUNCT
ejde-885	106	1	we	we	PRON
ejde-885	106	2	assume	assume	VERB
ejde-885	106	3	that	that	SCONJ
ejde-885	106	4	the	the	DET
ejde-885	106	5	vaccine	vaccine	NOUN
ejde-885	106	6	is	be	AUX
ejde-885	106	7	approved	approve	VERB
ejde-885	106	8	for	for	ADP
ejde-885	106	9	use	use	NOUN
ejde-885	106	10	in	in	ADP
ejde-885	106	11	adults	adult	NOUN
ejde-885	106	12	and	and	CCONJ
ejde-885	106	13	that	that	SCONJ
ejde-885	106	14	a	a	DET
ejde-885	106	15	certain	certain	ADJ
ejde-885	106	16	level	level	NOUN
ejde-885	106	17	of	of	ADP
ejde-885	106	18	vaccine	vaccine	NOUN
ejde-885	106	19	coverage	coverage	NOUN
ejde-885	106	20	has	have	AUX
ejde-885	106	21	been	be	AUX
ejde-885	106	22	achieved	achieve	VERB
ejde-885	106	23	by	by	ADP
ejde-885	106	24	the	the	DET
ejde-885	106	25	beginning	beginning	NOUN
ejde-885	106	26	of	of	ADP
ejde-885	106	27	the	the	DET
ejde-885	106	28	second	second	ADJ
ejde-885	106	29	wave	wave	NOUN
ejde-885	106	30	of	of	ADP
ejde-885	106	31	the	the	DET
ejde-885	106	32	epidemic	epidemic	NOUN
ejde-885	106	33	.	.	PUNCT
ejde-885	107	1	for	for	ADP
ejde-885	107	2	simplicity	simplicity	NOUN
ejde-885	107	3	,	,	PUNCT
ejde-885	107	4	this	this	DET
ejde-885	107	5	second	second	ADJ
ejde-885	107	6	wave	wave	NOUN
ejde-885	107	7	begins	begin	VERB
ejde-885	107	8	exactly	exactly	ADV
ejde-885	107	9	one	one	NUM
ejde-885	107	10	year	year	NOUN
ejde-885	107	11	after	after	ADP
ejde-885	107	12	the	the	DET
ejde-885	107	13	first	first	ADJ
ejde-885	107	14	wave	wave	NOUN
ejde-885	107	15	.	.	PUNCT
ejde-885	108	1	also	also	ADV
ejde-885	108	2	for	for	ADP
ejde-885	108	3	simplicity	simplicity	NOUN
ejde-885	108	4	,	,	PUNCT
ejde-885	108	5	the	the	DET
ejde-885	108	6	clinical	clinical	ADJ
ejde-885	108	7	trial	trial	NOUN
ejde-885	108	8	6	6	NUM
ejde-885	108	9	d.	d.	PROPN
ejde-885	108	10	gerberry	gerberry	PROPN
ejde-885	108	11	,	,	PUNCT
ejde-885	108	12	h.	h.	PROPN
ejde-885	108	13	joshi	joshi	PROPN
ejde-885	108	14	,	,	PUNCT
ejde-885	108	15	m.	m.	NOUN
ejde-885	108	16	peloquin	peloquin	NOUN
ejde-885	108	17	,	,	PUNCT
ejde-885	108	18	s.	s.	PROPN
ejde-885	108	19	vargas	vargas	PROPN
ejde-885	108	20	ejde-2022	ejde-2022	NOUN
ejde-885	108	21	/	/	SYM
ejde-885	108	22	conf/26	conf/26	NOUN
ejde-885	108	23	for	for	ADP
ejde-885	108	24	vaccination	vaccination	NOUN
ejde-885	108	25	in	in	ADP
ejde-885	108	26	children	child	NOUN
ejde-885	108	27	begins	begin	VERB
ejde-885	108	28	100	100	NUM
ejde-885	108	29	days	day	NOUN
ejde-885	108	30	into	into	ADP
ejde-885	108	31	this	this	DET
ejde-885	108	32	second	second	ADJ
ejde-885	108	33	wave	wave	NOUN
ejde-885	108	34	of	of	ADP
ejde-885	108	35	the	the	DET
ejde-885	108	36	epidemic	epidemic	NOUN
ejde-885	108	37	.	.	PUNCT
ejde-885	109	1	the	the	DET
ejde-885	109	2	only	only	ADJ
ejde-885	109	3	difference	difference	NOUN
ejde-885	109	4	between	between	ADP
ejde-885	109	5	the	the	DET
ejde-885	109	6	first	first	ADJ
ejde-885	109	7	and	and	CCONJ
ejde-885	109	8	second	second	ADJ
ejde-885	109	9	waves	wave	NOUN
ejde-885	109	10	is	be	AUX
ejde-885	109	11	the	the	DET
ejde-885	109	12	effect	effect	NOUN
ejde-885	109	13	of	of	ADP
ejde-885	109	14	adults	adult	NOUN
ejde-885	109	15	being	be	AUX
ejde-885	109	16	vaccinated	vaccinate	VERB
ejde-885	109	17	in	in	ADP
ejde-885	109	18	the	the	DET
ejde-885	109	19	population	population	NOUN
ejde-885	109	20	at	at	ADP
ejde-885	109	21	large	large	ADJ
ejde-885	109	22	during	during	ADP
ejde-885	109	23	the	the	DET
ejde-885	109	24	second	second	ADJ
ejde-885	109	25	wave	wave	NOUN
ejde-885	109	26	.	.	PUNCT
ejde-885	110	1	4	4	X
ejde-885	110	2	.	.	X
ejde-885	110	3	simulation	simulation	NOUN
ejde-885	110	4	results	result	VERB
ejde-885	110	5	in	in	ADP
ejde-885	110	6	this	this	DET
ejde-885	110	7	work	work	NOUN
ejde-885	110	8	,	,	PUNCT
ejde-885	110	9	our	our	PRON
ejde-885	110	10	goal	goal	NOUN
ejde-885	110	11	is	be	AUX
ejde-885	110	12	to	to	PART
ejde-885	110	13	examine	examine	VERB
ejde-885	110	14	the	the	DET
ejde-885	110	15	interplay	interplay	NOUN
ejde-885	110	16	between	between	ADP
ejde-885	110	17	background	background	NOUN
ejde-885	110	18	epidemiological	epidemiological	ADJ
ejde-885	110	19	dynamics	dynamic	NOUN
ejde-885	110	20	and	and	CCONJ
ejde-885	110	21	the	the	DET
ejde-885	110	22	outcomes	outcome	NOUN
ejde-885	110	23	of	of	ADP
ejde-885	110	24	clinical	clinical	ADJ
ejde-885	110	25	trials	trial	NOUN
ejde-885	110	26	for	for	ADP
ejde-885	110	27	a	a	DET
ejde-885	110	28	new	new	ADJ
ejde-885	110	29	vaccine	vaccine	NOUN
ejde-885	110	30	.	.	PUNCT
ejde-885	111	1	more	more	ADV
ejde-885	111	2	specifically	specifically	ADV
ejde-885	111	3	,	,	PUNCT
ejde-885	111	4	we	we	PRON
ejde-885	111	5	are	be	AUX
ejde-885	111	6	interested	interested	ADJ
ejde-885	111	7	in	in	ADP
ejde-885	111	8	the	the	DET
ejde-885	111	9	situation	situation	NOUN
ejde-885	111	10	where	where	SCONJ
ejde-885	111	11	a	a	DET
ejde-885	111	12	vaccine	vaccine	NOUN
ejde-885	111	13	is	be	AUX
ejde-885	111	14	tested	test	VERB
ejde-885	111	15	and	and	CCONJ
ejde-885	111	16	approved	approve	VERB
ejde-885	111	17	for	for	ADP
ejde-885	111	18	adults	adult	NOUN
ejde-885	111	19	before	before	ADP
ejde-885	111	20	a	a	DET
ejde-885	111	21	clinical	clinical	ADJ
ejde-885	111	22	trial	trial	NOUN
ejde-885	111	23	for	for	ADP
ejde-885	111	24	the	the	DET
ejde-885	111	25	vaccine	vaccine	NOUN
ejde-885	111	26	in	in	ADP
ejde-885	111	27	children	child	NOUN
ejde-885	111	28	begins	begin	VERB
ejde-885	111	29	.	.	PUNCT
ejde-885	112	1	to	to	PART
ejde-885	112	2	do	do	VERB
ejde-885	112	3	so	so	ADV
ejde-885	112	4	,	,	PUNCT
ejde-885	112	5	we	we	PRON
ejde-885	112	6	proceed	proceed	VERB
ejde-885	112	7	to	to	ADP
ejde-885	112	8	numerical	numerical	ADJ
ejde-885	112	9	simulations	simulation	NOUN
ejde-885	112	10	.	.	PUNCT
ejde-885	113	1	first	first	ADV
ejde-885	113	2	,	,	PUNCT
ejde-885	113	3	we	we	PRON
ejde-885	113	4	will	will	AUX
ejde-885	113	5	examine	examine	VERB
ejde-885	113	6	this	this	DET
ejde-885	113	7	interplay	interplay	NOUN
ejde-885	113	8	when	when	SCONJ
ejde-885	113	9	no	no	DET
ejde-885	113	10	heterogeneity	heterogeneity	NOUN
ejde-885	113	11	between	between	ADP
ejde-885	113	12	adults	adult	NOUN
ejde-885	113	13	and	and	CCONJ
ejde-885	113	14	children	child	NOUN
ejde-885	113	15	is	be	AUX
ejde-885	113	16	assumed	assume	VERB
ejde-885	113	17	in	in	ADP
ejde-885	113	18	population	population	NOUN
ejde-885	113	19	size	size	NOUN
ejde-885	113	20	,	,	PUNCT
ejde-885	113	21	contact	contact	NOUN
ejde-885	113	22	rates	rate	NOUN
ejde-885	113	23	,	,	PUNCT
ejde-885	113	24	and	and	CCONJ
ejde-885	113	25	disease	disease	NOUN
ejde-885	113	26	outcomes	outcome	NOUN
ejde-885	113	27	.	.	PUNCT
ejde-885	114	1	we	we	PRON
ejde-885	114	2	then	then	ADV
ejde-885	114	3	conduct	conduct	VERB
ejde-885	114	4	the	the	DET
ejde-885	114	5	same	same	ADJ
ejde-885	114	6	analyses	analysis	NOUN
ejde-885	114	7	when	when	SCONJ
ejde-885	114	8	heterogeneity	heterogeneity	NOUN
ejde-885	114	9	is	be	AUX
ejde-885	114	10	incorporated	incorporate	VERB
ejde-885	114	11	.	.	PUNCT
ejde-885	115	1	importantly	importantly	ADV
ejde-885	115	2	,	,	PUNCT
ejde-885	115	3	the	the	DET
ejde-885	115	4	epidemiological	epidemiological	ADJ
ejde-885	115	5	model	model	NOUN
ejde-885	115	6	stated	state	VERB
ejde-885	115	7	in	in	ADP
ejde-885	115	8	section	section	NOUN
ejde-885	115	9	2	2	NUM
ejde-885	115	10	does	do	AUX
ejde-885	115	11	not	not	PART
ejde-885	115	12	include	include	VERB
ejde-885	115	13	vaccination	vaccination	NOUN
ejde-885	115	14	.	.	PUNCT
ejde-885	116	1	for	for	ADP
ejde-885	116	2	the	the	DET
ejde-885	116	3	second	second	ADJ
ejde-885	116	4	wave	wave	NOUN
ejde-885	116	5	of	of	ADP
ejde-885	116	6	the	the	DET
ejde-885	116	7	epidemic	epidemic	NOUN
ejde-885	116	8	,	,	PUNCT
ejde-885	116	9	we	we	PRON
ejde-885	116	10	assume	assume	VERB
ejde-885	116	11	that	that	SCONJ
ejde-885	116	12	a	a	DET
ejde-885	116	13	vaccine	vaccine	NOUN
ejde-885	116	14	coverage	coverage	NOUN
ejde-885	116	15	of	of	ADP
ejde-885	116	16	c	c	PROPN
ejde-885	116	17	in	in	ADP
ejde-885	116	18	the	the	DET
ejde-885	116	19	adult	adult	NOUN
ejde-885	116	20	population	population	NOUN
ejde-885	116	21	because	because	SCONJ
ejde-885	116	22	the	the	DET
ejde-885	116	23	vaccine	vaccine	NOUN
ejde-885	116	24	was	be	AUX
ejde-885	116	25	tested	test	VERB
ejde-885	116	26	and	and	CCONJ
ejde-885	116	27	approved	approve	VERB
ejde-885	116	28	for	for	ADP
ejde-885	116	29	adults	adult	NOUN
ejde-885	116	30	during	during	ADP
ejde-885	116	31	the	the	DET
ejde-885	116	32	first	first	ADJ
ejde-885	116	33	wave	wave	NOUN
ejde-885	116	34	.	.	PUNCT
ejde-885	117	1	to	to	PART
ejde-885	117	2	account	account	VERB
ejde-885	117	3	for	for	ADP
ejde-885	117	4	this	this	PRON
ejde-885	117	5	most	most	ADV
ejde-885	117	6	clearly	clearly	ADV
ejde-885	117	7	,	,	PUNCT
ejde-885	117	8	we	we	PRON
ejde-885	117	9	adapt	adapt	VERB
ejde-885	117	10	the	the	DET
ejde-885	117	11	first	first	ADJ
ejde-885	117	12	two	two	NUM
ejde-885	117	13	equations	equation	NOUN
ejde-885	117	14	for	for	ADP
ejde-885	117	15	susceptible	susceptible	ADJ
ejde-885	117	16	and	and	CCONJ
ejde-885	117	17	exposed	expose	VERB
ejde-885	117	18	adults	adult	NOUN
ejde-885	117	19	to	to	PART
ejde-885	117	20	become	become	VERB
ejde-885	117	21	s′	s′	ADJ
ejde-885	117	22	a	a	PRON
ejde-885	117	23	=	=	X
ejde-885	117	24	(	(	PUNCT
ejde-885	117	25	csa(1−	csa(1−	PROPN
ejde-885	117	26	e	e	PROPN
ejde-885	117	27	)	)	PUNCT
ejde-885	117	28	+	+	CCONJ
ejde-885	117	29	(	(	PUNCT
ejde-885	117	30	1−	1−	NUM
ejde-885	117	31	c)sa	c)sa	PROPN
ejde-885	117	32	na	na	PART
ejde-885	117	33	)	)	PUNCT
ejde-885	117	34	p(βaaia	p(βaaia	NOUN
ejde-885	117	35	+	+	CCONJ
ejde-885	117	36	βkaik	βkaik	NOUN
ejde-885	117	37	)	)	PUNCT
ejde-885	117	38	,	,	PUNCT
ejde-885	117	39	(	(	PUNCT
ejde-885	117	40	4.1	4.1	NUM
ejde-885	117	41	)	)	PUNCT
ejde-885	117	42	e′	e′	NOUN
ejde-885	117	43	a	a	X
ejde-885	117	44	=	=	PUNCT
ejde-885	117	45	(	(	PUNCT
ejde-885	117	46	csa(1−	csa(1−	PROPN
ejde-885	117	47	e	e	PROPN
ejde-885	117	48	)	)	PUNCT
ejde-885	118	1	+	+	CCONJ
ejde-885	118	2	(	(	PUNCT
ejde-885	118	3	1−	1−	NUM
ejde-885	118	4	c)sa	c)sa	PROPN
ejde-885	118	5	na	na	PART
ejde-885	118	6	)	)	PUNCT
ejde-885	118	7	p(βaaia	p(βaaia	NOUN
ejde-885	118	8	+	+	CCONJ
ejde-885	118	9	βkaik)−	βkaik)−	PROPN
ejde-885	118	10	γ1ea	γ1ea	X
ejde-885	118	11	,	,	PUNCT
ejde-885	118	12	(	(	PUNCT
ejde-885	118	13	4.2	4.2	NUM
ejde-885	118	14	)	)	PUNCT
ejde-885	118	15	where	where	SCONJ
ejde-885	118	16	c	c	NOUN
ejde-885	118	17	is	be	AUX
ejde-885	118	18	the	the	DET
ejde-885	118	19	vaccine	vaccine	NOUN
ejde-885	118	20	coverage	coverage	NOUN
ejde-885	118	21	in	in	ADP
ejde-885	118	22	the	the	DET
ejde-885	118	23	adult	adult	NOUN
ejde-885	118	24	population	population	NOUN
ejde-885	118	25	during	during	ADP
ejde-885	118	26	the	the	DET
ejde-885	118	27	second	second	ADJ
ejde-885	118	28	wave	wave	NOUN
ejde-885	118	29	of	of	ADP
ejde-885	118	30	the	the	DET
ejde-885	118	31	epidemic	epidemic	NOUN
ejde-885	118	32	and	and	CCONJ
ejde-885	118	33	e	e	NOUN
ejde-885	118	34	is	be	AUX
ejde-885	118	35	the	the	DET
ejde-885	118	36	protective	protective	ADJ
ejde-885	118	37	efficacy	efficacy	NOUN
ejde-885	118	38	of	of	ADP
ejde-885	118	39	the	the	DET
ejde-885	118	40	vaccine	vaccine	NOUN
ejde-885	118	41	.	.	PUNCT
ejde-885	119	1	4.1	4.1	NUM
ejde-885	119	2	.	.	PUNCT
ejde-885	119	3	results	result	NOUN
ejde-885	119	4	assuming	assume	VERB
ejde-885	119	5	homogeneous	homogeneous	ADJ
ejde-885	119	6	populations	population	NOUN
ejde-885	119	7	.	.	PUNCT
ejde-885	120	1	as	as	SCONJ
ejde-885	120	2	mentioned	mention	VERB
ejde-885	120	3	above	above	ADV
ejde-885	120	4	,	,	PUNCT
ejde-885	120	5	our	our	PRON
ejde-885	120	6	model	model	NOUN
ejde-885	120	7	represents	represent	VERB
ejde-885	120	8	a	a	DET
ejde-885	120	9	general	general	ADJ
ejde-885	120	10	respiratory	respiratory	ADJ
ejde-885	120	11	infection	infection	NOUN
ejde-885	120	12	for	for	ADP
ejde-885	120	13	which	which	PRON
ejde-885	120	14	a	a	DET
ejde-885	120	15	new	new	ADJ
ejde-885	120	16	vaccine	vaccine	NOUN
ejde-885	120	17	is	be	AUX
ejde-885	120	18	developed	develop	VERB
ejde-885	120	19	.	.	PUNCT
ejde-885	121	1	we	we	PRON
ejde-885	121	2	assume	assume	VERB
ejde-885	121	3	parameter	parameter	NOUN
ejde-885	121	4	values	value	NOUN
ejde-885	121	5	relevant	relevant	ADJ
ejde-885	121	6	to	to	ADP
ejde-885	121	7	such	such	ADJ
ejde-885	121	8	infections	infection	NOUN
ejde-885	121	9	but	but	CCONJ
ejde-885	121	10	not	not	PART
ejde-885	121	11	for	for	ADP
ejde-885	121	12	a	a	DET
ejde-885	121	13	specific	specific	ADJ
ejde-885	121	14	disease	disease	NOUN
ejde-885	121	15	.	.	PUNCT
ejde-885	122	1	we	we	PRON
ejde-885	122	2	begin	begin	VERB
ejde-885	122	3	the	the	DET
ejde-885	122	4	simulation	simulation	NOUN
ejde-885	122	5	of	of	ADP
ejde-885	122	6	each	each	DET
ejde-885	122	7	wave	wave	NOUN
ejde-885	122	8	of	of	ADP
ejde-885	122	9	the	the	DET
ejde-885	122	10	epidemic	epidemic	NOUN
ejde-885	122	11	using	use	VERB
ejde-885	122	12	the	the	DET
ejde-885	122	13	initial	initial	ADJ
ejde-885	122	14	values	value	NOUN
ejde-885	122	15	in	in	ADP
ejde-885	122	16	table	table	NOUN
ejde-885	122	17	1	1	NUM
ejde-885	122	18	.	.	PUNCT
ejde-885	123	1	note	note	VERB
ejde-885	123	2	that	that	SCONJ
ejde-885	123	3	we	we	PRON
ejde-885	123	4	assume	assume	VERB
ejde-885	123	5	there	there	PRON
ejde-885	123	6	are	be	VERB
ejde-885	123	7	an	an	DET
ejde-885	123	8	equal	equal	ADJ
ejde-885	123	9	number	number	NOUN
ejde-885	123	10	of	of	ADP
ejde-885	123	11	adults	adult	NOUN
ejde-885	123	12	and	and	CCONJ
ejde-885	123	13	children	child	NOUN
ejde-885	123	14	in	in	ADP
ejde-885	123	15	the	the	DET
ejde-885	123	16	population	population	NOUN
ejde-885	123	17	and	and	CCONJ
ejde-885	123	18	seed	seed	VERB
ejde-885	123	19	the	the	DET
ejde-885	123	20	epidemic	epidemic	NOUN
ejde-885	123	21	with	with	ADP
ejde-885	123	22	equal	equal	ADJ
ejde-885	123	23	numbers	number	NOUN
ejde-885	123	24	of	of	ADP
ejde-885	123	25	exposed	expose	VERB
ejde-885	123	26	and	and	CCONJ
ejde-885	123	27	infectious	infectious	ADJ
ejde-885	123	28	individuals	individual	NOUN
ejde-885	123	29	.	.	PUNCT
ejde-885	124	1	table	table	NOUN
ejde-885	124	2	1	1	NUM
ejde-885	124	3	.	.	PUNCT
ejde-885	124	4	initial	initial	ADJ
ejde-885	124	5	values	value	NOUN
ejde-885	124	6	of	of	ADP
ejde-885	124	7	state	state	NOUN
ejde-885	124	8	variables	variable	NOUN
ejde-885	124	9	used	use	VERB
ejde-885	124	10	at	at	ADP
ejde-885	124	11	the	the	DET
ejde-885	124	12	beginning	beginning	NOUN
ejde-885	124	13	of	of	ADP
ejde-885	124	14	both	both	CCONJ
ejde-885	124	15	the	the	DET
ejde-885	124	16	first	first	ADJ
ejde-885	124	17	and	and	CCONJ
ejde-885	124	18	second	second	ADJ
ejde-885	124	19	wave	wave	NOUN
ejde-885	124	20	of	of	ADP
ejde-885	124	21	the	the	DET
ejde-885	124	22	epidemic	epidemic	NOUN
ejde-885	124	23	when	when	SCONJ
ejde-885	124	24	assuming	assume	VERB
ejde-885	124	25	homogeneous	homogeneous	ADJ
ejde-885	124	26	populations	population	NOUN
ejde-885	124	27	.	.	PUNCT
ejde-885	125	1	variable	variable	ADJ
ejde-885	125	2	description	description	NOUN
ejde-885	125	3	initial	initial	ADJ
ejde-885	125	4	value	value	NOUN
ejde-885	125	5	sa	sa	NOUN
ejde-885	125	6	susceptible	susceptible	ADJ
ejde-885	125	7	adults	adult	NOUN
ejde-885	125	8	50,000	50,000	NUM
ejde-885	125	9	sk	sk	NOUN
ejde-885	125	10	susceptible	susceptible	ADJ
ejde-885	125	11	children	child	NOUN
ejde-885	125	12	50,000	50,000	NUM
ejde-885	125	13	ea	ea	NOUN
ejde-885	125	14	exposed	expose	VERB
ejde-885	125	15	adults	adult	NOUN
ejde-885	125	16	50	50	NUM
ejde-885	125	17	ek	ek	NOUN
ejde-885	125	18	exposed	expose	VERB
ejde-885	125	19	children	child	NOUN
ejde-885	125	20	50	50	NUM
ejde-885	125	21	ia	ia	NOUN
ejde-885	125	22	infected	infect	VERB
ejde-885	125	23	adults	adult	NOUN
ejde-885	125	24	2	2	NUM
ejde-885	125	25	ik	ik	PROPN
ejde-885	125	26	infected	infect	VERB
ejde-885	125	27	children	child	NOUN
ejde-885	125	28	2	2	NUM
ejde-885	125	29	ra	ra	NOUN
ejde-885	125	30	recovered	recover	VERB
ejde-885	125	31	adults	adult	NOUN
ejde-885	125	32	0	0	NUM
ejde-885	125	33	rk	rk	NOUN
ejde-885	125	34	recovered	recover	VERB
ejde-885	125	35	children	child	NOUN
ejde-885	125	36	0	0	NUM
ejde-885	125	37	for	for	ADP
ejde-885	125	38	the	the	DET
ejde-885	125	39	simulation	simulation	NOUN
ejde-885	125	40	carried	carry	VERB
ejde-885	125	41	out	out	ADP
ejde-885	125	42	under	under	ADP
ejde-885	125	43	the	the	DET
ejde-885	125	44	homogeneity	homogeneity	NOUN
ejde-885	125	45	assumption	assumption	NOUN
ejde-885	125	46	,	,	PUNCT
ejde-885	125	47	we	we	PRON
ejde-885	125	48	use	use	VERB
ejde-885	125	49	the	the	DET
ejde-885	125	50	model	model	NOUN
ejde-885	125	51	parameters	parameter	NOUN
ejde-885	125	52	summarized	summarize	VERB
ejde-885	125	53	in	in	ADP
ejde-885	125	54	table	table	NOUN
ejde-885	125	55	2	2	NUM
ejde-885	125	56	.	.	PUNCT
ejde-885	126	1	importantly	importantly	ADV
ejde-885	126	2	,	,	PUNCT
ejde-885	126	3	we	we	PRON
ejde-885	126	4	note	note	VERB
ejde-885	126	5	that	that	SCONJ
ejde-885	126	6	identical	identical	ADJ
ejde-885	126	7	ejde-2024	ejde-2024	ADJ
ejde-885	126	8	/	/	SYM
ejde-885	126	9	conf/27	conf/27	NOUN
ejde-885	126	10	clinical	clinical	ADJ
ejde-885	126	11	trial	trial	NOUN
ejde-885	126	12	modeling	model	VERB
ejde-885	126	13	7	7	NUM
ejde-885	126	14	contact	contact	NOUN
ejde-885	126	15	rates	rate	NOUN
ejde-885	126	16	are	be	AUX
ejde-885	126	17	used	use	VERB
ejde-885	126	18	between	between	ADP
ejde-885	126	19	the	the	DET
ejde-885	126	20	age	age	NOUN
ejde-885	126	21	groups	group	NOUN
ejde-885	126	22	in	in	ADP
ejde-885	126	23	the	the	DET
ejde-885	126	24	population	population	NOUN
ejde-885	126	25	.	.	PUNCT
ejde-885	127	1	moreover	moreover	ADV
ejde-885	127	2	,	,	PUNCT
ejde-885	127	3	disease	disease	NOUN
ejde-885	127	4	progression	progression	NOUN
ejde-885	127	5	,	,	PUNCT
ejde-885	127	6	mortality	mortality	NOUN
ejde-885	127	7	and	and	CCONJ
ejde-885	127	8	recovery	recovery	NOUN
ejde-885	127	9	rates	rate	NOUN
ejde-885	127	10	for	for	ADP
ejde-885	127	11	adults	adult	NOUN
ejde-885	127	12	and	and	CCONJ
ejde-885	127	13	children	child	NOUN
ejde-885	127	14	are	be	AUX
ejde-885	127	15	identical	identical	ADJ
ejde-885	127	16	.	.	PUNCT
ejde-885	128	1	table	table	NOUN
ejde-885	128	2	2	2	NUM
ejde-885	128	3	.	.	PUNCT
ejde-885	129	1	parameter	parameter	NOUN
ejde-885	129	2	values	value	NOUN
ejde-885	129	3	for	for	ADP
ejde-885	129	4	simulations	simulation	NOUN
ejde-885	129	5	when	when	SCONJ
ejde-885	129	6	assuming	assume	VERB
ejde-885	129	7	homogeneous	homogeneous	ADJ
ejde-885	129	8	populations	population	NOUN
ejde-885	129	9	.	.	PUNCT
ejde-885	130	1	†,‡	†,‡	PROPN
ejde-885	130	2	values	value	NOUN
ejde-885	130	3	used	use	VERB
ejde-885	130	4	for	for	ADP
ejde-885	130	5	first	first	ADJ
ejde-885	130	6	and	and	CCONJ
ejde-885	130	7	second	second	ADJ
ejde-885	130	8	waves	wave	NOUN
ejde-885	130	9	of	of	ADP
ejde-885	130	10	epidemic	epidemic	NOUN
ejde-885	130	11	respectively	respectively	ADV
ejde-885	130	12	.	.	PUNCT
ejde-885	131	1	∗	∗	NOUN
ejde-885	131	2	value	value	NOUN
ejde-885	131	3	adapted	adapt	VERB
ejde-885	131	4	from	from	ADP
ejde-885	131	5	[	[	X
ejde-885	131	6	13	13	NUM
ejde-885	131	7	]	]	PUNCT
ejde-885	131	8	by	by	ADP
ejde-885	131	9	averaging	average	VERB
ejde-885	131	10	age	age	NOUN
ejde-885	131	11	-	-	PUNCT
ejde-885	131	12	specific	specific	ADJ
ejde-885	131	13	contact	contact	NOUN
ejde-885	131	14	rates	rate	NOUN
ejde-885	131	15	.	.	PUNCT
ejde-885	132	1	parameter	parameter	NOUN
ejde-885	132	2	description	description	NOUN
ejde-885	132	3	value	value	NOUN
ejde-885	132	4	c	c	PROPN
ejde-885	132	5	vaccine	vaccine	NOUN
ejde-885	132	6	coverage	coverage	NOUN
ejde-885	132	7	in	in	ADP
ejde-885	132	8	adults	adult	NOUN
ejde-885	132	9	0†	0†	ADP
ejde-885	132	10	,	,	PUNCT
ejde-885	132	11	0.80‡	0.80‡	NUM
ejde-885	132	12	e	e	NOUN
ejde-885	132	13	vaccine	vaccine	NOUN
ejde-885	132	14	efficacy	efficacy	NOUN
ejde-885	132	15	0†	0†	ADP
ejde-885	132	16	,	,	PUNCT
ejde-885	132	17	0.80‡	0.80‡	X
ejde-885	133	1	p	p	PRON
ejde-885	133	2	probability	probability	NOUN
ejde-885	133	3	of	of	ADP
ejde-885	133	4	transmission	transmission	NOUN
ejde-885	133	5	0.10	0.10	NUM
ejde-885	133	6	βaa	βaa	NOUN
ejde-885	133	7	,	,	PUNCT
ejde-885	133	8	βka	βka	INTJ
ejde-885	133	9	,	,	PUNCT
ejde-885	133	10	βkk	βkk	ADJ
ejde-885	133	11	,	,	PUNCT
ejde-885	133	12	βak	βak	ADJ
ejde-885	133	13	contact	contact	NOUN
ejde-885	133	14	coefficient	coefficient	NOUN
ejde-885	133	15	0.974∗	0.974∗	NUM
ejde-885	133	16	γ1	γ1	PROPN
ejde-885	133	17	adult	adult	NOUN
ejde-885	133	18	progression	progression	NOUN
ejde-885	133	19	rate	rate	NOUN
ejde-885	133	20	1/21	1/21	NUM
ejde-885	133	21	γ2	γ2	ADJ
ejde-885	133	22	child	child	NOUN
ejde-885	133	23	progression	progression	NOUN
ejde-885	133	24	rate	rate	NOUN
ejde-885	133	25	1/21	1/21	NUM
ejde-885	133	26	ρ1	ρ1	NOUN
ejde-885	133	27	adult	adult	NOUN
ejde-885	133	28	recovery	recovery	NOUN
ejde-885	133	29	rate	rate	NOUN
ejde-885	133	30	1/21	1/21	NUM
ejde-885	133	31	ρ2	ρ2	NOUN
ejde-885	133	32	child	child	NOUN
ejde-885	133	33	recovery	recovery	NOUN
ejde-885	133	34	rate	rate	NOUN
ejde-885	133	35	1/21	1/21	NUM
ejde-885	133	36	δ1	δ1	NOUN
ejde-885	133	37	adult	adult	NOUN
ejde-885	133	38	disease	disease	NOUN
ejde-885	133	39	death	death	NOUN
ejde-885	133	40	rate	rate	NOUN
ejde-885	133	41	0.001	0.001	NUM
ejde-885	133	42	δ2	δ2	VERB
ejde-885	133	43	child	child	NOUN
ejde-885	133	44	disease	disease	NOUN
ejde-885	133	45	death	death	NOUN
ejde-885	133	46	rate	rate	NOUN
ejde-885	133	47	0.001	0.001	NUM
ejde-885	133	48	∆t	∆t	NOUN
ejde-885	133	49	days	day	NOUN
ejde-885	133	50	between	between	ADP
ejde-885	133	51	disease	disease	NOUN
ejde-885	133	52	14	14	NUM
ejde-885	133	53	days	day	NOUN
ejde-885	133	54	monitoring	monitor	VERB
ejde-885	133	55	in	in	ADP
ejde-885	133	56	ct	ct	NUM
ejde-885	133	57	for	for	ADP
ejde-885	133	58	illustration	illustration	NOUN
ejde-885	133	59	,	,	PUNCT
ejde-885	133	60	we	we	PRON
ejde-885	133	61	assume	assume	VERB
ejde-885	133	62	each	each	DET
ejde-885	133	63	vaccine	vaccine	NOUN
ejde-885	133	64	clinical	clinical	ADJ
ejde-885	133	65	trial	trial	NOUN
ejde-885	133	66	consists	consist	VERB
ejde-885	133	67	of	of	ADP
ejde-885	133	68	100	100	NUM
ejde-885	133	69	participants	participant	NOUN
ejde-885	133	70	;	;	PUNCT
ejde-885	133	71	50	50	NUM
ejde-885	133	72	randomly	randomly	ADV
ejde-885	133	73	assigned	assign	VERB
ejde-885	133	74	to	to	ADP
ejde-885	133	75	the	the	DET
ejde-885	133	76	treatment	treatment	NOUN
ejde-885	133	77	(	(	PUNCT
ejde-885	133	78	i.e.	i.e.	X
ejde-885	133	79	vaccination	vaccination	NOUN
ejde-885	133	80	)	)	PUNCT
ejde-885	133	81	arm	arm	NOUN
ejde-885	133	82	and	and	CCONJ
ejde-885	133	83	50	50	NUM
ejde-885	133	84	randomly	randomly	ADV
ejde-885	133	85	assigned	assign	VERB
ejde-885	133	86	to	to	ADP
ejde-885	133	87	the	the	DET
ejde-885	133	88	control	control	NOUN
ejde-885	133	89	group	group	NOUN
ejde-885	133	90	.	.	PUNCT
ejde-885	134	1	the	the	DET
ejde-885	134	2	number	number	NOUN
ejde-885	134	3	of	of	ADP
ejde-885	134	4	infections	infection	NOUN
ejde-885	134	5	in	in	ADP
ejde-885	134	6	the	the	DET
ejde-885	134	7	two	two	NUM
ejde-885	134	8	groups	group	NOUN
ejde-885	134	9	is	be	AUX
ejde-885	134	10	tracked	track	VERB
ejde-885	134	11	using	use	VERB
ejde-885	134	12	the	the	DET
ejde-885	134	13	clinical	clinical	ADJ
ejde-885	134	14	trial	trial	NOUN
ejde-885	134	15	model	model	NOUN
ejde-885	134	16	of	of	ADP
ejde-885	134	17	equations	equation	NOUN
ejde-885	134	18	3.1	3.1	NUM
ejde-885	134	19	-	-	SYM
ejde-885	134	20	3.4	3.4	NUM
ejde-885	134	21	.	.	PUNCT
ejde-885	135	1	through	through	ADP
ejde-885	135	2	the	the	DET
ejde-885	135	3	course	course	NOUN
ejde-885	135	4	of	of	ADP
ejde-885	135	5	the	the	DET
ejde-885	135	6	clinical	clinical	ADJ
ejde-885	135	7	trial	trial	NOUN
ejde-885	135	8	simulation	simulation	NOUN
ejde-885	135	9	,	,	PUNCT
ejde-885	135	10	we	we	PRON
ejde-885	135	11	track	track	VERB
ejde-885	135	12	the	the	DET
ejde-885	135	13	p	p	NOUN
ejde-885	135	14	-	-	PUNCT
ejde-885	135	15	value	value	NOUN
ejde-885	135	16	of	of	ADP
ejde-885	135	17	the	the	DET
ejde-885	135	18	different	different	ADJ
ejde-885	135	19	infection	infection	NOUN
ejde-885	135	20	rates	rate	NOUN
ejde-885	135	21	using	use	VERB
ejde-885	135	22	the	the	DET
ejde-885	135	23	fisher	fisher	PROPN
ejde-885	135	24	exact	exact	ADJ
ejde-885	135	25	test	test	NOUN
ejde-885	135	26	;	;	PUNCT
ejde-885	135	27	a	a	DET
ejde-885	135	28	test	test	NOUN
ejde-885	135	29	for	for	ADP
ejde-885	135	30	determining	determine	VERB
ejde-885	135	31	whether	whether	SCONJ
ejde-885	135	32	the	the	DET
ejde-885	135	33	proportions	proportion	NOUN
ejde-885	135	34	of	of	ADP
ejde-885	135	35	data	datum	NOUN
ejde-885	135	36	described	describe	VERB
ejde-885	135	37	by	by	ADP
ejde-885	135	38	two	two	NUM
ejde-885	135	39	or	or	CCONJ
ejde-885	135	40	more	more	ADJ
ejde-885	135	41	categorical	categorical	ADJ
ejde-885	135	42	variables	variable	NOUN
ejde-885	135	43	are	be	AUX
ejde-885	135	44	random	random	ADJ
ejde-885	135	45	.	.	PUNCT
ejde-885	136	1	while	while	SCONJ
ejde-885	136	2	our	our	PRON
ejde-885	136	3	modeling	modeling	NOUN
ejde-885	136	4	work	work	NOUN
ejde-885	136	5	is	be	AUX
ejde-885	136	6	deterministic	deterministic	ADJ
ejde-885	136	7	with	with	ADP
ejde-885	136	8	no	no	DET
ejde-885	136	9	random	random	ADJ
ejde-885	136	10	effects	effect	NOUN
ejde-885	136	11	,	,	PUNCT
ejde-885	136	12	the	the	DET
ejde-885	136	13	p	p	NOUN
ejde-885	136	14	-	-	PUNCT
ejde-885	136	15	value	value	NOUN
ejde-885	136	16	quantifies	quantifie	NOUN
ejde-885	136	17	the	the	DET
ejde-885	136	18	probability	probability	NOUN
ejde-885	136	19	of	of	ADP
ejde-885	136	20	our	our	PRON
ejde-885	136	21	observed	observed	ADJ
ejde-885	136	22	infection	infection	NOUN
ejde-885	136	23	rates	rate	NOUN
ejde-885	136	24	if	if	SCONJ
ejde-885	136	25	the	the	DET
ejde-885	136	26	vaccine	vaccine	NOUN
ejde-885	136	27	had	have	VERB
ejde-885	136	28	no	no	DET
ejde-885	136	29	efficacy	efficacy	NOUN
ejde-885	136	30	at	at	ADV
ejde-885	136	31	all	all	ADV
ejde-885	136	32	.	.	PUNCT
ejde-885	137	1	in	in	ADP
ejde-885	137	2	a	a	DET
ejde-885	137	3	true	true	ADJ
ejde-885	137	4	clinical	clinical	ADJ
ejde-885	137	5	trial	trial	NOUN
ejde-885	137	6	,	,	PUNCT
ejde-885	137	7	many	many	ADJ
ejde-885	137	8	details	detail	NOUN
ejde-885	137	9	and	and	CCONJ
ejde-885	137	10	considerations	consideration	NOUN
ejde-885	137	11	can	can	AUX
ejde-885	137	12	go	go	VERB
ejde-885	137	13	into	into	ADP
ejde-885	137	14	deciding	decide	VERB
ejde-885	137	15	when	when	SCONJ
ejde-885	137	16	a	a	DET
ejde-885	137	17	clinical	clinical	ADJ
ejde-885	137	18	trial	trial	NOUN
ejde-885	137	19	will	will	AUX
ejde-885	137	20	stop	stop	VERB
ejde-885	137	21	.	.	PUNCT
ejde-885	138	1	even	even	ADV
ejde-885	138	2	in	in	ADP
ejde-885	138	3	the	the	DET
ejde-885	138	4	most	most	ADV
ejde-885	138	5	basic	basic	ADJ
ejde-885	138	6	plans	plan	NOUN
ejde-885	138	7	,	,	PUNCT
ejde-885	138	8	researchers	researcher	NOUN
ejde-885	138	9	would	would	AUX
ejde-885	138	10	want	want	VERB
ejde-885	138	11	statistical	statistical	ADJ
ejde-885	138	12	evidence	evidence	NOUN
ejde-885	138	13	that	that	SCONJ
ejde-885	138	14	the	the	DET
ejde-885	138	15	vaccine	vaccine	NOUN
ejde-885	138	16	efficacy	efficacy	NOUN
ejde-885	138	17	was	be	AUX
ejde-885	138	18	greater	great	ADJ
ejde-885	138	19	than	than	ADP
ejde-885	138	20	a	a	DET
ejde-885	138	21	certain	certain	ADJ
ejde-885	138	22	value	value	NOUN
ejde-885	138	23	(	(	PUNCT
ejde-885	138	24	e.g.	e.g.	ADV
ejde-885	138	25	50	50	NUM
ejde-885	138	26	%	%	NOUN
ejde-885	138	27	,	,	PUNCT
ejde-885	138	28	70	70	NUM
ejde-885	138	29	%	%	NOUN
ejde-885	138	30	,	,	PUNCT
ejde-885	138	31	etc	etc	X
ejde-885	138	32	.	.	X
ejde-885	138	33	)	)	PUNCT
ejde-885	138	34	.	.	PUNCT
ejde-885	139	1	our	our	PRON
ejde-885	139	2	simplified	simplified	ADJ
ejde-885	139	3	estimates	estimate	NOUN
ejde-885	139	4	looks	look	VERB
ejde-885	139	5	simply	simply	ADV
ejde-885	139	6	for	for	ADP
ejde-885	139	7	evidence	evidence	NOUN
ejde-885	139	8	that	that	SCONJ
ejde-885	139	9	the	the	DET
ejde-885	139	10	vaccine	vaccine	NOUN
ejde-885	139	11	is	be	AUX
ejde-885	139	12	showing	show	VERB
ejde-885	139	13	any	any	DET
ejde-885	139	14	positive	positive	ADJ
ejde-885	139	15	efficacy	efficacy	NOUN
ejde-885	139	16	at	at	ADV
ejde-885	139	17	all	all	ADV
ejde-885	139	18	,	,	PUNCT
ejde-885	139	19	regardless	regardless	ADV
ejde-885	139	20	of	of	ADP
ejde-885	139	21	how	how	SCONJ
ejde-885	139	22	small	small	ADJ
ejde-885	139	23	.	.	PUNCT
ejde-885	140	1	while	while	SCONJ
ejde-885	140	2	clinical	clinical	ADJ
ejde-885	140	3	trials	trial	NOUN
ejde-885	140	4	would	would	AUX
ejde-885	140	5	continue	continue	VERB
ejde-885	140	6	longer	long	ADV
ejde-885	140	7	to	to	PART
ejde-885	140	8	achieve	achieve	VERB
ejde-885	140	9	more	more	ADV
ejde-885	140	10	rigorous	rigorous	ADJ
ejde-885	140	11	results	result	NOUN
ejde-885	140	12	,	,	PUNCT
ejde-885	140	13	our	our	PRON
ejde-885	140	14	simplification	simplification	NOUN
ejde-885	140	15	illustrates	illustrate	VERB
ejde-885	140	16	the	the	DET
ejde-885	140	17	effects	effect	NOUN
ejde-885	140	18	that	that	PRON
ejde-885	140	19	would	would	AUX
ejde-885	140	20	most	most	ADV
ejde-885	140	21	likely	likely	ADV
ejde-885	140	22	be	be	AUX
ejde-885	140	23	amplified	amplify	VERB
ejde-885	140	24	with	with	ADP
ejde-885	140	25	more	more	ADV
ejde-885	140	26	-	-	PUNCT
ejde-885	140	27	detailed	detailed	ADJ
ejde-885	140	28	stopping	stopping	NOUN
ejde-885	140	29	conditions	condition	NOUN
ejde-885	140	30	.	.	PUNCT
ejde-885	141	1	the	the	DET
ejde-885	141	2	results	result	NOUN
ejde-885	141	3	of	of	ADP
ejde-885	141	4	our	our	PRON
ejde-885	141	5	numerical	numerical	ADJ
ejde-885	141	6	experiment	experiment	NOUN
ejde-885	141	7	are	be	AUX
ejde-885	141	8	illustrated	illustrate	VERB
ejde-885	141	9	in	in	ADP
ejde-885	141	10	figure	figure	NOUN
ejde-885	141	11	2	2	NUM
ejde-885	141	12	.	.	PUNCT
ejde-885	142	1	in	in	ADP
ejde-885	142	2	figure	figure	NOUN
ejde-885	142	3	2a	2a	NUM
ejde-885	142	4	,	,	PUNCT
ejde-885	142	5	we	we	PRON
ejde-885	142	6	see	see	VERB
ejde-885	142	7	the	the	DET
ejde-885	142	8	first	first	ADJ
ejde-885	142	9	wave	wave	NOUN
ejde-885	142	10	of	of	ADP
ejde-885	142	11	the	the	DET
ejde-885	142	12	epidemic	epidemic	NOUN
ejde-885	142	13	through	through	ADP
ejde-885	142	14	an	an	DET
ejde-885	142	15	entirely	entirely	ADV
ejde-885	142	16	unvaccinated	unvaccinate	VERB
ejde-885	142	17	population	population	NOUN
ejde-885	142	18	.	.	PUNCT
ejde-885	143	1	notably	notably	ADV
ejde-885	143	2	,	,	PUNCT
ejde-885	143	3	the	the	DET
ejde-885	143	4	figure	figure	NOUN
ejde-885	143	5	illustrates	illustrate	VERB
ejde-885	143	6	curve	curve	NOUN
ejde-885	143	7	for	for	ADP
ejde-885	143	8	both	both	DET
ejde-885	143	9	adults	adult	NOUN
ejde-885	143	10	and	and	CCONJ
ejde-885	143	11	children	child	NOUN
ejde-885	143	12	,	,	PUNCT
ejde-885	143	13	but	but	CCONJ
ejde-885	143	14	the	the	DET
ejde-885	143	15	dashed	dash	VERB
ejde-885	143	16	curves	curve	NOUN
ejde-885	143	17	for	for	ADP
ejde-885	143	18	children	child	NOUN
ejde-885	143	19	are	be	AUX
ejde-885	143	20	entirely	entirely	ADV
ejde-885	143	21	obscured	obscure	VERB
ejde-885	143	22	by	by	ADP
ejde-885	143	23	the	the	DET
ejde-885	143	24	curves	curve	NOUN
ejde-885	143	25	for	for	ADP
ejde-885	143	26	adults	adult	NOUN
ejde-885	143	27	.	.	PUNCT
ejde-885	144	1	this	this	PRON
ejde-885	144	2	is	be	AUX
ejde-885	144	3	to	to	PART
ejde-885	144	4	be	be	AUX
ejde-885	144	5	expected	expect	VERB
ejde-885	144	6	as	as	SCONJ
ejde-885	144	7	we	we	PRON
ejde-885	144	8	are	be	AUX
ejde-885	144	9	assuming	assume	VERB
ejde-885	144	10	complete	complete	ADJ
ejde-885	144	11	homogeneity	homogeneity	NOUN
ejde-885	144	12	between	between	ADP
ejde-885	144	13	adults	adult	NOUN
ejde-885	144	14	and	and	CCONJ
ejde-885	144	15	kids	kid	NOUN
ejde-885	144	16	.	.	PUNCT
ejde-885	145	1	therefore	therefore	ADV
ejde-885	145	2	,	,	PUNCT
ejde-885	145	3	with	with	ADP
ejde-885	145	4	identical	identical	ADJ
ejde-885	145	5	initial	initial	ADJ
ejde-885	145	6	conditions	condition	NOUN
ejde-885	145	7	and	and	CCONJ
ejde-885	145	8	parameters	parameter	NOUN
ejde-885	145	9	,	,	PUNCT
ejde-885	145	10	the	the	DET
ejde-885	145	11	epidemic	epidemic	NOUN
ejde-885	145	12	plays	play	VERB
ejde-885	145	13	out	out	ADP
ejde-885	145	14	the	the	DET
ejde-885	145	15	same	same	ADJ
ejde-885	145	16	for	for	ADP
ejde-885	145	17	both	both	DET
ejde-885	145	18	sub	sub	NOUN
ejde-885	145	19	populations	population	NOUN
ejde-885	145	20	.	.	PUNCT
ejde-885	146	1	in	in	ADP
ejde-885	146	2	figure	figure	NOUN
ejde-885	146	3	2b	2b	NOUN
ejde-885	146	4	,	,	PUNCT
ejde-885	146	5	we	we	PRON
ejde-885	146	6	see	see	VERB
ejde-885	146	7	the	the	DET
ejde-885	146	8	results	result	NOUN
ejde-885	146	9	of	of	ADP
ejde-885	146	10	the	the	DET
ejde-885	146	11	vaccine	vaccine	NOUN
ejde-885	146	12	clinical	clinical	ADJ
ejde-885	146	13	trial	trial	NOUN
ejde-885	146	14	in	in	ADP
ejde-885	146	15	adults	adult	NOUN
ejde-885	146	16	which	which	PRON
ejde-885	146	17	starts	start	VERB
ejde-885	146	18	100	100	NUM
ejde-885	146	19	days	day	NOUN
ejde-885	146	20	into	into	ADP
ejde-885	146	21	the	the	DET
ejde-885	146	22	first	first	ADJ
ejde-885	146	23	wave	wave	NOUN
ejde-885	146	24	.	.	PUNCT
ejde-885	147	1	the	the	DET
ejde-885	147	2	black	black	ADJ
ejde-885	147	3	line	line	NOUN
ejde-885	147	4	tracks	track	VERB
ejde-885	147	5	the	the	DET
ejde-885	147	6	cumulative	cumulative	ADJ
ejde-885	147	7	number	number	NOUN
ejde-885	147	8	of	of	ADP
ejde-885	147	9	infections	infection	NOUN
ejde-885	147	10	in	in	ADP
ejde-885	147	11	the	the	DET
ejde-885	147	12	control	control	NOUN
ejde-885	147	13	group	group	NOUN
ejde-885	147	14	and	and	CCONJ
ejde-885	147	15	the	the	DET
ejde-885	147	16	red	red	ADJ
ejde-885	147	17	line	line	NOUN
ejde-885	147	18	tracks	track	VERB
ejde-885	147	19	those	those	PRON
ejde-885	147	20	in	in	ADP
ejde-885	147	21	the	the	DET
ejde-885	147	22	vaccine	vaccine	NOUN
ejde-885	147	23	group	group	NOUN
ejde-885	147	24	.	.	PUNCT
ejde-885	148	1	in	in	ADP
ejde-885	148	2	blue	blue	ADJ
ejde-885	148	3	,	,	PUNCT
ejde-885	148	4	we	we	PRON
ejde-885	148	5	calculate	calculate	VERB
ejde-885	148	6	the	the	DET
ejde-885	148	7	p	p	NOUN
ejde-885	148	8	-	-	PUNCT
ejde-885	148	9	value	value	NOUN
ejde-885	148	10	of	of	ADP
ejde-885	148	11	the	the	DET
ejde-885	148	12	protective	protective	ADJ
ejde-885	148	13	efficacy	efficacy	NOUN
ejde-885	148	14	of	of	ADP
ejde-885	148	15	the	the	DET
ejde-885	148	16	vaccine	vaccine	NOUN
ejde-885	148	17	on	on	ADP
ejde-885	148	18	a	a	DET
ejde-885	148	19	logarithmic	logarithmic	ADJ
ejde-885	148	20	scale	scale	NOUN
ejde-885	148	21	.	.	PUNCT
ejde-885	149	1	using	use	VERB
ejde-885	149	2	our	our	PRON
ejde-885	149	3	simplified	simplified	ADJ
ejde-885	149	4	approach	approach	NOUN
ejde-885	149	5	,	,	PUNCT
ejde-885	149	6	we	we	PRON
ejde-885	149	7	see	see	VERB
ejde-885	149	8	8	8	NUM
ejde-885	149	9	d.	d.	PROPN
ejde-885	149	10	gerberry	gerberry	PROPN
ejde-885	149	11	,	,	PUNCT
ejde-885	150	1	h.	h.	PROPN
ejde-885	150	2	joshi	joshi	PROPN
ejde-885	150	3	,	,	PUNCT
ejde-885	150	4	m.	m.	NOUN
ejde-885	150	5	peloquin	peloquin	NOUN
ejde-885	150	6	,	,	PUNCT
ejde-885	150	7	s.	s.	PROPN
ejde-885	150	8	vargas	vargas	PROPN
ejde-885	150	9	ejde-2022	ejde-2022	NOUN
ejde-885	150	10	/	/	SYM
ejde-885	150	11	conf/26	conf/26	NOUN
ejde-885	150	12	that	that	PRON
ejde-885	150	13	a	a	DET
ejde-885	150	14	p	p	NOUN
ejde-885	150	15	-	-	PUNCT
ejde-885	150	16	value	value	NOUN
ejde-885	150	17	of	of	ADP
ejde-885	150	18	10−4	10−4	NUM
ejde-885	150	19	is	be	AUX
ejde-885	150	20	achieved	achieve	VERB
ejde-885	150	21	after	after	ADP
ejde-885	150	22	6	6	NUM
ejde-885	150	23	steps	step	NOUN
ejde-885	150	24	of	of	ADP
ejde-885	150	25	the	the	DET
ejde-885	150	26	clinical	clinical	ADJ
ejde-885	150	27	trials	trial	NOUN
ejde-885	150	28	(	(	PUNCT
ejde-885	150	29	i.e.	i.e.	X
ejde-885	150	30	12	12	NUM
ejde-885	150	31	weeks	week	NOUN
ejde-885	150	32	,	,	PUNCT
ejde-885	150	33	84	84	NUM
ejde-885	150	34	days	day	NOUN
ejde-885	150	35	)	)	PUNCT
ejde-885	150	36	.	.	PUNCT
ejde-885	151	1	0	0	NUM
ejde-885	152	1	100	100	NUM
ejde-885	152	2	200	200	NUM
ejde-885	152	3	300	300	NUM
ejde-885	152	4	0	0	NUM
ejde-885	152	5	.	.	NOUN
ejde-885	152	6	0	0	NUM
ejde-885	152	7	0	0	NUM
ejde-885	152	8	.	.	NOUN
ejde-885	152	9	2	2	NUM
ejde-885	152	10	0	0	NUM
ejde-885	152	11	.	.	NOUN
ejde-885	152	12	4	4	NUM
ejde-885	152	13	0	0	NUM
ejde-885	152	14	.	.	NOUN
ejde-885	152	15	6	6	NUM
ejde-885	152	16	days	day	NOUN
ejde-885	152	17	p	p	PROPN
ejde-885	152	18	ro	ro	INTJ
ejde-885	152	19	po	po	PROPN
ejde-885	152	20	rt	rt	PROPN
ejde-885	152	21	io	io	PROPN
ejde-885	153	1	n	n	PROPN
ejde-885	153	2	of	of	ADP
ejde-885	153	3	p	p	PRON
ejde-885	153	4	op	op	NOUN
ejde-885	153	5	ul	ul	NOUN
ejde-885	153	6	at	at	ADP
ejde-885	153	7	io	io	PROPN
ejde-885	153	8	n	n	ADV
ejde-885	153	9	0	0	NUM
ejde-885	153	10	100	100	NUM
ejde-885	153	11	200	200	NUM
ejde-885	153	12	300	300	NUM
ejde-885	153	13	0	0	NUM
ejde-885	153	14	.	.	NOUN
ejde-885	153	15	0	0	NUM
ejde-885	153	16	0	0	NUM
ejde-885	153	17	.	.	NOUN
ejde-885	153	18	2	2	NUM
ejde-885	153	19	0	0	NUM
ejde-885	153	20	.	.	NOUN
ejde-885	153	21	4	4	NUM
ejde-885	153	22	0	0	NUM
ejde-885	153	23	.	.	NOUN
ejde-885	153	24	6	6	NUM
ejde-885	153	25	days	day	NOUN
ejde-885	153	26	p	p	PROPN
ejde-885	153	27	ro	ro	INTJ
ejde-885	153	28	po	po	PROPN
ejde-885	153	29	rt	rt	PROPN
ejde-885	153	30	io	io	PROPN
ejde-885	154	1	n	n	PROPN
ejde-885	154	2	of	of	ADP
ejde-885	154	3	p	p	PRON
ejde-885	154	4	op	op	NOUN
ejde-885	154	5	ul	ul	NOUN
ejde-885	154	6	at	at	ADP
ejde-885	154	7	io	io	PROPN
ejde-885	154	8	n	n	ADV
ejde-885	154	9	0	0	NUM
ejde-885	154	10	100	100	NUM
ejde-885	154	11	200	200	NUM
ejde-885	154	12	300	300	NUM
ejde-885	154	13	0	0	NUM
ejde-885	154	14	.	.	NOUN
ejde-885	154	15	0	0	NUM
ejde-885	154	16	0	0	NUM
ejde-885	154	17	.	.	NOUN
ejde-885	154	18	2	2	NUM
ejde-885	154	19	0	0	NUM
ejde-885	154	20	.	.	NOUN
ejde-885	154	21	4	4	NUM
ejde-885	154	22	0	0	NUM
ejde-885	154	23	.	.	NOUN
ejde-885	154	24	6	6	NUM
ejde-885	154	25	days	day	NOUN
ejde-885	154	26	0	0	NUM
ejde-885	154	27	100	100	NUM
ejde-885	154	28	200	200	NUM
ejde-885	154	29	300	300	NUM
ejde-885	154	30	0	0	NUM
ejde-885	154	31	.	.	NOUN
ejde-885	154	32	0	0	NUM
ejde-885	154	33	0	0	NUM
ejde-885	154	34	.	.	NOUN
ejde-885	154	35	2	2	NUM
ejde-885	154	36	0	0	NUM
ejde-885	154	37	.	.	NOUN
ejde-885	154	38	4	4	NUM
ejde-885	154	39	0	0	NUM
ejde-885	154	40	.	.	NOUN
ejde-885	154	41	6	6	NUM
ejde-885	154	42	days	day	NOUN
ejde-885	154	43	0	0	NUM
ejde-885	154	44	100	100	NUM
ejde-885	154	45	200	200	NUM
ejde-885	154	46	300	300	NUM
ejde-885	154	47	0	0	NUM
ejde-885	154	48	.	.	NOUN
ejde-885	154	49	0	0	NUM
ejde-885	154	50	0	0	NUM
ejde-885	154	51	.	.	NOUN
ejde-885	154	52	2	2	NUM
ejde-885	154	53	0	0	NUM
ejde-885	154	54	.	.	NOUN
ejde-885	154	55	4	4	NUM
ejde-885	154	56	0	0	NUM
ejde-885	154	57	.	.	NOUN
ejde-885	154	58	6	6	NUM
ejde-885	154	59	days	day	NOUN
ejde-885	154	60	0	0	NUM
ejde-885	154	61	100	100	NUM
ejde-885	154	62	200	200	NUM
ejde-885	154	63	300	300	NUM
ejde-885	154	64	0	0	NUM
ejde-885	154	65	.	.	NOUN
ejde-885	154	66	0	0	NUM
ejde-885	154	67	0	0	NUM
ejde-885	154	68	.	.	NOUN
ejde-885	154	69	2	2	NUM
ejde-885	154	70	0	0	NUM
ejde-885	154	71	.	.	NOUN
ejde-885	154	72	4	4	NUM
ejde-885	154	73	0	0	NUM
ejde-885	154	74	.	.	NOUN
ejde-885	154	75	6	6	NUM
ejde-885	154	76	days	day	NOUN
ejde-885	154	77	0	0	NUM
ejde-885	154	78	100	100	NUM
ejde-885	154	79	200	200	NUM
ejde-885	154	80	300	300	NUM
ejde-885	154	81	0	0	NUM
ejde-885	154	82	.	.	NOUN
ejde-885	154	83	0	0	NUM
ejde-885	154	84	0	0	NUM
ejde-885	154	85	.	.	NOUN
ejde-885	154	86	2	2	NUM
ejde-885	154	87	0	0	NUM
ejde-885	154	88	.	.	NOUN
ejde-885	154	89	4	4	NUM
ejde-885	154	90	0	0	NUM
ejde-885	154	91	.	.	NOUN
ejde-885	154	92	6	6	NUM
ejde-885	154	93	days	day	NOUN
ejde-885	154	94	0	0	NUM
ejde-885	154	95	100	100	NUM
ejde-885	154	96	200	200	NUM
ejde-885	154	97	300	300	NUM
ejde-885	154	98	0	0	NUM
ejde-885	154	99	.	.	NOUN
ejde-885	154	100	0	0	NUM
ejde-885	154	101	0	0	NUM
ejde-885	154	102	.	.	NOUN
ejde-885	154	103	2	2	NUM
ejde-885	154	104	0	0	NUM
ejde-885	154	105	.	.	NOUN
ejde-885	154	106	4	4	NUM
ejde-885	154	107	0	0	NUM
ejde-885	154	108	.	.	NOUN
ejde-885	154	109	6	6	NUM
ejde-885	154	110	days	day	NOUN
ejde-885	154	111	susc	susc	NOUN
ejde-885	154	112	adults	adult	NOUN
ejde-885	154	113	susc	susc	PROPN
ejde-885	154	114	kids	kid	NOUN
ejde-885	154	115	exposed	expose	VERB
ejde-885	154	116	adults	adult	NOUN
ejde-885	154	117	exposed	expose	VERB
ejde-885	154	118	kids	kid	NOUN
ejde-885	154	119	infected	infect	VERB
ejde-885	154	120	adults	adult	NOUN
ejde-885	154	121	infected	infect	VERB
ejde-885	154	122	kids	kid	NOUN
ejde-885	154	123	rec	rec	X
ejde-885	154	124	adults	adult	NOUN
ejde-885	154	125	rec	rec	X
ejde-885	154	126	kids	kid	NOUN
ejde-885	154	127	5	5	NUM
ejde-885	154	128	10	10	NUM
ejde-885	154	129	15	15	NUM
ejde-885	154	130	0	0	NUM
ejde-885	154	131	5	5	NUM
ejde-885	154	132	10	10	NUM
ejde-885	154	133	15	15	NUM
ejde-885	154	134	20	20	NUM
ejde-885	154	135	25	25	NUM
ejde-885	154	136	30	30	NUM
ejde-885	154	137	steps	step	NOUN
ejde-885	154	138	(	(	PUNCT
ejde-885	154	139	each	each	DET
ejde-885	154	140	14	14	NUM
ejde-885	154	141	days	day	NOUN
ejde-885	154	142	)	)	PUNCT
ejde-885	154	143	in	in	ADP
ejde-885	154	144	fe	fe	X
ejde-885	154	145	ct	ct	PROPN
ejde-885	154	146	io	io	PROPN
ejde-885	154	147	ns	ns	NUM
ejde-885	154	148	5	5	NUM
ejde-885	154	149	10	10	NUM
ejde-885	154	150	15	15	NUM
ejde-885	154	151	0	0	NUM
ejde-885	154	152	5	5	NUM
ejde-885	154	153	10	10	NUM
ejde-885	154	154	15	15	NUM
ejde-885	154	155	20	20	NUM
ejde-885	154	156	25	25	NUM
ejde-885	154	157	30	30	NUM
ejde-885	154	158	steps	step	NOUN
ejde-885	154	159	(	(	PUNCT
ejde-885	154	160	each	each	DET
ejde-885	154	161	14	14	NUM
ejde-885	154	162	days	day	NOUN
ejde-885	154	163	)	)	PUNCT
ejde-885	154	164	in	in	ADP
ejde-885	154	165	fe	fe	X
ejde-885	154	166	ct	ct	PROPN
ejde-885	154	167	io	io	PROPN
ejde-885	154	168	ns	ns	NUM
ejde-885	154	169	1e	1e	PROPN
ejde-885	154	170	−	−	PROPN
ejde-885	154	171	04	04	NUM
ejde-885	155	1	1e	1e	NOUN
ejde-885	155	2	−	−	PROPN
ejde-885	155	3	02	02	NUM
ejde-885	155	4	1e	1e	PROPN
ejde-885	156	1	+	+	CCONJ
ejde-885	156	2	00	00	NUM
ejde-885	157	1	p	p	PRON
ejde-885	157	2	−	−	PROPN
ejde-885	157	3	va	va	NOUN
ejde-885	157	4	lu	lu	PROPN
ejde-885	157	5	e	e	PROPN
ejde-885	157	6	of	of	ADP
ejde-885	157	7	p	p	NOUN
ejde-885	157	8	ro	ro	X
ejde-885	157	9	te	te	INTJ
ejde-885	157	10	ct	ct	NUM
ejde-885	157	11	iv	iv	NUM
ejde-885	157	12	e	e	PROPN
ejde-885	157	13	ef	ef	X
ejde-885	157	14	fe	fe	PROPN
ejde-885	157	15	ctcontrol	ctcontrol	PROPN
ejde-885	157	16	vaccinated	vaccinate	VERB
ejde-885	157	17	p−value	p−value	NOUN
ejde-885	157	18	(	(	PUNCT
ejde-885	157	19	a	a	X
ejde-885	157	20	)	)	PUNCT
ejde-885	157	21	first	first	ADJ
ejde-885	157	22	wave	wave	NOUN
ejde-885	157	23	of	of	ADP
ejde-885	157	24	epidemic	epidemic	NOUN
ejde-885	157	25	;	;	PUNCT
ejde-885	157	26	no	no	DET
ejde-885	157	27	one	one	NOUN
ejde-885	157	28	vaccinated	vaccinate	VERB
ejde-885	157	29	(	(	PUNCT
ejde-885	157	30	b	b	NOUN
ejde-885	157	31	)	)	PUNCT
ejde-885	157	32	clinical	clinical	ADJ
ejde-885	157	33	trial	trial	NOUN
ejde-885	157	34	for	for	ADP
ejde-885	157	35	adults	adult	NOUN
ejde-885	157	36	that	that	PRON
ejde-885	157	37	begins	begin	VERB
ejde-885	157	38	on	on	ADP
ejde-885	157	39	day	day	NOUN
ejde-885	157	40	100	100	NUM
ejde-885	157	41	of	of	ADP
ejde-885	157	42	the	the	DET
ejde-885	157	43	first	first	ADJ
ejde-885	157	44	wave	wave	NOUN
ejde-885	157	45	0	0	NUM
ejde-885	157	46	100	100	NUM
ejde-885	157	47	200	200	NUM
ejde-885	157	48	300	300	NUM
ejde-885	157	49	0	0	NUM
ejde-885	157	50	.	.	NOUN
ejde-885	157	51	0	0	NUM
ejde-885	157	52	0	0	NUM
ejde-885	157	53	.	.	NOUN
ejde-885	157	54	2	2	NUM
ejde-885	157	55	0	0	NUM
ejde-885	157	56	.	.	NOUN
ejde-885	157	57	4	4	NUM
ejde-885	157	58	0	0	NUM
ejde-885	157	59	.	.	NOUN
ejde-885	157	60	6	6	NUM
ejde-885	157	61	days	day	NOUN
ejde-885	157	62	p	p	PROPN
ejde-885	157	63	ro	ro	INTJ
ejde-885	157	64	po	po	PROPN
ejde-885	157	65	rt	rt	PROPN
ejde-885	157	66	io	io	PROPN
ejde-885	158	1	n	n	PROPN
ejde-885	158	2	of	of	ADP
ejde-885	158	3	p	p	PRON
ejde-885	158	4	op	op	NOUN
ejde-885	158	5	ul	ul	NOUN
ejde-885	158	6	at	at	ADP
ejde-885	158	7	io	io	PROPN
ejde-885	158	8	n	n	ADV
ejde-885	158	9	0	0	NUM
ejde-885	158	10	100	100	NUM
ejde-885	158	11	200	200	NUM
ejde-885	158	12	300	300	NUM
ejde-885	158	13	0	0	NUM
ejde-885	158	14	.	.	NOUN
ejde-885	158	15	0	0	NUM
ejde-885	158	16	0	0	NUM
ejde-885	158	17	.	.	NOUN
ejde-885	158	18	2	2	NUM
ejde-885	158	19	0	0	NUM
ejde-885	158	20	.	.	NOUN
ejde-885	158	21	4	4	NUM
ejde-885	158	22	0	0	NUM
ejde-885	158	23	.	.	NOUN
ejde-885	158	24	6	6	NUM
ejde-885	158	25	days	day	NOUN
ejde-885	158	26	p	p	PROPN
ejde-885	158	27	ro	ro	INTJ
ejde-885	158	28	po	po	PROPN
ejde-885	158	29	rt	rt	PROPN
ejde-885	158	30	io	io	PROPN
ejde-885	159	1	n	n	PROPN
ejde-885	159	2	of	of	ADP
ejde-885	159	3	p	p	PRON
ejde-885	159	4	op	op	NOUN
ejde-885	159	5	ul	ul	NOUN
ejde-885	159	6	at	at	ADP
ejde-885	159	7	io	io	PROPN
ejde-885	159	8	n	n	ADV
ejde-885	159	9	0	0	NUM
ejde-885	159	10	100	100	NUM
ejde-885	159	11	200	200	NUM
ejde-885	159	12	300	300	NUM
ejde-885	159	13	0	0	NUM
ejde-885	159	14	.	.	NOUN
ejde-885	159	15	0	0	NUM
ejde-885	159	16	0	0	NUM
ejde-885	159	17	.	.	NOUN
ejde-885	159	18	2	2	NUM
ejde-885	159	19	0	0	NUM
ejde-885	159	20	.	.	NOUN
ejde-885	159	21	4	4	NUM
ejde-885	159	22	0	0	NUM
ejde-885	159	23	.	.	NOUN
ejde-885	159	24	6	6	NUM
ejde-885	159	25	days	day	NOUN
ejde-885	159	26	0	0	NUM
ejde-885	159	27	100	100	NUM
ejde-885	159	28	200	200	NUM
ejde-885	159	29	300	300	NUM
ejde-885	159	30	0	0	NUM
ejde-885	159	31	.	.	NOUN
ejde-885	159	32	0	0	NUM
ejde-885	159	33	0	0	NUM
ejde-885	159	34	.	.	NOUN
ejde-885	159	35	2	2	NUM
ejde-885	159	36	0	0	NUM
ejde-885	159	37	.	.	NOUN
ejde-885	159	38	4	4	NUM
ejde-885	159	39	0	0	NUM
ejde-885	159	40	.	.	NOUN
ejde-885	159	41	6	6	NUM
ejde-885	159	42	days	day	NOUN
ejde-885	159	43	0	0	NUM
ejde-885	159	44	100	100	NUM
ejde-885	159	45	200	200	NUM
ejde-885	159	46	300	300	NUM
ejde-885	159	47	0	0	NUM
ejde-885	159	48	.	.	NOUN
ejde-885	159	49	0	0	NUM
ejde-885	159	50	0	0	NUM
ejde-885	159	51	.	.	NOUN
ejde-885	159	52	2	2	NUM
ejde-885	159	53	0	0	NUM
ejde-885	159	54	.	.	NOUN
ejde-885	159	55	4	4	NUM
ejde-885	159	56	0	0	NUM
ejde-885	159	57	.	.	NOUN
ejde-885	159	58	6	6	NUM
ejde-885	159	59	days	day	NOUN
ejde-885	159	60	0	0	NUM
ejde-885	159	61	100	100	NUM
ejde-885	159	62	200	200	NUM
ejde-885	159	63	300	300	NUM
ejde-885	159	64	0	0	NUM
ejde-885	159	65	.	.	NOUN
ejde-885	159	66	0	0	NUM
ejde-885	159	67	0	0	NUM
ejde-885	159	68	.	.	NOUN
ejde-885	159	69	2	2	NUM
ejde-885	159	70	0	0	NUM
ejde-885	159	71	.	.	NOUN
ejde-885	159	72	4	4	NUM
ejde-885	159	73	0	0	NUM
ejde-885	159	74	.	.	NOUN
ejde-885	159	75	6	6	NUM
ejde-885	159	76	days	day	NOUN
ejde-885	159	77	0	0	NUM
ejde-885	159	78	100	100	NUM
ejde-885	159	79	200	200	NUM
ejde-885	159	80	300	300	NUM
ejde-885	159	81	0	0	NUM
ejde-885	159	82	.	.	NOUN
ejde-885	159	83	0	0	NUM
ejde-885	159	84	0	0	NUM
ejde-885	159	85	.	.	NOUN
ejde-885	159	86	2	2	NUM
ejde-885	159	87	0	0	NUM
ejde-885	159	88	.	.	NOUN
ejde-885	159	89	4	4	NUM
ejde-885	159	90	0	0	NUM
ejde-885	159	91	.	.	NOUN
ejde-885	159	92	6	6	NUM
ejde-885	159	93	days	day	NOUN
ejde-885	159	94	0	0	NUM
ejde-885	159	95	100	100	NUM
ejde-885	159	96	200	200	NUM
ejde-885	159	97	300	300	NUM
ejde-885	159	98	0	0	NUM
ejde-885	159	99	.	.	NOUN
ejde-885	159	100	0	0	NUM
ejde-885	159	101	0	0	NUM
ejde-885	159	102	.	.	NOUN
ejde-885	159	103	2	2	NUM
ejde-885	159	104	0	0	NUM
ejde-885	159	105	.	.	NOUN
ejde-885	159	106	4	4	NUM
ejde-885	159	107	0	0	NUM
ejde-885	159	108	.	.	NOUN
ejde-885	159	109	6	6	NUM
ejde-885	159	110	days	day	NOUN
ejde-885	159	111	susc	susc	NOUN
ejde-885	159	112	adults	adult	NOUN
ejde-885	159	113	susc	susc	PROPN
ejde-885	159	114	kids	kid	NOUN
ejde-885	159	115	exposed	expose	VERB
ejde-885	159	116	adults	adult	NOUN
ejde-885	159	117	exposed	expose	VERB
ejde-885	159	118	kids	kid	NOUN
ejde-885	159	119	infected	infect	VERB
ejde-885	159	120	adults	adult	NOUN
ejde-885	159	121	infected	infect	VERB
ejde-885	159	122	kids	kid	NOUN
ejde-885	159	123	rec	rec	X
ejde-885	159	124	adults	adult	NOUN
ejde-885	159	125	rec	rec	X
ejde-885	159	126	kids	kid	NOUN
ejde-885	159	127	5	5	NUM
ejde-885	159	128	10	10	NUM
ejde-885	159	129	15	15	NUM
ejde-885	159	130	0	0	NUM
ejde-885	159	131	5	5	NUM
ejde-885	159	132	10	10	NUM
ejde-885	159	133	15	15	NUM
ejde-885	159	134	20	20	NUM
ejde-885	159	135	25	25	NUM
ejde-885	159	136	steps	step	NOUN
ejde-885	159	137	(	(	PUNCT
ejde-885	159	138	each	each	DET
ejde-885	159	139	14	14	NUM
ejde-885	159	140	days	day	NOUN
ejde-885	159	141	)	)	PUNCT
ejde-885	159	142	in	in	ADP
ejde-885	159	143	fe	fe	X
ejde-885	159	144	ct	ct	PROPN
ejde-885	159	145	io	io	PROPN
ejde-885	159	146	ns	ns	NUM
ejde-885	159	147	5	5	NUM
ejde-885	159	148	10	10	NUM
ejde-885	159	149	15	15	NUM
ejde-885	159	150	0	0	NUM
ejde-885	159	151	5	5	NUM
ejde-885	159	152	10	10	NUM
ejde-885	159	153	15	15	NUM
ejde-885	159	154	20	20	NUM
ejde-885	159	155	25	25	NUM
ejde-885	159	156	steps	step	NOUN
ejde-885	159	157	(	(	PUNCT
ejde-885	159	158	each	each	DET
ejde-885	159	159	14	14	NUM
ejde-885	159	160	days	day	NOUN
ejde-885	159	161	)	)	PUNCT
ejde-885	159	162	in	in	ADP
ejde-885	159	163	fe	fe	X
ejde-885	159	164	ct	ct	PROPN
ejde-885	159	165	io	io	PROPN
ejde-885	159	166	ns	ns	NUM
ejde-885	159	167	1e	1e	PROPN
ejde-885	159	168	−	−	PROPN
ejde-885	159	169	04	04	NUM
ejde-885	160	1	1e	1e	NOUN
ejde-885	160	2	−	−	PROPN
ejde-885	160	3	02	02	NUM
ejde-885	160	4	1e	1e	PROPN
ejde-885	161	1	+	+	CCONJ
ejde-885	161	2	00	00	NUM
ejde-885	162	1	p	p	PRON
ejde-885	162	2	−	−	PROPN
ejde-885	162	3	va	va	NOUN
ejde-885	162	4	lu	lu	PROPN
ejde-885	162	5	e	e	PROPN
ejde-885	162	6	of	of	ADP
ejde-885	162	7	p	p	NOUN
ejde-885	162	8	ro	ro	X
ejde-885	162	9	te	te	INTJ
ejde-885	162	10	ct	ct	NUM
ejde-885	162	11	iv	iv	NUM
ejde-885	162	12	e	e	PROPN
ejde-885	162	13	ef	ef	X
ejde-885	162	14	fe	fe	PROPN
ejde-885	162	15	ctcontrol	ctcontrol	PROPN
ejde-885	162	16	vaccinated	vaccinate	VERB
ejde-885	162	17	p−value	p−value	NOUN
ejde-885	162	18	(	(	PUNCT
ejde-885	162	19	c	c	NOUN
ejde-885	162	20	)	)	PUNCT
ejde-885	162	21	second	second	ADJ
ejde-885	162	22	wave	wave	NOUN
ejde-885	162	23	of	of	ADP
ejde-885	162	24	epidemic	epidemic	NOUN
ejde-885	162	25	;	;	PUNCT
ejde-885	162	26	80	80	NUM
ejde-885	162	27	%	%	NOUN
ejde-885	162	28	of	of	ADP
ejde-885	162	29	adults	adult	NOUN
ejde-885	162	30	are	be	AUX
ejde-885	162	31	vaccinated	vaccinate	VERB
ejde-885	162	32	(	(	PUNCT
ejde-885	162	33	d	d	NOUN
ejde-885	162	34	)	)	PUNCT
ejde-885	162	35	clinical	clinical	ADJ
ejde-885	162	36	trial	trial	NOUN
ejde-885	162	37	for	for	ADP
ejde-885	162	38	kids	kid	NOUN
ejde-885	162	39	that	that	PRON
ejde-885	162	40	begins	begin	VERB
ejde-885	162	41	on	on	ADP
ejde-885	162	42	day	day	NOUN
ejde-885	162	43	100	100	NUM
ejde-885	162	44	of	of	ADP
ejde-885	162	45	the	the	DET
ejde-885	162	46	second	second	ADJ
ejde-885	162	47	wave	wave	NOUN
ejde-885	162	48	figure	figure	NOUN
ejde-885	162	49	2	2	NUM
ejde-885	162	50	.	.	PUNCT
ejde-885	162	51	simulation	simulation	NOUN
ejde-885	162	52	results	result	NOUN
ejde-885	162	53	when	when	SCONJ
ejde-885	162	54	assuming	assume	VERB
ejde-885	162	55	population	population	NOUN
ejde-885	162	56	homogeneity	homogeneity	NOUN
ejde-885	162	57	between	between	ADP
ejde-885	162	58	adults	adult	NOUN
ejde-885	162	59	and	and	CCONJ
ejde-885	162	60	kids	kid	NOUN
ejde-885	162	61	(	(	PUNCT
ejde-885	162	62	i.e.	i.e.	X
ejde-885	162	63	equal	equal	ADJ
ejde-885	162	64	size	size	NOUN
ejde-885	162	65	populations	population	NOUN
ejde-885	162	66	and	and	CCONJ
ejde-885	162	67	random	random	ADJ
ejde-885	162	68	mixing	mixing	NOUN
ejde-885	162	69	between	between	ADP
ejde-885	162	70	populations	population	NOUN
ejde-885	162	71	)	)	PUNCT
ejde-885	162	72	and	and	CCONJ
ejde-885	162	73	a	a	DET
ejde-885	162	74	vaccine	vaccine	NOUN
ejde-885	162	75	efficacy	efficacy	NOUN
ejde-885	162	76	of	of	ADP
ejde-885	162	77	e	e	NOUN
ejde-885	162	78	=	=	PROPN
ejde-885	162	79	0.80	0.80	NUM
ejde-885	162	80	.	.	PUNCT
ejde-885	163	1	in	in	ADP
ejde-885	163	2	figure	figure	NOUN
ejde-885	163	3	2(c	2(c	NUM
ejde-885	163	4	)	)	PUNCT
ejde-885	163	5	,	,	PUNCT
ejde-885	163	6	the	the	DET
ejde-885	163	7	simulation	simulation	NOUN
ejde-885	163	8	moves	move	VERB
ejde-885	163	9	to	to	ADP
ejde-885	163	10	the	the	DET
ejde-885	163	11	second	second	ADJ
ejde-885	163	12	wave	wave	NOUN
ejde-885	163	13	of	of	ADP
ejde-885	163	14	the	the	DET
ejde-885	163	15	epidemic	epidemic	NOUN
ejde-885	163	16	where	where	SCONJ
ejde-885	163	17	we	we	PRON
ejde-885	163	18	assume	assume	VERB
ejde-885	163	19	that	that	SCONJ
ejde-885	163	20	80	80	NUM
ejde-885	163	21	%	%	NOUN
ejde-885	163	22	of	of	ADP
ejde-885	163	23	the	the	DET
ejde-885	163	24	adult	adult	NOUN
ejde-885	163	25	population	population	NOUN
ejde-885	163	26	is	be	AUX
ejde-885	163	27	vaccinated	vaccinate	VERB
ejde-885	163	28	with	with	ADP
ejde-885	163	29	the	the	DET
ejde-885	163	30	80	80	NUM
ejde-885	163	31	%	%	NOUN
ejde-885	163	32	effective	effective	ADJ
ejde-885	163	33	vaccine	vaccine	NOUN
ejde-885	163	34	.	.	PUNCT
ejde-885	164	1	we	we	PRON
ejde-885	164	2	see	see	VERB
ejde-885	164	3	this	this	DET
ejde-885	164	4	protective	protective	ADJ
ejde-885	164	5	effect	effect	NOUN
ejde-885	164	6	as	as	SCONJ
ejde-885	164	7	the	the	DET
ejde-885	164	8	second	second	ADJ
ejde-885	164	9	wave	wave	NOUN
ejde-885	164	10	moves	move	VERB
ejde-885	164	11	more	more	ADV
ejde-885	164	12	slowly	slowly	ADV
ejde-885	164	13	through	through	ADP
ejde-885	164	14	the	the	DET
ejde-885	164	15	adult	adult	NOUN
ejde-885	164	16	population	population	NOUN
ejde-885	164	17	than	than	ADP
ejde-885	164	18	in	in	ADP
ejde-885	164	19	children	child	NOUN
ejde-885	164	20	.	.	PUNCT
ejde-885	165	1	in	in	ADP
ejde-885	165	2	figure	figure	NOUN
ejde-885	165	3	2(d	2(d	NUM
ejde-885	165	4	)	)	PUNCT
ejde-885	165	5	,	,	PUNCT
ejde-885	165	6	we	we	PRON
ejde-885	165	7	see	see	VERB
ejde-885	165	8	the	the	DET
ejde-885	165	9	results	result	NOUN
ejde-885	165	10	of	of	ADP
ejde-885	165	11	the	the	DET
ejde-885	165	12	vaccine	vaccine	NOUN
ejde-885	165	13	clinical	clinical	ADJ
ejde-885	165	14	trial	trial	NOUN
ejde-885	165	15	for	for	ADP
ejde-885	165	16	kids	kid	NOUN
ejde-885	165	17	.	.	PUNCT
ejde-885	166	1	infections	infection	NOUN
ejde-885	166	2	in	in	ADP
ejde-885	166	3	the	the	DET
ejde-885	166	4	clinical	clinical	ADJ
ejde-885	166	5	trial	trial	NOUN
ejde-885	166	6	for	for	ADP
ejde-885	166	7	kids	kid	NOUN
ejde-885	166	8	accumulate	accumulate	VERB
ejde-885	166	9	more	more	ADV
ejde-885	166	10	slowly	slowly	ADV
ejde-885	166	11	than	than	ADP
ejde-885	166	12	in	in	ADP
ejde-885	166	13	the	the	DET
ejde-885	166	14	adult	adult	NOUN
ejde-885	166	15	clinical	clinical	ADJ
ejde-885	166	16	trial	trial	NOUN
ejde-885	166	17	.	.	PUNCT
ejde-885	167	1	as	as	SCONJ
ejde-885	167	2	these	these	DET
ejde-885	167	3	simulations	simulation	NOUN
ejde-885	167	4	assume	assume	VERB
ejde-885	167	5	complete	complete	ADJ
ejde-885	167	6	homogeneity	homogeneity	NOUN
ejde-885	167	7	between	between	ADP
ejde-885	167	8	adults	adult	NOUN
ejde-885	167	9	and	and	CCONJ
ejde-885	167	10	kids	kid	NOUN
ejde-885	167	11	,	,	PUNCT
ejde-885	167	12	we	we	PRON
ejde-885	167	13	know	know	VERB
ejde-885	167	14	that	that	SCONJ
ejde-885	167	15	this	this	DET
ejde-885	167	16	difference	difference	NOUN
ejde-885	167	17	is	be	AUX
ejde-885	167	18	caused	cause	VERB
ejde-885	167	19	entirely	entirely	ADV
ejde-885	167	20	by	by	ADP
ejde-885	167	21	the	the	DET
ejde-885	167	22	vaccine	vaccine	NOUN
ejde-885	167	23	protection	protection	NOUN
ejde-885	167	24	in	in	ADP
ejde-885	167	25	adults	adult	NOUN
ejde-885	167	26	during	during	ADP
ejde-885	167	27	the	the	DET
ejde-885	167	28	second	second	ADJ
ejde-885	167	29	wave	wave	NOUN
ejde-885	167	30	(	(	PUNCT
ejde-885	167	31	and	and	CCONJ
ejde-885	167	32	consequently	consequently	ADV
ejde-885	167	33	fewer	few	ADJ
ejde-885	167	34	infections	infection	NOUN
ejde-885	167	35	in	in	ADP
ejde-885	167	36	the	the	DET
ejde-885	167	37	population	population	NOUN
ejde-885	167	38	overall	overall	ADV
ejde-885	167	39	)	)	PUNCT
ejde-885	167	40	.	.	PUNCT
ejde-885	168	1	while	while	SCONJ
ejde-885	168	2	fewer	few	ADJ
ejde-885	168	3	infections	infection	NOUN
ejde-885	168	4	during	during	ADP
ejde-885	168	5	the	the	DET
ejde-885	168	6	second	second	ADJ
ejde-885	168	7	wave	wave	NOUN
ejde-885	168	8	is	be	AUX
ejde-885	168	9	clearly	clearly	ADV
ejde-885	168	10	a	a	DET
ejde-885	168	11	desirable	desirable	ADJ
ejde-885	168	12	outcome	outcome	NOUN
ejde-885	168	13	,	,	PUNCT
ejde-885	168	14	we	we	PRON
ejde-885	168	15	do	do	AUX
ejde-885	168	16	see	see	VERB
ejde-885	168	17	that	that	SCONJ
ejde-885	168	18	the	the	DET
ejde-885	168	19	clinical	clinical	ADJ
ejde-885	168	20	trial	trial	NOUN
ejde-885	168	21	for	for	ADP
ejde-885	168	22	children	child	NOUN
ejde-885	168	23	must	must	AUX
ejde-885	168	24	continue	continue	VERB
ejde-885	168	25	for	for	ADP
ejde-885	168	26	a	a	DET
ejde-885	168	27	longer	long	ADJ
ejde-885	168	28	time	time	NOUN
ejde-885	168	29	period	period	NOUN
ejde-885	168	30	to	to	PART
ejde-885	168	31	achieve	achieve	VERB
ejde-885	168	32	the	the	DET
ejde-885	168	33	same	same	ADJ
ejde-885	168	34	p	p	NOUN
ejde-885	168	35	-	-	PUNCT
ejde-885	168	36	value	value	NOUN
ejde-885	168	37	as	as	ADP
ejde-885	168	38	the	the	DET
ejde-885	168	39	adult	adult	NOUN
ejde-885	168	40	clinical	clinical	ADJ
ejde-885	168	41	trial	trial	NOUN
ejde-885	168	42	.	.	PUNCT
ejde-885	169	1	specifically	specifically	ADV
ejde-885	169	2	,	,	PUNCT
ejde-885	169	3	to	to	PART
ejde-885	169	4	get	get	VERB
ejde-885	169	5	to	to	ADP
ejde-885	169	6	the	the	DET
ejde-885	169	7	same	same	ADJ
ejde-885	169	8	10−4	10−4	NUM
ejde-885	169	9	level	level	NOUN
ejde-885	169	10	of	of	ADP
ejde-885	169	11	significance	significance	NOUN
ejde-885	169	12	,	,	PUNCT
ejde-885	169	13	the	the	DET
ejde-885	169	14	clinical	clinical	ADJ
ejde-885	169	15	trial	trial	NOUN
ejde-885	169	16	in	in	ADP
ejde-885	169	17	kids	kid	NOUN
ejde-885	169	18	would	would	AUX
ejde-885	169	19	need	need	VERB
ejde-885	169	20	to	to	PART
ejde-885	169	21	run	run	VERB
ejde-885	169	22	10	10	NUM
ejde-885	169	23	steps	step	NOUN
ejde-885	169	24	(	(	PUNCT
ejde-885	169	25	i.e.	i.e.	X
ejde-885	169	26	20	20	NUM
ejde-885	169	27	weeks	week	NOUN
ejde-885	169	28	,	,	PUNCT
ejde-885	169	29	140	140	NUM
ejde-885	169	30	days	day	NOUN
ejde-885	169	31	)	)	PUNCT
ejde-885	169	32	.	.	PUNCT
ejde-885	170	1	4.2	4.2	NUM
ejde-885	170	2	.	.	PUNCT
ejde-885	170	3	results	result	NOUN
ejde-885	170	4	assuming	assume	VERB
ejde-885	170	5	differences	difference	NOUN
ejde-885	170	6	between	between	ADP
ejde-885	170	7	adults	adult	NOUN
ejde-885	170	8	and	and	CCONJ
ejde-885	170	9	children	child	NOUN
ejde-885	170	10	.	.	PUNCT
ejde-885	171	1	in	in	ADP
ejde-885	171	2	the	the	DET
ejde-885	171	3	previous	previous	ADJ
ejde-885	171	4	section	section	NOUN
ejde-885	171	5	,	,	PUNCT
ejde-885	171	6	we	we	PRON
ejde-885	171	7	saw	see	VERB
ejde-885	171	8	that	that	SCONJ
ejde-885	171	9	a	a	DET
ejde-885	171	10	vaccine	vaccine	NOUN
ejde-885	171	11	clinical	clinical	ADJ
ejde-885	171	12	trial	trial	NOUN
ejde-885	171	13	in	in	ADP
ejde-885	171	14	children	child	NOUN
ejde-885	171	15	can	can	AUX
ejde-885	171	16	be	be	AUX
ejde-885	171	17	affected	affect	VERB
ejde-885	171	18	by	by	ADP
ejde-885	171	19	vaccination	vaccination	NOUN
ejde-885	171	20	among	among	ADP
ejde-885	171	21	adults	adult	NOUN
ejde-885	171	22	in	in	ADP
ejde-885	171	23	the	the	DET
ejde-885	171	24	general	general	ADJ
ejde-885	171	25	population	population	NOUN
ejde-885	171	26	.	.	PUNCT
ejde-885	172	1	more	more	ADV
ejde-885	172	2	specifically	specifically	ADV
ejde-885	172	3	,	,	PUNCT
ejde-885	172	4	the	the	DET
ejde-885	172	5	clinical	clinical	ADJ
ejde-885	172	6	trial	trial	NOUN
ejde-885	172	7	would	would	AUX
ejde-885	172	8	need	need	VERB
ejde-885	172	9	to	to	PART
ejde-885	172	10	run	run	VERB
ejde-885	172	11	longer	long	ADV
ejde-885	172	12	to	to	PART
ejde-885	172	13	establish	establish	VERB
ejde-885	172	14	statistically	statistically	ADV
ejde-885	172	15	significant	significant	ADJ
ejde-885	172	16	protection	protection	NOUN
ejde-885	172	17	.	.	PUNCT
ejde-885	173	1	however	however	ADV
ejde-885	173	2	,	,	PUNCT
ejde-885	173	3	this	this	DET
ejde-885	173	4	behavior	behavior	NOUN
ejde-885	173	5	was	be	AUX
ejde-885	173	6	exhibited	exhibit	VERB
ejde-885	173	7	under	under	ADP
ejde-885	173	8	an	an	DET
ejde-885	173	9	assumption	assumption	NOUN
ejde-885	173	10	of	of	ADP
ejde-885	173	11	identical	identical	ADJ
ejde-885	173	12	populations	population	NOUN
ejde-885	173	13	of	of	ADP
ejde-885	173	14	adults	adult	NOUN
ejde-885	173	15	and	and	CCONJ
ejde-885	173	16	children	child	NOUN
ejde-885	173	17	.	.	PUNCT
ejde-885	174	1	for	for	ADP
ejde-885	174	2	some	some	DET
ejde-885	174	3	respiratory	respiratory	ADJ
ejde-885	174	4	infections	infection	NOUN
ejde-885	174	5	,	,	PUNCT
ejde-885	174	6	such	such	DET
ejde-885	174	7	an	an	DET
ejde-885	174	8	assumption	assumption	NOUN
ejde-885	174	9	does	do	AUX
ejde-885	174	10	not	not	PART
ejde-885	174	11	hold	hold	VERB
ejde-885	174	12	.	.	PUNCT
ejde-885	175	1	ejde-2024	ejde-2024	ADJ
ejde-885	175	2	/	/	SYM
ejde-885	175	3	conf/27	conf/27	NOUN
ejde-885	175	4	clinical	clinical	ADJ
ejde-885	175	5	trial	trial	NOUN
ejde-885	175	6	modeling	model	VERB
ejde-885	175	7	9	9	NUM
ejde-885	175	8	in	in	ADP
ejde-885	175	9	this	this	DET
ejde-885	175	10	section	section	NOUN
ejde-885	175	11	,	,	PUNCT
ejde-885	175	12	we	we	PRON
ejde-885	175	13	investigate	investigate	VERB
ejde-885	175	14	the	the	DET
ejde-885	175	15	same	same	ADJ
ejde-885	175	16	ideas	idea	NOUN
ejde-885	175	17	when	when	SCONJ
ejde-885	175	18	assuming	assume	VERB
ejde-885	175	19	heterogeneity	heterogeneity	NOUN
ejde-885	175	20	(	(	PUNCT
ejde-885	175	21	both	both	CCONJ
ejde-885	175	22	in	in	ADP
ejde-885	175	23	population	population	NOUN
ejde-885	175	24	size	size	NOUN
ejde-885	175	25	and	and	CCONJ
ejde-885	175	26	epidemiological	epidemiological	ADJ
ejde-885	175	27	characteristics	characteristic	NOUN
ejde-885	175	28	)	)	PUNCT
ejde-885	175	29	among	among	ADP
ejde-885	175	30	adults	adult	NOUN
ejde-885	175	31	in	in	ADP
ejde-885	175	32	children	child	NOUN
ejde-885	175	33	.	.	PUNCT
ejde-885	176	1	in	in	ADP
ejde-885	176	2	table	table	NOUN
ejde-885	176	3	3	3	NUM
ejde-885	176	4	,	,	PUNCT
ejde-885	176	5	we	we	PRON
ejde-885	176	6	see	see	VERB
ejde-885	176	7	the	the	DET
ejde-885	176	8	initial	initial	ADJ
ejde-885	176	9	values	value	NOUN
ejde-885	176	10	for	for	ADP
ejde-885	176	11	our	our	PRON
ejde-885	176	12	simulations	simulation	NOUN
ejde-885	176	13	.	.	PUNCT
ejde-885	177	1	notably	notably	ADV
ejde-885	177	2	,	,	PUNCT
ejde-885	177	3	we	we	PRON
ejde-885	177	4	assume	assume	VERB
ejde-885	177	5	that	that	SCONJ
ejde-885	177	6	there	there	PRON
ejde-885	177	7	are	be	VERB
ejde-885	177	8	significantly	significantly	ADV
ejde-885	177	9	more	more	ADJ
ejde-885	177	10	adults	adult	NOUN
ejde-885	177	11	than	than	ADP
ejde-885	177	12	children	child	NOUN
ejde-885	177	13	(	(	PUNCT
ejde-885	177	14	70	70	NUM
ejde-885	177	15	%	%	NOUN
ejde-885	177	16	vs.	vs.	ADP
ejde-885	177	17	30	30	NUM
ejde-885	177	18	%	%	NOUN
ejde-885	177	19	)	)	PUNCT
ejde-885	177	20	.	.	PUNCT
ejde-885	178	1	table	table	NOUN
ejde-885	178	2	3	3	NUM
ejde-885	178	3	.	.	PUNCT
ejde-885	178	4	initial	initial	ADJ
ejde-885	178	5	values	value	NOUN
ejde-885	178	6	of	of	ADP
ejde-885	178	7	state	state	NOUN
ejde-885	178	8	variables	variable	NOUN
ejde-885	178	9	used	use	VERB
ejde-885	178	10	at	at	ADP
ejde-885	178	11	the	the	DET
ejde-885	178	12	beginning	beginning	NOUN
ejde-885	178	13	of	of	ADP
ejde-885	178	14	both	both	CCONJ
ejde-885	178	15	the	the	DET
ejde-885	178	16	first	first	ADJ
ejde-885	178	17	and	and	CCONJ
ejde-885	178	18	second	second	ADJ
ejde-885	178	19	wave	wave	NOUN
ejde-885	178	20	of	of	ADP
ejde-885	178	21	the	the	DET
ejde-885	178	22	epidemic	epidemic	NOUN
ejde-885	178	23	when	when	SCONJ
ejde-885	178	24	assuming	assume	VERB
ejde-885	178	25	heterogeneous	heterogeneous	ADJ
ejde-885	178	26	populations	population	NOUN
ejde-885	178	27	.	.	PUNCT
ejde-885	179	1	variable	variable	ADJ
ejde-885	179	2	description	description	NOUN
ejde-885	179	3	initial	initial	ADJ
ejde-885	179	4	value	value	NOUN
ejde-885	179	5	sa	sa	NOUN
ejde-885	179	6	susceptible	susceptible	ADJ
ejde-885	179	7	adults	adult	NOUN
ejde-885	179	8	70,000	70,000	NUM
ejde-885	179	9	sk	sk	NOUN
ejde-885	179	10	susceptible	susceptible	ADJ
ejde-885	179	11	children	child	NOUN
ejde-885	179	12	30,000	30,000	NUM
ejde-885	179	13	ea	ea	NOUN
ejde-885	179	14	exposed	expose	VERB
ejde-885	179	15	adults	adult	NOUN
ejde-885	179	16	50	50	NUM
ejde-885	179	17	ek	ek	NOUN
ejde-885	179	18	exposed	expose	VERB
ejde-885	179	19	children	child	NOUN
ejde-885	179	20	50	50	NUM
ejde-885	179	21	ia	ia	NOUN
ejde-885	179	22	infected	infect	VERB
ejde-885	179	23	adults	adult	NOUN
ejde-885	179	24	2	2	NUM
ejde-885	179	25	ik	ik	PROPN
ejde-885	179	26	infected	infect	VERB
ejde-885	179	27	children	child	NOUN
ejde-885	179	28	2	2	NUM
ejde-885	179	29	ra	ra	NOUN
ejde-885	179	30	recovered	recover	VERB
ejde-885	179	31	adults	adult	NOUN
ejde-885	179	32	0	0	NUM
ejde-885	179	33	rk	rk	NOUN
ejde-885	179	34	recovered	recover	VERB
ejde-885	179	35	children	child	NOUN
ejde-885	179	36	0	0	NUM
ejde-885	179	37	in	in	ADP
ejde-885	179	38	table	table	NOUN
ejde-885	179	39	4	4	NUM
ejde-885	179	40	,	,	PUNCT
ejde-885	179	41	we	we	PRON
ejde-885	179	42	now	now	ADV
ejde-885	179	43	use	use	VERB
ejde-885	179	44	age	age	NOUN
ejde-885	179	45	-	-	PUNCT
ejde-885	179	46	specific	specific	ADJ
ejde-885	179	47	contact	contact	NOUN
ejde-885	179	48	rates	rate	NOUN
ejde-885	179	49	to	to	PART
ejde-885	179	50	estimate	estimate	VERB
ejde-885	179	51	mixing	mix	VERB
ejde-885	179	52	patterns	pattern	NOUN
ejde-885	179	53	between	between	ADP
ejde-885	179	54	children	child	NOUN
ejde-885	179	55	and	and	CCONJ
ejde-885	179	56	adults	adult	NOUN
ejde-885	179	57	.	.	PUNCT
ejde-885	180	1	to	to	PART
ejde-885	180	2	establish	establish	VERB
ejde-885	180	3	these	these	DET
ejde-885	180	4	parameters	parameter	NOUN
ejde-885	180	5	,	,	PUNCT
ejde-885	180	6	we	we	PRON
ejde-885	180	7	use	use	VERB
ejde-885	180	8	the	the	DET
ejde-885	180	9	results	result	NOUN
ejde-885	180	10	of	of	ADP
ejde-885	180	11	del	del	PROPN
ejde-885	180	12	valle	valle	NOUN
ejde-885	180	13	,	,	PUNCT
ejde-885	180	14	et	et	PROPN
ejde-885	180	15	al	al	PROPN
ejde-885	180	16	.	.	PUNCT
ejde-885	181	1	[	[	X
ejde-885	181	2	13	13	NUM
ejde-885	181	3	]	]	PUNCT
ejde-885	181	4	who	who	PRON
ejde-885	181	5	built	build	VERB
ejde-885	181	6	a	a	DET
ejde-885	181	7	detailed	detailed	ADJ
ejde-885	181	8	agent	agent	NOUN
ejde-885	181	9	-	-	PUNCT
ejde-885	181	10	based	base	VERB
ejde-885	181	11	model	model	NOUN
ejde-885	181	12	from	from	ADP
ejde-885	181	13	data	datum	NOUN
ejde-885	181	14	on	on	ADP
ejde-885	181	15	daily	daily	ADJ
ejde-885	181	16	interactions	interaction	NOUN
ejde-885	181	17	between	between	ADP
ejde-885	181	18	different	different	ADJ
ejde-885	181	19	age	age	NOUN
ejde-885	181	20	groups	group	NOUN
ejde-885	181	21	.	.	PUNCT
ejde-885	182	1	more	more	ADV
ejde-885	182	2	specifically	specifically	ADV
ejde-885	182	3	,	,	PUNCT
ejde-885	182	4	we	we	PRON
ejde-885	182	5	used	use	VERB
ejde-885	182	6	the	the	DET
ejde-885	182	7	averages	average	NOUN
ejde-885	182	8	of	of	ADP
ejde-885	182	9	the	the	DET
ejde-885	182	10	age	age	NOUN
ejde-885	182	11	-	-	PUNCT
ejde-885	182	12	structured	structure	VERB
ejde-885	182	13	contact	contact	NOUN
ejde-885	182	14	rates	rate	NOUN
ejde-885	182	15	in	in	ADP
ejde-885	182	16	[	[	X
ejde-885	182	17	13	13	NUM
ejde-885	182	18	,	,	PUNCT
ejde-885	182	19	table	table	NOUN
ejde-885	182	20	2	2	NUM
ejde-885	182	21	]	]	PUNCT
ejde-885	182	22	for	for	ADP
ejde-885	182	23	adults	adult	NOUN
ejde-885	182	24	and	and	CCONJ
ejde-885	182	25	children	child	NOUN
ejde-885	182	26	to	to	PART
ejde-885	182	27	establish	establish	VERB
ejde-885	182	28	our	our	PRON
ejde-885	182	29	values	value	NOUN
ejde-885	182	30	for	for	ADP
ejde-885	182	31	βaa	βaa	NOUN
ejde-885	182	32	,	,	PUNCT
ejde-885	182	33	βka	βka	INTJ
ejde-885	182	34	,	,	PUNCT
ejde-885	182	35	βkk	βkk	ADJ
ejde-885	182	36	,	,	PUNCT
ejde-885	182	37	and	and	CCONJ
ejde-885	182	38	βak	βak	VERB
ejde-885	182	39	in	in	ADP
ejde-885	182	40	table	table	NOUN
ejde-885	182	41	4	4	NUM
ejde-885	182	42	.	.	PUNCT
ejde-885	182	43	table	table	NOUN
ejde-885	182	44	4	4	NUM
ejde-885	182	45	.	.	PUNCT
ejde-885	183	1	parameter	parameter	NOUN
ejde-885	183	2	values	value	NOUN
ejde-885	183	3	for	for	ADP
ejde-885	183	4	simulations	simulation	NOUN
ejde-885	183	5	when	when	SCONJ
ejde-885	183	6	assuming	assume	VERB
ejde-885	183	7	heterogeneous	heterogeneous	ADJ
ejde-885	183	8	populations	population	NOUN
ejde-885	183	9	.	.	PUNCT
ejde-885	184	1	†,‡	†,‡	NOUN
ejde-885	184	2	values	value	NOUN
ejde-885	184	3	used	use	VERB
ejde-885	184	4	for	for	ADP
ejde-885	184	5	the	the	DET
ejde-885	184	6	first	first	ADJ
ejde-885	184	7	and	and	CCONJ
ejde-885	184	8	second	second	ADJ
ejde-885	184	9	waves	wave	NOUN
ejde-885	184	10	of	of	ADP
ejde-885	184	11	epidemic	epidemic	NOUN
ejde-885	184	12	respectively	respectively	ADV
ejde-885	184	13	.	.	PUNCT
ejde-885	185	1	∗	∗	NOUN
ejde-885	185	2	value	value	NOUN
ejde-885	185	3	adapted	adapt	VERB
ejde-885	185	4	from	from	ADP
ejde-885	185	5	[	[	X
ejde-885	185	6	13	13	NUM
ejde-885	185	7	]	]	PUNCT
ejde-885	185	8	by	by	ADP
ejde-885	185	9	averaging	average	VERB
ejde-885	185	10	age	age	NOUN
ejde-885	185	11	-	-	PUNCT
ejde-885	185	12	specific	specific	ADJ
ejde-885	185	13	contact	contact	NOUN
ejde-885	185	14	rates	rate	NOUN
ejde-885	185	15	.	.	PUNCT
ejde-885	186	1	parameter	parameter	NOUN
ejde-885	186	2	description	description	NOUN
ejde-885	186	3	value	value	NOUN
ejde-885	186	4	c	c	PROPN
ejde-885	186	5	vaccine	vaccine	NOUN
ejde-885	186	6	coverage	coverage	NOUN
ejde-885	186	7	in	in	ADP
ejde-885	186	8	adults	adult	NOUN
ejde-885	186	9	0†	0†	ADP
ejde-885	186	10	,	,	PUNCT
ejde-885	186	11	0.80‡	0.80‡	NUM
ejde-885	186	12	e	e	NOUN
ejde-885	186	13	vaccine	vaccine	NOUN
ejde-885	186	14	efficacy	efficacy	NOUN
ejde-885	186	15	0†	0†	ADP
ejde-885	186	16	,	,	PUNCT
ejde-885	186	17	0.80‡	0.80‡	X
ejde-885	187	1	p	p	PRON
ejde-885	187	2	probability	probability	NOUN
ejde-885	187	3	of	of	ADP
ejde-885	187	4	transmission	transmission	NOUN
ejde-885	187	5	0.10	0.10	NUM
ejde-885	187	6	βaa	βaa	NOUN
ejde-885	187	7	adult	adult	NOUN
ejde-885	187	8	-	-	PUNCT
ejde-885	187	9	to	to	ADP
ejde-885	187	10	-	-	PUNCT
ejde-885	187	11	adult	adult	NOUN
ejde-885	187	12	contact	contact	NOUN
ejde-885	187	13	coefficient	coefficient	NOUN
ejde-885	187	14	1.15	1.15	NUM
ejde-885	187	15	βka	βka	NOUN
ejde-885	187	16	child	child	NOUN
ejde-885	187	17	-	-	PUNCT
ejde-885	187	18	to	to	ADP
ejde-885	187	19	-	-	PUNCT
ejde-885	187	20	adult	adult	NOUN
ejde-885	187	21	contact	contact	NOUN
ejde-885	187	22	coefficient	coefficient	NOUN
ejde-885	187	23	0.438	0.438	NUM
ejde-885	187	24	βkk	βkk	PROPN
ejde-885	187	25	child	child	NOUN
ejde-885	187	26	-	-	PUNCT
ejde-885	187	27	to	to	ADP
ejde-885	187	28	-	-	PUNCT
ejde-885	187	29	child	child	NOUN
ejde-885	187	30	contact	contact	NOUN
ejde-885	187	31	coefficient	coefficient	NOUN
ejde-885	187	32	1.61	1.61	NUM
ejde-885	187	33	βak	βak	NOUN
ejde-885	187	34	adult	adult	NOUN
ejde-885	187	35	-	-	PUNCT
ejde-885	187	36	to	to	ADP
ejde-885	187	37	-	-	PUNCT
ejde-885	187	38	child	child	NOUN
ejde-885	187	39	contact	contact	NOUN
ejde-885	187	40	coefficient	coefficient	VERB
ejde-885	187	41	0.697	0.697	NUM
ejde-885	187	42	γ1	γ1	NOUN
ejde-885	187	43	adult	adult	NOUN
ejde-885	187	44	progression	progression	NOUN
ejde-885	187	45	rate	rate	NOUN
ejde-885	187	46	1/21	1/21	NUM
ejde-885	187	47	γ2	γ2	ADJ
ejde-885	187	48	child	child	NOUN
ejde-885	187	49	progression	progression	NOUN
ejde-885	187	50	rate	rate	NOUN
ejde-885	187	51	1/14	1/14	NUM
ejde-885	187	52	ρ1	ρ1	NOUN
ejde-885	187	53	adult	adult	NOUN
ejde-885	187	54	recovery	recovery	NOUN
ejde-885	187	55	rate	rate	NOUN
ejde-885	187	56	1/21	1/21	NUM
ejde-885	187	57	ρ2	ρ2	NOUN
ejde-885	187	58	child	child	NOUN
ejde-885	187	59	recovery	recovery	NOUN
ejde-885	187	60	rate	rate	NOUN
ejde-885	187	61	1/14	1/14	NUM
ejde-885	187	62	δ1	δ1	NOUN
ejde-885	187	63	adult	adult	NOUN
ejde-885	187	64	disease	disease	NOUN
ejde-885	187	65	death	death	NOUN
ejde-885	187	66	rate	rate	NOUN
ejde-885	187	67	0.01	0.01	NUM
ejde-885	187	68	δ2	δ2	VERB
ejde-885	187	69	child	child	NOUN
ejde-885	187	70	disease	disease	NOUN
ejde-885	187	71	death	death	NOUN
ejde-885	187	72	rate	rate	NOUN
ejde-885	187	73	0.001	0.001	NUM
ejde-885	187	74	∆t	∆t	NOUN
ejde-885	187	75	days	day	NOUN
ejde-885	187	76	between	between	ADP
ejde-885	187	77	disease	disease	NOUN
ejde-885	187	78	14	14	NUM
ejde-885	187	79	days	day	NOUN
ejde-885	187	80	monitoring	monitor	VERB
ejde-885	187	81	in	in	ADP
ejde-885	187	82	ct	ct	PROPN
ejde-885	187	83	10	10	NUM
ejde-885	187	84	d.	d.	PROPN
ejde-885	187	85	gerberry	gerberry	PROPN
ejde-885	187	86	,	,	PUNCT
ejde-885	187	87	h.	h.	PROPN
ejde-885	187	88	joshi	joshi	PROPN
ejde-885	187	89	,	,	PUNCT
ejde-885	187	90	m.	m.	NOUN
ejde-885	187	91	peloquin	peloquin	NOUN
ejde-885	187	92	,	,	PUNCT
ejde-885	187	93	s.	s.	PROPN
ejde-885	187	94	vargas	vargas	PROPN
ejde-885	187	95	ejde-2022	ejde-2022	NOUN
ejde-885	187	96	/	/	SYM
ejde-885	187	97	conf/26	conf/26	NOUN
ejde-885	187	98	in	in	ADP
ejde-885	187	99	line	line	NOUN
ejde-885	187	100	with	with	ADP
ejde-885	187	101	several	several	ADJ
ejde-885	187	102	respiratory	respiratory	ADJ
ejde-885	187	103	infections	infection	NOUN
ejde-885	187	104	,	,	PUNCT
ejde-885	187	105	we	we	PRON
ejde-885	187	106	include	include	VERB
ejde-885	187	107	additional	additional	ADJ
ejde-885	187	108	heterogeneity	heterogeneity	NOUN
ejde-885	187	109	by	by	ADP
ejde-885	187	110	assuming	assume	VERB
ejde-885	187	111	faster	fast	ADJ
ejde-885	187	112	disease	disease	NOUN
ejde-885	187	113	dynamics	dynamic	NOUN
ejde-885	187	114	in	in	ADP
ejde-885	187	115	children	child	NOUN
ejde-885	187	116	(	(	PUNCT
ejde-885	187	117	i.e.	i.e.	X
ejde-885	187	118	ρ2	ρ2	NOUN
ejde-885	187	119	=	=	SYM
ejde-885	187	120	γ2	γ2	NOUN
ejde-885	187	121	=	=	NOUN
ejde-885	187	122	1	1	NUM
ejde-885	187	123	14	14	NUM
ejde-885	187	124	)	)	PUNCT
ejde-885	187	125	and	and	CCONJ
ejde-885	187	126	higher	high	ADJ
ejde-885	187	127	disease	disease	NOUN
ejde-885	187	128	-	-	PUNCT
ejde-885	187	129	induced	induce	VERB
ejde-885	187	130	mortality	mortality	NOUN
ejde-885	187	131	in	in	ADP
ejde-885	187	132	children	child	NOUN
ejde-885	187	133	(	(	PUNCT
ejde-885	187	134	i.e.	i.e.	X
ejde-885	187	135	µ1	µ1	NOUN
ejde-885	187	136	=	=	SYM
ejde-885	187	137	0.01	0.01	NUM
ejde-885	187	138	)	)	PUNCT
ejde-885	187	139	.	.	PUNCT
ejde-885	188	1	the	the	DET
ejde-885	188	2	results	result	NOUN
ejde-885	188	3	of	of	ADP
ejde-885	188	4	this	this	DET
ejde-885	188	5	simulation	simulation	NOUN
ejde-885	188	6	are	be	AUX
ejde-885	188	7	illustrated	illustrate	VERB
ejde-885	188	8	in	in	ADP
ejde-885	188	9	figure	figure	NOUN
ejde-885	188	10	3	3	NUM
ejde-885	188	11	.	.	PUNCT
ejde-885	189	1	in	in	ADP
ejde-885	189	2	figure	figure	NOUN
ejde-885	189	3	3a	3a	NUM
ejde-885	189	4	,	,	PUNCT
ejde-885	189	5	we	we	PRON
ejde-885	189	6	see	see	VERB
ejde-885	189	7	disease	disease	NOUN
ejde-885	189	8	dynamics	dynamic	NOUN
ejde-885	189	9	in	in	ADP
ejde-885	189	10	the	the	DET
ejde-885	189	11	first	first	ADJ
ejde-885	189	12	wave	wave	NOUN
ejde-885	189	13	that	that	PRON
ejde-885	189	14	differ	differ	VERB
ejde-885	189	15	for	for	ADP
ejde-885	189	16	adults	adult	NOUN
ejde-885	189	17	and	and	CCONJ
ejde-885	189	18	children	child	NOUN
ejde-885	189	19	.	.	PUNCT
ejde-885	190	1	in	in	ADP
ejde-885	190	2	addition	addition	NOUN
ejde-885	190	3	to	to	ADP
ejde-885	190	4	different	different	ADJ
ejde-885	190	5	population	population	NOUN
ejde-885	190	6	sizes	size	NOUN
ejde-885	190	7	,	,	PUNCT
ejde-885	190	8	we	we	PRON
ejde-885	190	9	see	see	VERB
ejde-885	190	10	the	the	DET
ejde-885	190	11	epidemic	epidemic	NOUN
ejde-885	190	12	peaks	peak	NOUN
ejde-885	190	13	slightly	slightly	ADV
ejde-885	190	14	earlier	early	ADV
ejde-885	190	15	in	in	ADP
ejde-885	190	16	children	child	NOUN
ejde-885	190	17	.	.	PUNCT
ejde-885	191	1	in	in	ADP
ejde-885	191	2	figure	figure	NOUN
ejde-885	191	3	3(b	3(b	NUM
ejde-885	191	4	)	)	PUNCT
ejde-885	191	5	,	,	PUNCT
ejde-885	191	6	the	the	DET
ejde-885	191	7	clinical	clinical	ADJ
ejde-885	191	8	trial	trial	NOUN
ejde-885	191	9	in	in	ADP
ejde-885	191	10	adults	adult	NOUN
ejde-885	191	11	follows	follow	VERB
ejde-885	191	12	an	an	DET
ejde-885	191	13	almost	almost	ADV
ejde-885	191	14	indistinguishable	indistinguishable	ADJ
ejde-885	191	15	pattern	pattern	NOUN
ejde-885	191	16	from	from	ADP
ejde-885	191	17	that	that	PRON
ejde-885	191	18	of	of	ADP
ejde-885	191	19	figure	figure	NOUN
ejde-885	191	20	2(b	2(b	NUM
ejde-885	191	21	)	)	PUNCT
ejde-885	191	22	,	,	PUNCT
ejde-885	191	23	with	with	ADP
ejde-885	191	24	the	the	DET
ejde-885	191	25	clinical	clinical	ADJ
ejde-885	191	26	trial	trial	NOUN
ejde-885	191	27	reaching	reach	VERB
ejde-885	191	28	a	a	DET
ejde-885	191	29	p	p	NOUN
ejde-885	191	30	-	-	PUNCT
ejde-885	191	31	value	value	NOUN
ejde-885	191	32	of	of	ADP
ejde-885	191	33	10−4	10−4	NUM
ejde-885	191	34	in	in	ADP
ejde-885	191	35	6	6	NUM
ejde-885	191	36	steps	step	NOUN
ejde-885	191	37	(	(	PUNCT
ejde-885	191	38	i.e.	i.e.	X
ejde-885	191	39	12	12	NUM
ejde-885	191	40	weeks	week	NOUN
ejde-885	191	41	,	,	PUNCT
ejde-885	191	42	84	84	NUM
ejde-885	191	43	days	day	NOUN
ejde-885	191	44	)	)	PUNCT
ejde-885	191	45	.	.	PUNCT
ejde-885	192	1	figure	figure	VERB
ejde-885	192	2	3(c	3(c	NUM
ejde-885	192	3	)	)	PUNCT
ejde-885	193	1	shows	show	VERB
ejde-885	193	2	the	the	DET
ejde-885	193	3	second	second	ADJ
ejde-885	193	4	wave	wave	NOUN
ejde-885	193	5	of	of	ADP
ejde-885	193	6	the	the	DET
ejde-885	193	7	epidemic	epidemic	NOUN
ejde-885	193	8	with	with	ADP
ejde-885	193	9	80	80	NUM
ejde-885	193	10	%	%	NOUN
ejde-885	193	11	of	of	ADP
ejde-885	193	12	adults	adult	NOUN
ejde-885	193	13	vaccinated	vaccinate	VERB
ejde-885	193	14	and	and	CCONJ
ejde-885	193	15	receiving	receive	VERB
ejde-885	193	16	80	80	NUM
ejde-885	193	17	%	%	NOUN
ejde-885	193	18	efficacy	efficacy	NOUN
ejde-885	193	19	from	from	ADP
ejde-885	193	20	the	the	DET
ejde-885	193	21	vaccine	vaccine	NOUN
ejde-885	193	22	.	.	PUNCT
ejde-885	194	1	the	the	DET
ejde-885	194	2	most	most	ADV
ejde-885	194	3	notable	notable	ADJ
ejde-885	194	4	results	result	NOUN
ejde-885	194	5	are	be	AUX
ejde-885	194	6	illustrated	illustrate	VERB
ejde-885	194	7	in	in	ADP
ejde-885	194	8	the	the	DET
ejde-885	194	9	clinical	clinical	ADJ
ejde-885	194	10	trial	trial	NOUN
ejde-885	194	11	in	in	ADP
ejde-885	194	12	children	child	NOUN
ejde-885	194	13	shown	show	VERB
ejde-885	194	14	in	in	ADP
ejde-885	194	15	figure	figure	NOUN
ejde-885	194	16	3(d	3(d	NUM
ejde-885	194	17	)	)	PUNCT
ejde-885	194	18	.	.	PUNCT
ejde-885	195	1	with	with	SCONJ
ejde-885	195	2	heterogeneity	heterogeneity	NOUN
ejde-885	195	3	included	include	VERB
ejde-885	195	4	,	,	PUNCT
ejde-885	195	5	we	we	PRON
ejde-885	195	6	see	see	VERB
ejde-885	195	7	that	that	SCONJ
ejde-885	195	8	the	the	DET
ejde-885	195	9	clinical	clinical	ADJ
ejde-885	195	10	trial	trial	NOUN
ejde-885	195	11	in	in	ADP
ejde-885	195	12	children	child	NOUN
ejde-885	195	13	would	would	AUX
ejde-885	195	14	reach	reach	VERB
ejde-885	195	15	a	a	DET
ejde-885	195	16	p	p	NOUN
ejde-885	195	17	-	-	PUNCT
ejde-885	195	18	value	value	NOUN
ejde-885	195	19	of	of	ADP
ejde-885	195	20	10−4	10−4	NUM
ejde-885	195	21	in	in	ADP
ejde-885	195	22	roughly	roughly	ADV
ejde-885	195	23	the	the	DET
ejde-885	195	24	same	same	ADJ
ejde-885	195	25	number	number	NOUN
ejde-885	195	26	of	of	ADP
ejde-885	195	27	steps	step	NOUN
ejde-885	195	28	as	as	ADP
ejde-885	195	29	the	the	DET
ejde-885	195	30	adult	adult	NOUN
ejde-885	195	31	clinical	clinical	ADJ
ejde-885	195	32	trial	trial	NOUN
ejde-885	195	33	;	;	PUNCT
ejde-885	195	34	specifically	specifically	ADV
ejde-885	195	35	7	7	NUM
ejde-885	195	36	steps	step	NOUN
ejde-885	195	37	(	(	PUNCT
ejde-885	195	38	i.e.	i.e.	X
ejde-885	195	39	14	14	NUM
ejde-885	195	40	weeks	week	NOUN
ejde-885	195	41	,	,	PUNCT
ejde-885	195	42	98	98	NUM
ejde-885	195	43	days	day	NOUN
ejde-885	195	44	)	)	PUNCT
ejde-885	195	45	.	.	PUNCT
ejde-885	196	1	therefore	therefore	ADV
ejde-885	196	2	,	,	PUNCT
ejde-885	196	3	we	we	PRON
ejde-885	196	4	see	see	VERB
ejde-885	196	5	that	that	SCONJ
ejde-885	196	6	the	the	DET
ejde-885	196	7	result	result	NOUN
ejde-885	196	8	of	of	ADP
ejde-885	196	9	vaccine	vaccine	NOUN
ejde-885	196	10	clinical	clinical	ADJ
ejde-885	196	11	trials	trial	NOUN
ejde-885	196	12	taking	take	VERB
ejde-885	196	13	longer	long	ADJ
ejde-885	196	14	in	in	ADP
ejde-885	196	15	children	child	NOUN
ejde-885	196	16	than	than	ADP
ejde-885	196	17	in	in	ADP
ejde-885	196	18	the	the	DET
ejde-885	196	19	adult	adult	NOUN
ejde-885	196	20	population	population	NOUN
ejde-885	196	21	can	can	AUX
ejde-885	196	22	be	be	AUX
ejde-885	196	23	largely	largely	ADV
ejde-885	196	24	erased	erase	VERB
ejde-885	196	25	due	due	ADJ
ejde-885	196	26	to	to	ADP
ejde-885	196	27	epidemiological	epidemiological	ADJ
ejde-885	196	28	differences	difference	NOUN
ejde-885	196	29	between	between	ADP
ejde-885	196	30	adults	adult	NOUN
ejde-885	196	31	and	and	CCONJ
ejde-885	196	32	children	child	NOUN
ejde-885	196	33	.	.	PUNCT
ejde-885	197	1	0	0	NUM
ejde-885	197	2	100	100	NUM
ejde-885	197	3	200	200	NUM
ejde-885	197	4	300	300	NUM
ejde-885	197	5	0	0	NUM
ejde-885	197	6	.	.	NOUN
ejde-885	197	7	0	0	NUM
ejde-885	197	8	0	0	NUM
ejde-885	197	9	.	.	NOUN
ejde-885	197	10	2	2	NUM
ejde-885	197	11	0	0	NUM
ejde-885	197	12	.	.	NOUN
ejde-885	197	13	4	4	NUM
ejde-885	197	14	0	0	NUM
ejde-885	197	15	.	.	NOUN
ejde-885	197	16	6	6	NUM
ejde-885	197	17	days	day	NOUN
ejde-885	197	18	p	p	PROPN
ejde-885	197	19	ro	ro	INTJ
ejde-885	197	20	po	po	PROPN
ejde-885	197	21	rt	rt	PROPN
ejde-885	197	22	io	io	PROPN
ejde-885	198	1	n	n	PROPN
ejde-885	198	2	of	of	ADP
ejde-885	198	3	p	p	PRON
ejde-885	198	4	op	op	NOUN
ejde-885	198	5	ul	ul	NOUN
ejde-885	198	6	at	at	ADP
ejde-885	198	7	io	io	PROPN
ejde-885	198	8	n	n	ADV
ejde-885	198	9	0	0	NUM
ejde-885	198	10	100	100	NUM
ejde-885	198	11	200	200	NUM
ejde-885	198	12	300	300	NUM
ejde-885	198	13	0	0	NUM
ejde-885	198	14	.	.	NOUN
ejde-885	198	15	0	0	NUM
ejde-885	198	16	0	0	NUM
ejde-885	198	17	.	.	NOUN
ejde-885	198	18	2	2	NUM
ejde-885	198	19	0	0	NUM
ejde-885	198	20	.	.	NOUN
ejde-885	198	21	4	4	NUM
ejde-885	198	22	0	0	NUM
ejde-885	198	23	.	.	NOUN
ejde-885	198	24	6	6	NUM
ejde-885	198	25	days	day	NOUN
ejde-885	198	26	p	p	PROPN
ejde-885	198	27	ro	ro	INTJ
ejde-885	198	28	po	po	PROPN
ejde-885	198	29	rt	rt	PROPN
ejde-885	198	30	io	io	PROPN
ejde-885	199	1	n	n	PROPN
ejde-885	199	2	of	of	ADP
ejde-885	199	3	p	p	PRON
ejde-885	199	4	op	op	NOUN
ejde-885	199	5	ul	ul	NOUN
ejde-885	199	6	at	at	ADP
ejde-885	199	7	io	io	PROPN
ejde-885	199	8	n	n	ADV
ejde-885	199	9	0	0	NUM
ejde-885	199	10	100	100	NUM
ejde-885	199	11	200	200	NUM
ejde-885	199	12	300	300	NUM
ejde-885	199	13	0	0	NUM
ejde-885	199	14	.	.	NOUN
ejde-885	199	15	0	0	NUM
ejde-885	199	16	0	0	NUM
ejde-885	199	17	.	.	NOUN
ejde-885	199	18	2	2	NUM
ejde-885	199	19	0	0	NUM
ejde-885	199	20	.	.	NOUN
ejde-885	199	21	4	4	NUM
ejde-885	199	22	0	0	NUM
ejde-885	199	23	.	.	NOUN
ejde-885	199	24	6	6	NUM
ejde-885	199	25	days	day	NOUN
ejde-885	199	26	0	0	NUM
ejde-885	199	27	100	100	NUM
ejde-885	199	28	200	200	NUM
ejde-885	199	29	300	300	NUM
ejde-885	199	30	0	0	NUM
ejde-885	199	31	.	.	NOUN
ejde-885	199	32	0	0	NUM
ejde-885	199	33	0	0	NUM
ejde-885	199	34	.	.	NOUN
ejde-885	199	35	2	2	NUM
ejde-885	199	36	0	0	NUM
ejde-885	199	37	.	.	NOUN
ejde-885	199	38	4	4	NUM
ejde-885	199	39	0	0	NUM
ejde-885	199	40	.	.	NOUN
ejde-885	199	41	6	6	NUM
ejde-885	199	42	days	day	NOUN
ejde-885	199	43	0	0	NUM
ejde-885	199	44	100	100	NUM
ejde-885	199	45	200	200	NUM
ejde-885	199	46	300	300	NUM
ejde-885	199	47	0	0	NUM
ejde-885	199	48	.	.	NOUN
ejde-885	199	49	0	0	NUM
ejde-885	199	50	0	0	NUM
ejde-885	199	51	.	.	NOUN
ejde-885	199	52	2	2	NUM
ejde-885	199	53	0	0	NUM
ejde-885	199	54	.	.	NOUN
ejde-885	199	55	4	4	NUM
ejde-885	199	56	0	0	NUM
ejde-885	199	57	.	.	NOUN
ejde-885	199	58	6	6	NUM
ejde-885	199	59	days	day	NOUN
ejde-885	199	60	0	0	NUM
ejde-885	199	61	100	100	NUM
ejde-885	199	62	200	200	NUM
ejde-885	199	63	300	300	NUM
ejde-885	199	64	0	0	NUM
ejde-885	199	65	.	.	NOUN
ejde-885	199	66	0	0	NUM
ejde-885	199	67	0	0	NUM
ejde-885	199	68	.	.	NOUN
ejde-885	199	69	2	2	NUM
ejde-885	199	70	0	0	NUM
ejde-885	199	71	.	.	NOUN
ejde-885	199	72	4	4	NUM
ejde-885	199	73	0	0	NUM
ejde-885	199	74	.	.	NOUN
ejde-885	199	75	6	6	NUM
ejde-885	199	76	days	day	NOUN
ejde-885	199	77	0	0	NUM
ejde-885	199	78	100	100	NUM
ejde-885	199	79	200	200	NUM
ejde-885	199	80	300	300	NUM
ejde-885	199	81	0	0	NUM
ejde-885	199	82	.	.	NOUN
ejde-885	199	83	0	0	NUM
ejde-885	199	84	0	0	NUM
ejde-885	199	85	.	.	NOUN
ejde-885	199	86	2	2	NUM
ejde-885	199	87	0	0	NUM
ejde-885	199	88	.	.	NOUN
ejde-885	199	89	4	4	NUM
ejde-885	199	90	0	0	NUM
ejde-885	199	91	.	.	NOUN
ejde-885	199	92	6	6	NUM
ejde-885	199	93	days	day	NOUN
ejde-885	199	94	0	0	NUM
ejde-885	199	95	100	100	NUM
ejde-885	199	96	200	200	NUM
ejde-885	199	97	300	300	NUM
ejde-885	199	98	0	0	NUM
ejde-885	199	99	.	.	NOUN
ejde-885	199	100	0	0	NUM
ejde-885	199	101	0	0	NUM
ejde-885	199	102	.	.	NOUN
ejde-885	199	103	2	2	NUM
ejde-885	199	104	0	0	NUM
ejde-885	199	105	.	.	NOUN
ejde-885	199	106	4	4	NUM
ejde-885	199	107	0	0	NUM
ejde-885	199	108	.	.	NOUN
ejde-885	199	109	6	6	NUM
ejde-885	199	110	days	day	NOUN
ejde-885	199	111	susc	susc	NOUN
ejde-885	199	112	adults	adult	NOUN
ejde-885	199	113	susc	susc	PROPN
ejde-885	199	114	kids	kid	NOUN
ejde-885	199	115	exposed	expose	VERB
ejde-885	199	116	adults	adult	NOUN
ejde-885	199	117	exposed	expose	VERB
ejde-885	199	118	kids	kid	NOUN
ejde-885	199	119	infected	infect	VERB
ejde-885	199	120	adults	adult	NOUN
ejde-885	199	121	infected	infect	VERB
ejde-885	199	122	kids	kid	NOUN
ejde-885	199	123	rec	rec	X
ejde-885	199	124	adults	adult	NOUN
ejde-885	199	125	rec	rec	X
ejde-885	199	126	kids	kid	NOUN
ejde-885	199	127	5	5	NUM
ejde-885	199	128	10	10	NUM
ejde-885	199	129	15	15	NUM
ejde-885	199	130	0	0	NUM
ejde-885	199	131	5	5	NUM
ejde-885	199	132	10	10	NUM
ejde-885	199	133	15	15	NUM
ejde-885	199	134	20	20	NUM
ejde-885	199	135	25	25	NUM
ejde-885	199	136	30	30	NUM
ejde-885	199	137	steps	step	NOUN
ejde-885	199	138	(	(	PUNCT
ejde-885	199	139	each	each	DET
ejde-885	199	140	14	14	NUM
ejde-885	199	141	days	day	NOUN
ejde-885	199	142	)	)	PUNCT
ejde-885	199	143	in	in	ADP
ejde-885	199	144	fe	fe	X
ejde-885	199	145	ct	ct	PROPN
ejde-885	199	146	io	io	PROPN
ejde-885	199	147	ns	ns	NUM
ejde-885	199	148	5	5	NUM
ejde-885	199	149	10	10	NUM
ejde-885	199	150	15	15	NUM
ejde-885	199	151	0	0	NUM
ejde-885	199	152	5	5	NUM
ejde-885	199	153	10	10	NUM
ejde-885	199	154	15	15	NUM
ejde-885	199	155	20	20	NUM
ejde-885	199	156	25	25	NUM
ejde-885	199	157	30	30	NUM
ejde-885	199	158	steps	step	NOUN
ejde-885	199	159	(	(	PUNCT
ejde-885	199	160	each	each	DET
ejde-885	199	161	14	14	NUM
ejde-885	199	162	days	day	NOUN
ejde-885	199	163	)	)	PUNCT
ejde-885	199	164	in	in	ADP
ejde-885	199	165	fe	fe	X
ejde-885	199	166	ct	ct	PROPN
ejde-885	199	167	io	io	PROPN
ejde-885	199	168	ns	ns	NUM
ejde-885	199	169	1e	1e	PROPN
ejde-885	199	170	−	−	PROPN
ejde-885	199	171	04	04	NUM
ejde-885	200	1	1e	1e	NOUN
ejde-885	200	2	−	−	PROPN
ejde-885	200	3	02	02	NUM
ejde-885	200	4	1e	1e	PROPN
ejde-885	201	1	+	+	CCONJ
ejde-885	201	2	00	00	NUM
ejde-885	202	1	p	p	PRON
ejde-885	202	2	−	−	PROPN
ejde-885	202	3	va	va	NOUN
ejde-885	202	4	lu	lu	PROPN
ejde-885	202	5	e	e	PROPN
ejde-885	202	6	of	of	ADP
ejde-885	202	7	p	p	NOUN
ejde-885	202	8	ro	ro	X
ejde-885	202	9	te	te	INTJ
ejde-885	202	10	ct	ct	NUM
ejde-885	202	11	iv	iv	NUM
ejde-885	202	12	e	e	PROPN
ejde-885	202	13	ef	ef	X
ejde-885	202	14	fe	fe	PROPN
ejde-885	202	15	ctcontrol	ctcontrol	PROPN
ejde-885	202	16	vaccinated	vaccinate	VERB
ejde-885	202	17	p−value	p−value	NOUN
ejde-885	202	18	(	(	PUNCT
ejde-885	202	19	a	a	X
ejde-885	202	20	)	)	PUNCT
ejde-885	202	21	first	first	ADJ
ejde-885	202	22	wave	wave	NOUN
ejde-885	202	23	of	of	ADP
ejde-885	202	24	epidemic	epidemic	NOUN
ejde-885	202	25	;	;	PUNCT
ejde-885	202	26	no	no	DET
ejde-885	202	27	one	one	NOUN
ejde-885	202	28	vaccinated	vaccinate	VERB
ejde-885	202	29	(	(	PUNCT
ejde-885	202	30	b	b	NOUN
ejde-885	202	31	)	)	PUNCT
ejde-885	202	32	clinical	clinical	ADJ
ejde-885	202	33	trial	trial	NOUN
ejde-885	202	34	for	for	ADP
ejde-885	202	35	adults	adult	NOUN
ejde-885	202	36	that	that	PRON
ejde-885	202	37	begins	begin	VERB
ejde-885	202	38	on	on	ADP
ejde-885	202	39	day	day	NOUN
ejde-885	202	40	100	100	NUM
ejde-885	202	41	of	of	ADP
ejde-885	202	42	the	the	DET
ejde-885	202	43	first	first	ADJ
ejde-885	202	44	wave	wave	NOUN
ejde-885	202	45	0	0	NUM
ejde-885	202	46	100	100	NUM
ejde-885	202	47	200	200	NUM
ejde-885	202	48	300	300	NUM
ejde-885	202	49	0	0	NUM
ejde-885	202	50	.	.	NOUN
ejde-885	202	51	0	0	NUM
ejde-885	202	52	0	0	NUM
ejde-885	202	53	.	.	NOUN
ejde-885	202	54	2	2	NUM
ejde-885	202	55	0	0	NUM
ejde-885	202	56	.	.	NOUN
ejde-885	202	57	4	4	NUM
ejde-885	202	58	0	0	NUM
ejde-885	202	59	.	.	NOUN
ejde-885	202	60	6	6	NUM
ejde-885	202	61	days	day	NOUN
ejde-885	202	62	p	p	PROPN
ejde-885	202	63	ro	ro	INTJ
ejde-885	202	64	po	po	PROPN
ejde-885	202	65	rt	rt	PROPN
ejde-885	202	66	io	io	PROPN
ejde-885	203	1	n	n	PROPN
ejde-885	203	2	of	of	ADP
ejde-885	203	3	p	p	PRON
ejde-885	203	4	op	op	NOUN
ejde-885	203	5	ul	ul	NOUN
ejde-885	203	6	at	at	ADP
ejde-885	203	7	io	io	PROPN
ejde-885	203	8	n	n	ADV
ejde-885	203	9	0	0	NUM
ejde-885	203	10	100	100	NUM
ejde-885	203	11	200	200	NUM
ejde-885	203	12	300	300	NUM
ejde-885	203	13	0	0	NUM
ejde-885	203	14	.	.	NOUN
ejde-885	203	15	0	0	NUM
ejde-885	203	16	0	0	NUM
ejde-885	203	17	.	.	NOUN
ejde-885	203	18	2	2	NUM
ejde-885	203	19	0	0	NUM
ejde-885	203	20	.	.	NOUN
ejde-885	203	21	4	4	NUM
ejde-885	203	22	0	0	NUM
ejde-885	203	23	.	.	NOUN
ejde-885	203	24	6	6	NUM
ejde-885	203	25	days	day	NOUN
ejde-885	203	26	p	p	PROPN
ejde-885	203	27	ro	ro	INTJ
ejde-885	203	28	po	po	PROPN
ejde-885	203	29	rt	rt	PROPN
ejde-885	203	30	io	io	PROPN
ejde-885	204	1	n	n	PROPN
ejde-885	204	2	of	of	ADP
ejde-885	204	3	p	p	PRON
ejde-885	204	4	op	op	NOUN
ejde-885	204	5	ul	ul	NOUN
ejde-885	204	6	at	at	ADP
ejde-885	204	7	io	io	PROPN
ejde-885	204	8	n	n	ADV
ejde-885	204	9	0	0	NUM
ejde-885	204	10	100	100	NUM
ejde-885	204	11	200	200	NUM
ejde-885	204	12	300	300	NUM
ejde-885	204	13	0	0	NUM
ejde-885	204	14	.	.	NOUN
ejde-885	204	15	0	0	NUM
ejde-885	204	16	0	0	NUM
ejde-885	204	17	.	.	NOUN
ejde-885	204	18	2	2	NUM
ejde-885	204	19	0	0	NUM
ejde-885	204	20	.	.	NOUN
ejde-885	204	21	4	4	NUM
ejde-885	204	22	0	0	NUM
ejde-885	204	23	.	.	NOUN
ejde-885	204	24	6	6	NUM
ejde-885	204	25	days	day	NOUN
ejde-885	204	26	0	0	NUM
ejde-885	204	27	100	100	NUM
ejde-885	204	28	200	200	NUM
ejde-885	204	29	300	300	NUM
ejde-885	204	30	0	0	NUM
ejde-885	204	31	.	.	NOUN
ejde-885	204	32	0	0	NUM
ejde-885	204	33	0	0	NUM
ejde-885	204	34	.	.	NOUN
ejde-885	204	35	2	2	NUM
ejde-885	204	36	0	0	NUM
ejde-885	204	37	.	.	NOUN
ejde-885	204	38	4	4	NUM
ejde-885	204	39	0	0	NUM
ejde-885	204	40	.	.	NOUN
ejde-885	204	41	6	6	NUM
ejde-885	204	42	days	day	NOUN
ejde-885	204	43	0	0	NUM
ejde-885	204	44	100	100	NUM
ejde-885	204	45	200	200	NUM
ejde-885	204	46	300	300	NUM
ejde-885	204	47	0	0	NUM
ejde-885	204	48	.	.	NOUN
ejde-885	204	49	0	0	NUM
ejde-885	204	50	0	0	NUM
ejde-885	204	51	.	.	NOUN
ejde-885	204	52	2	2	NUM
ejde-885	204	53	0	0	NUM
ejde-885	204	54	.	.	NOUN
ejde-885	204	55	4	4	NUM
ejde-885	204	56	0	0	NUM
ejde-885	204	57	.	.	NOUN
ejde-885	204	58	6	6	NUM
ejde-885	204	59	days	day	NOUN
ejde-885	204	60	0	0	NUM
ejde-885	204	61	100	100	NUM
ejde-885	204	62	200	200	NUM
ejde-885	204	63	300	300	NUM
ejde-885	204	64	0	0	NUM
ejde-885	204	65	.	.	NOUN
ejde-885	204	66	0	0	NUM
ejde-885	204	67	0	0	NUM
ejde-885	204	68	.	.	NOUN
ejde-885	204	69	2	2	NUM
ejde-885	204	70	0	0	NUM
ejde-885	204	71	.	.	NOUN
ejde-885	204	72	4	4	NUM
ejde-885	204	73	0	0	NUM
ejde-885	204	74	.	.	NOUN
ejde-885	204	75	6	6	NUM
ejde-885	204	76	days	day	NOUN
ejde-885	204	77	0	0	NUM
ejde-885	204	78	100	100	NUM
ejde-885	204	79	200	200	NUM
ejde-885	204	80	300	300	NUM
ejde-885	204	81	0	0	NUM
ejde-885	204	82	.	.	NOUN
ejde-885	204	83	0	0	NUM
ejde-885	204	84	0	0	NUM
ejde-885	204	85	.	.	NOUN
ejde-885	204	86	2	2	NUM
ejde-885	204	87	0	0	NUM
ejde-885	204	88	.	.	NOUN
ejde-885	204	89	4	4	NUM
ejde-885	204	90	0	0	NUM
ejde-885	204	91	.	.	NOUN
ejde-885	204	92	6	6	NUM
ejde-885	204	93	days	day	NOUN
ejde-885	204	94	0	0	NUM
ejde-885	204	95	100	100	NUM
ejde-885	204	96	200	200	NUM
ejde-885	204	97	300	300	NUM
ejde-885	204	98	0	0	NUM
ejde-885	204	99	.	.	NOUN
ejde-885	204	100	0	0	NUM
ejde-885	204	101	0	0	NUM
ejde-885	204	102	.	.	NOUN
ejde-885	204	103	2	2	NUM
ejde-885	204	104	0	0	NUM
ejde-885	204	105	.	.	NOUN
ejde-885	204	106	4	4	NUM
ejde-885	204	107	0	0	NUM
ejde-885	204	108	.	.	NOUN
ejde-885	204	109	6	6	NUM
ejde-885	204	110	days	day	NOUN
ejde-885	204	111	susc	susc	NOUN
ejde-885	204	112	adults	adult	NOUN
ejde-885	204	113	susc	susc	PROPN
ejde-885	204	114	kids	kid	NOUN
ejde-885	204	115	exposed	expose	VERB
ejde-885	204	116	adults	adult	NOUN
ejde-885	204	117	exposed	expose	VERB
ejde-885	204	118	kids	kid	NOUN
ejde-885	204	119	infected	infect	VERB
ejde-885	204	120	adults	adult	NOUN
ejde-885	204	121	infected	infect	VERB
ejde-885	204	122	kids	kid	NOUN
ejde-885	204	123	rec	rec	X
ejde-885	204	124	adults	adult	NOUN
ejde-885	204	125	rec	rec	X
ejde-885	204	126	kids	kid	NOUN
ejde-885	204	127	5	5	NUM
ejde-885	204	128	10	10	NUM
ejde-885	204	129	15	15	NUM
ejde-885	204	130	0	0	NUM
ejde-885	204	131	5	5	NUM
ejde-885	204	132	10	10	NUM
ejde-885	204	133	15	15	NUM
ejde-885	204	134	20	20	NUM
ejde-885	204	135	25	25	NUM
ejde-885	204	136	steps	step	NOUN
ejde-885	204	137	(	(	PUNCT
ejde-885	204	138	each	each	DET
ejde-885	204	139	14	14	NUM
ejde-885	204	140	days	day	NOUN
ejde-885	204	141	)	)	PUNCT
ejde-885	204	142	in	in	ADP
ejde-885	204	143	fe	fe	X
ejde-885	204	144	ct	ct	PROPN
ejde-885	204	145	io	io	PROPN
ejde-885	204	146	ns	ns	NUM
ejde-885	204	147	5	5	NUM
ejde-885	204	148	10	10	NUM
ejde-885	204	149	15	15	NUM
ejde-885	204	150	0	0	NUM
ejde-885	204	151	5	5	NUM
ejde-885	204	152	10	10	NUM
ejde-885	204	153	15	15	NUM
ejde-885	204	154	20	20	NUM
ejde-885	204	155	25	25	NUM
ejde-885	204	156	steps	step	NOUN
ejde-885	204	157	(	(	PUNCT
ejde-885	204	158	each	each	DET
ejde-885	204	159	14	14	NUM
ejde-885	204	160	days	day	NOUN
ejde-885	204	161	)	)	PUNCT
ejde-885	204	162	in	in	ADP
ejde-885	204	163	fe	fe	X
ejde-885	204	164	ct	ct	PROPN
ejde-885	204	165	io	io	PROPN
ejde-885	204	166	ns	ns	NUM
ejde-885	204	167	1e	1e	PROPN
ejde-885	204	168	−	−	PROPN
ejde-885	204	169	04	04	NUM
ejde-885	205	1	1e	1e	NOUN
ejde-885	205	2	−	−	PROPN
ejde-885	205	3	02	02	NUM
ejde-885	205	4	1e	1e	PROPN
ejde-885	206	1	+	+	CCONJ
ejde-885	206	2	00	00	NUM
ejde-885	207	1	p	p	PRON
ejde-885	207	2	−	−	PROPN
ejde-885	207	3	va	va	NOUN
ejde-885	207	4	lu	lu	PROPN
ejde-885	207	5	e	e	PROPN
ejde-885	207	6	of	of	ADP
ejde-885	207	7	p	p	NOUN
ejde-885	207	8	ro	ro	X
ejde-885	207	9	te	te	INTJ
ejde-885	207	10	ct	ct	NUM
ejde-885	207	11	iv	iv	NUM
ejde-885	207	12	e	e	PROPN
ejde-885	207	13	ef	ef	X
ejde-885	207	14	fe	fe	PROPN
ejde-885	207	15	ctcontrol	ctcontrol	PROPN
ejde-885	207	16	vaccinated	vaccinate	VERB
ejde-885	207	17	p−value	p−value	NOUN
ejde-885	207	18	(	(	PUNCT
ejde-885	207	19	c	c	NOUN
ejde-885	207	20	)	)	PUNCT
ejde-885	207	21	second	second	ADJ
ejde-885	207	22	wave	wave	NOUN
ejde-885	207	23	of	of	ADP
ejde-885	207	24	epidemic	epidemic	NOUN
ejde-885	207	25	;	;	PUNCT
ejde-885	207	26	80	80	NUM
ejde-885	207	27	%	%	NOUN
ejde-885	207	28	of	of	ADP
ejde-885	207	29	adults	adult	NOUN
ejde-885	207	30	are	be	AUX
ejde-885	207	31	vaccinated	vaccinate	VERB
ejde-885	207	32	(	(	PUNCT
ejde-885	207	33	d	d	NOUN
ejde-885	207	34	)	)	PUNCT
ejde-885	207	35	clinical	clinical	ADJ
ejde-885	207	36	trial	trial	NOUN
ejde-885	207	37	for	for	ADP
ejde-885	207	38	kids	kid	NOUN
ejde-885	207	39	that	that	PRON
ejde-885	207	40	begins	begin	VERB
ejde-885	207	41	on	on	ADP
ejde-885	207	42	day	day	NOUN
ejde-885	207	43	100	100	NUM
ejde-885	207	44	of	of	ADP
ejde-885	207	45	the	the	DET
ejde-885	207	46	second	second	ADJ
ejde-885	207	47	wave	wave	NOUN
ejde-885	207	48	figure	figure	NOUN
ejde-885	207	49	3	3	NUM
ejde-885	207	50	.	.	PUNCT
ejde-885	207	51	simulation	simulation	NOUN
ejde-885	207	52	results	result	NOUN
ejde-885	207	53	when	when	SCONJ
ejde-885	207	54	assuming	assume	VERB
ejde-885	207	55	population	population	NOUN
ejde-885	207	56	heterogeneity	heterogeneity	NOUN
ejde-885	207	57	between	between	ADP
ejde-885	207	58	adults	adult	NOUN
ejde-885	207	59	and	and	CCONJ
ejde-885	207	60	kids	kid	NOUN
ejde-885	207	61	(	(	PUNCT
ejde-885	207	62	i.e.	i.e.	X
ejde-885	207	63	population	population	NOUN
ejde-885	207	64	is	be	AUX
ejde-885	207	65	70	70	NUM
ejde-885	207	66	%	%	NOUN
ejde-885	207	67	adult	adult	NOUN
ejde-885	207	68	and	and	CCONJ
ejde-885	207	69	30	30	NUM
ejde-885	207	70	%	%	NOUN
ejde-885	207	71	kids	kid	NOUN
ejde-885	207	72	,	,	PUNCT
ejde-885	207	73	and	and	CCONJ
ejde-885	207	74	age	age	NOUN
ejde-885	207	75	-	-	PUNCT
ejde-885	207	76	based	base	VERB
ejde-885	207	77	mixing	mix	VERB
ejde-885	207	78	patterns	pattern	NOUN
ejde-885	207	79	adapted	adapt	VERB
ejde-885	207	80	from	from	ADP
ejde-885	207	81	[	[	X
ejde-885	207	82	13	13	NUM
ejde-885	207	83	]	]	PUNCT
ejde-885	207	84	)	)	PUNCT
ejde-885	207	85	and	and	CCONJ
ejde-885	207	86	a	a	DET
ejde-885	207	87	vaccine	vaccine	NOUN
ejde-885	207	88	efficacy	efficacy	NOUN
ejde-885	207	89	of	of	ADP
ejde-885	207	90	e	e	NOUN
ejde-885	207	91	=	=	PROPN
ejde-885	207	92	0.80	0.80	NUM
ejde-885	207	93	.	.	PUNCT
ejde-885	208	1	5	5	NUM
ejde-885	208	2	.	.	X
ejde-885	208	3	conclusions	conclusion	NOUN
ejde-885	208	4	and	and	CCONJ
ejde-885	208	5	further	further	ADJ
ejde-885	208	6	research	research	VERB
ejde-885	208	7	our	our	PRON
ejde-885	208	8	objective	objective	NOUN
ejde-885	208	9	was	be	AUX
ejde-885	208	10	to	to	PART
ejde-885	208	11	model	model	VERB
ejde-885	208	12	the	the	DET
ejde-885	208	13	interaction	interaction	NOUN
ejde-885	208	14	between	between	ADP
ejde-885	208	15	epidemiological	epidemiological	ADJ
ejde-885	208	16	dynamics	dynamic	NOUN
ejde-885	208	17	and	and	CCONJ
ejde-885	208	18	clinical	clinical	ADJ
ejde-885	208	19	trials	trial	NOUN
ejde-885	208	20	for	for	ADP
ejde-885	208	21	a	a	DET
ejde-885	208	22	new	new	ADJ
ejde-885	208	23	vaccine	vaccine	NOUN
ejde-885	208	24	targeting	target	VERB
ejde-885	208	25	a	a	DET
ejde-885	208	26	general	general	ADJ
ejde-885	208	27	respiratory	respiratory	ADJ
ejde-885	208	28	infection	infection	NOUN
ejde-885	208	29	.	.	PUNCT
ejde-885	209	1	the	the	DET
ejde-885	209	2	clinical	clinical	ADJ
ejde-885	209	3	trial	trial	NOUN
ejde-885	209	4	for	for	ADP
ejde-885	209	5	children	child	NOUN
ejde-885	209	6	was	be	AUX
ejde-885	209	7	initiated	initiate	VERB
ejde-885	209	8	only	only	ADV
ejde-885	209	9	after	after	ADP
ejde-885	209	10	the	the	DET
ejde-885	209	11	completion	completion	NOUN
ejde-885	209	12	of	of	ADP
ejde-885	209	13	the	the	DET
ejde-885	209	14	adult	adult	NOUN
ejde-885	209	15	trials	trial	NOUN
ejde-885	209	16	,	,	PUNCT
ejde-885	209	17	utilizing	utilize	VERB
ejde-885	209	18	the	the	DET
ejde-885	209	19	data	datum	NOUN
ejde-885	209	20	from	from	ADP
ejde-885	209	21	the	the	DET
ejde-885	209	22	adult	adult	NOUN
ejde-885	209	23	trials	trial	NOUN
ejde-885	209	24	to	to	PART
ejde-885	209	25	inform	inform	VERB
ejde-885	209	26	the	the	DET
ejde-885	209	27	children	child	NOUN
ejde-885	209	28	’s	’s	PART
ejde-885	209	29	trials	trial	NOUN
ejde-885	209	30	.	.	PUNCT
ejde-885	210	1	a	a	DET
ejde-885	210	2	key	key	ADJ
ejde-885	210	3	finding	finding	NOUN
ejde-885	210	4	ejde-2024	ejde-2024	ADJ
ejde-885	210	5	/	/	SYM
ejde-885	210	6	conf/27	conf/27	NOUN
ejde-885	210	7	clinical	clinical	ADJ
ejde-885	210	8	trial	trial	NOUN
ejde-885	210	9	modeling	model	VERB
ejde-885	210	10	11	11	NUM
ejde-885	210	11	was	be	AUX
ejde-885	210	12	that	that	SCONJ
ejde-885	210	13	the	the	DET
ejde-885	210	14	timeline	timeline	NOUN
ejde-885	210	15	for	for	ADP
ejde-885	210	16	children	child	NOUN
ejde-885	210	17	’s	’s	PART
ejde-885	210	18	clinical	clinical	ADJ
ejde-885	210	19	trials	trial	NOUN
ejde-885	210	20	is	be	AUX
ejde-885	210	21	affected	affect	VERB
ejde-885	210	22	by	by	ADP
ejde-885	210	23	adult	adult	NOUN
ejde-885	210	24	vaccination	vaccination	NOUN
ejde-885	210	25	rates	rate	NOUN
ejde-885	210	26	and	and	CCONJ
ejde-885	210	27	the	the	DET
ejde-885	210	28	resultant	resultant	NOUN
ejde-885	210	29	herd	herd	NOUN
ejde-885	210	30	immunity	immunity	NOUN
ejde-885	210	31	.	.	PUNCT
ejde-885	211	1	although	although	SCONJ
ejde-885	211	2	the	the	DET
ejde-885	211	3	timing	timing	NOUN
ejde-885	211	4	of	of	ADP
ejde-885	211	5	another	another	DET
ejde-885	211	6	pandemic	pandemic	ADJ
ejde-885	211	7	event	event	NOUN
ejde-885	211	8	similar	similar	ADJ
ejde-885	211	9	to	to	ADP
ejde-885	211	10	covid-19	covid-19	PROPN
ejde-885	211	11	is	be	AUX
ejde-885	211	12	unpredictable	unpredictable	ADJ
ejde-885	211	13	,	,	PUNCT
ejde-885	211	14	preparedness	preparedness	NOUN
ejde-885	211	15	is	be	AUX
ejde-885	211	16	crucial	crucial	ADJ
ejde-885	211	17	.	.	PUNCT
ejde-885	212	1	our	our	PRON
ejde-885	212	2	model	model	NOUN
ejde-885	212	3	simulates	simulate	VERB
ejde-885	212	4	a	a	DET
ejde-885	212	5	general	general	ADJ
ejde-885	212	6	scenario	scenario	NOUN
ejde-885	212	7	and	and	CCONJ
ejde-885	212	8	could	could	AUX
ejde-885	212	9	be	be	AUX
ejde-885	212	10	valuable	valuable	ADJ
ejde-885	212	11	for	for	ADP
ejde-885	212	12	future	future	ADJ
ejde-885	212	13	pandemic	pandemic	ADJ
ejde-885	212	14	preparedness	preparedness	NOUN
ejde-885	212	15	.	.	PUNCT
ejde-885	213	1	further	further	ADJ
ejde-885	213	2	refinement	refinement	NOUN
ejde-885	213	3	of	of	ADP
ejde-885	213	4	our	our	PRON
ejde-885	213	5	results	result	NOUN
ejde-885	213	6	using	use	VERB
ejde-885	213	7	more	more	ADV
ejde-885	213	8	precise	precise	ADJ
ejde-885	213	9	parameters	parameter	NOUN
ejde-885	213	10	is	be	AUX
ejde-885	213	11	an	an	DET
ejde-885	213	12	area	area	NOUN
ejde-885	213	13	for	for	ADP
ejde-885	213	14	future	future	ADJ
ejde-885	213	15	research	research	NOUN
ejde-885	213	16	.	.	PUNCT
ejde-885	214	1	acknowledgements	acknowledgement	NOUN
ejde-885	214	2	.	.	PUNCT
ejde-885	215	1	this	this	DET
ejde-885	215	2	research	research	NOUN
ejde-885	215	3	wass	wass	NOUN
ejde-885	215	4	partially	partially	ADV
ejde-885	215	5	supported	support	VERB
ejde-885	215	6	by	by	ADP
ejde-885	215	7	xavier	xavier	PROPN
ejde-885	215	8	university	university	PROPN
ejde-885	215	9	’s	’s	PART
ejde-885	215	10	summer	summer	NOUN
ejde-885	215	11	undergraduate	undergraduate	NOUN
ejde-885	215	12	research	research	NOUN
ejde-885	215	13	funding	funding	NOUN
ejde-885	215	14	during	during	ADP
ejde-885	215	15	summer	summer	NOUN
ejde-885	215	16	2023	2023	NUM
ejde-885	215	17	.	.	PUNCT
ejde-885	216	1	references	reference	NOUN
ejde-885	216	2	[	[	X
ejde-885	216	3	1	1	NUM
ejde-885	216	4	]	]	PUNCT
ejde-885	216	5	p.	p.	NOUN
ejde-885	216	6	white	white	PROPN
ejde-885	216	7	,	,	PUNCT
ejde-885	216	8	m.	m.	NOUN
ejde-885	216	9	enright	enright	PROPN
ejde-885	216	10	;	;	PUNCT
ejde-885	216	11	mathematicals	mathematical	NOUN
ejde-885	216	12	models	model	NOUN
ejde-885	216	13	in	in	ADP
ejde-885	216	14	infectious	infectious	ADJ
ejde-885	216	15	disease	disease	NOUN
ejde-885	216	16	epidemiology	epidemiology	NOUN
ejde-885	216	17	,	,	PUNCT
ejde-885	216	18	infectious	infectious	ADJ
ejde-885	216	19	diseases	disease	NOUN
ejde-885	216	20	.	.	PUNCT
ejde-885	217	1	2010	2010	NUM
ejde-885	217	2	:	:	PUNCT
ejde-885	218	1	70–75	70–75	X
ejde-885	218	2	.	.	PUNCT
ejde-885	219	1	[	[	X
ejde-885	219	2	2	2	NUM
ejde-885	219	3	]	]	PUNCT
ejde-885	219	4	infection	infection	NOUN
ejde-885	219	5	exposure	exposure	NOUN
ejde-885	219	6	questions	question	NOUN
ejde-885	219	7	.	.	PUNCT
ejde-885	220	1	seattle	seattle	PROPN
ejde-885	220	2	children	children	PROPN
ejde-885	220	3	’s	’s	PART
ejde-885	220	4	hospital	hospital	NOUN
ejde-885	220	5	,	,	PUNCT
ejde-885	220	6	30	30	NUM
ejde-885	220	7	dec	dec	PROPN
ejde-885	220	8	.	.	PROPN
ejde-885	220	9	2022	2022	NUM
ejde-885	220	10	,	,	PUNCT
ejde-885	220	11	www.seattlechildrens.org/conditions/a-z/infection-exposure-questions/.	www.seattlechildrens.org/conditions/a-z/infection-exposure-questions/.	PRON
ejde-885	220	12	[	[	X
ejde-885	220	13	3	3	X
ejde-885	220	14	]	]	X
ejde-885	220	15	y.	y.	PROPN
ejde-885	220	16	li	li	PROPN
ejde-885	220	17	,	,	PUNCT
ejde-885	220	18	j.	j.	PROPN
ejde-885	220	19	tan	tan	PROPN
ejde-885	220	20	,	,	PUNCT
ejde-885	220	21	s.	s.	PROPN
ejde-885	220	22	tan	tan	PROPN
ejde-885	220	23	,	,	PUNCT
ejde-885	220	24	et	et	PROPN
ejde-885	220	25	al	al	PROPN
ejde-885	220	26	.	.	PROPN
ejde-885	220	27	;	;	PUNCT
ejde-885	220	28	infection	infection	NOUN
ejde-885	220	29	rate	rate	NOUN
ejde-885	220	30	and	and	CCONJ
ejde-885	220	31	factors	factor	NOUN
ejde-885	220	32	affecting	affect	VERB
ejde-885	220	33	close	close	ADJ
ejde-885	220	34	contacts	contact	NOUN
ejde-885	220	35	of	of	ADP
ejde-885	220	36	covid19	covid19	NOUN
ejde-885	220	37	cases	case	NOUN
ejde-885	220	38	:	:	PUNCT
ejde-885	220	39	a	a	DET
ejde-885	220	40	systematic	systematic	ADJ
ejde-885	220	41	review	review	NOUN
ejde-885	220	42	.	.	PUNCT
ejde-885	221	1	journal	journal	NOUN
ejde-885	221	2	of	of	ADP
ejde-885	221	3	evidence	evidence	NOUN
ejde-885	221	4	-	-	PUNCT
ejde-885	221	5	based	base	VERB
ejde-885	221	6	medicine	medicine	NOUN
ejde-885	221	7	,	,	PUNCT
ejde-885	221	8	u.s	u.s	PROPN
ejde-885	221	9	.	.	PROPN
ejde-885	221	10	national	national	PROPN
ejde-885	221	11	library	library	NOUN
ejde-885	221	12	of	of	ADP
ejde-885	221	13	medicine	medicine	NOUN
ejde-885	221	14	,	,	PUNCT
ejde-885	221	15	dec	dec	PROPN
ejde-885	221	16	.	.	PROPN
ejde-885	221	17	2022	2022	NUM
ejde-885	221	18	,	,	PUNCT
ejde-885	221	19	www.ncbi.nlm.nih.gov/pmc/articles/pmc9877962/.	www.ncbi.nlm.nih.gov/pmc/articles/pmc9877962/.	PROPN
ejde-885	221	20	[	[	X
ejde-885	221	21	4	4	X
ejde-885	221	22	]	]	X
ejde-885	222	1	v.	v.	CCONJ
ejde-885	222	2	racaniello	racaniello	PROPN
ejde-885	222	3	;	;	PUNCT
ejde-885	222	4	the	the	DET
ejde-885	222	5	incubation	incubation	NOUN
ejde-885	222	6	period	period	NOUN
ejde-885	222	7	of	of	ADP
ejde-885	222	8	a	a	DET
ejde-885	222	9	viral	viral	ADJ
ejde-885	222	10	infection	infection	NOUN
ejde-885	222	11	,	,	PUNCT
ejde-885	222	12	8	8	NUM
ejde-885	222	13	oct	oct	PROPN
ejde-885	222	14	.	.	PROPN
ejde-885	222	15	2014	2014	NUM
ejde-885	222	16	,	,	PUNCT
ejde-885	222	17	virology.ws/2014/10/08/the-incubation-period-of-a-viral-infection/.	virology.ws/2014/10/08/the-incubation-period-of-a-viral-infection/.	VERB
ejde-885	223	1	[	[	X
ejde-885	223	2	5	5	NUM
ejde-885	223	3	]	]	PUNCT
ejde-885	223	4	t.	t.	PROPN
ejde-885	223	5	tsang	tsang	PROPN
ejde-885	223	6	,	,	PUNCT
ejde-885	223	7	l.	l.	PROPN
ejde-885	223	8	lau	lau	PROPN
ejde-885	223	9	,	,	PUNCT
ejde-885	223	10	s.	s.	PROPN
ejde-885	223	11	cauchemez	cauchemez	PROPN
ejde-885	223	12	,	,	PUNCT
ejde-885	223	13	et	et	PROPN
ejde-885	223	14	al	al	PROPN
ejde-885	223	15	.	.	PROPN
ejde-885	223	16	;	;	PUNCT
ejde-885	223	17	household	household	NOUN
ejde-885	223	18	transmission	transmission	NOUN
ejde-885	223	19	of	of	ADP
ejde-885	223	20	influenza	influenza	NOUN
ejde-885	223	21	virus	virus	NOUN
ejde-885	223	22	.	.	PUNCT
ejde-885	224	1	trends	trend	NOUN
ejde-885	224	2	in	in	ADP
ejde-885	224	3	microbiology	microbiology	NOUN
ejde-885	224	4	,	,	PUNCT
ejde-885	224	5	2016	2016	NUM
ejde-885	224	6	,	,	PUNCT
ejde-885	224	7	vol	vol	NOUN
ejde-885	224	8	.	.	PROPN
ejde-885	224	9	24	24	NUM
ejde-885	224	10	,	,	PUNCT
ejde-885	224	11	no	no	INTJ
ejde-885	224	12	.	.	NOUN
ejde-885	224	13	2	2	NUM
ejde-885	224	14	http://dx.doi.org/10.1016/j.tim.2015.10.012	http://dx.doi.org/10.1016/j.tim.2015.10.012	NOUN
ejde-885	224	15	[	[	X
ejde-885	224	16	6	6	NUM
ejde-885	224	17	]	]	PUNCT
ejde-885	224	18	hosseinzadeh	hosseinzadeh	NOUN
ejde-885	224	19	,	,	PUNCT
ejde-885	224	20	pouya	pouya	PROPN
ejde-885	224	21	,	,	PUNCT
ejde-885	224	22	et	et	PROPN
ejde-885	224	23	al	al	PROPN
ejde-885	224	24	.	.	PROPN
ejde-885	224	25	;	;	PUNCT
ejde-885	224	26	social	social	ADJ
ejde-885	224	27	consequences	consequence	NOUN
ejde-885	224	28	of	of	ADP
ejde-885	224	29	the	the	DET
ejde-885	224	30	covid-19	covid-19	PROPN
ejde-885	224	31	pandemic	pandemic	NOUN
ejde-885	224	32	.	.	PUNCT
ejde-885	225	1	a	a	DET
ejde-885	225	2	systematic	systematic	ADJ
ejde-885	225	3	review	review	NOUN
ejde-885	225	4	.	.	PUNCT
ejde-885	226	1	u.s	u.s	PROPN
ejde-885	226	2	.	.	PROPN
ejde-885	226	3	national	national	PROPN
ejde-885	226	4	library	library	NOUN
ejde-885	226	5	of	of	ADP
ejde-885	226	6	medicine	medicine	NOUN
ejde-885	226	7	,	,	PUNCT
ejde-885	226	8	mar	mar	PROPN
ejde-885	226	9	.	.	PROPN
ejde-885	226	10	2022	2022	NUM
ejde-885	227	1	[	[	X
ejde-885	227	2	7	7	X
ejde-885	227	3	]	]	PUNCT
ejde-885	227	4	about	about	ADP
ejde-885	227	5	our	our	PRON
ejde-885	227	6	landmark	landmark	NOUN
ejde-885	227	7	trial	trial	NOUN
ejde-885	227	8	,	,	PUNCT
ejde-885	227	9	pfizer	pfizer	NOUN
ejde-885	227	10	,	,	PUNCT
ejde-885	227	11	www.pfizer.com/science/coronavirus/vaccine/about-ourlandmark-trial	www.pfizer.com/science/coronavirus/vaccine/about-ourlandmark-trial	NOUN
ejde-885	227	12	.	.	PUNCT
ejde-885	228	1	[	[	X
ejde-885	228	2	8	8	NUM
ejde-885	228	3	]	]	PUNCT
ejde-885	228	4	the	the	DET
ejde-885	228	5	fda	fda	PROPN
ejde-885	228	6	’s	’s	PART
ejde-885	228	7	drug	drug	PROPN
ejde-885	228	8	review	review	NOUN
ejde-885	228	9	process	process	NOUN
ejde-885	228	10	:	:	PUNCT
ejde-885	228	11	ensuring	ensure	VERB
ejde-885	228	12	drugs	drug	NOUN
ejde-885	228	13	are	be	AUX
ejde-885	228	14	safe	safe	ADJ
ejde-885	228	15	and	and	CCONJ
ejde-885	228	16	effective	effective	ADJ
ejde-885	228	17	,	,	PUNCT
ejde-885	228	18	u.s	u.s	PROPN
ejde-885	228	19	.	.	PROPN
ejde-885	228	20	food	food	PROPN
ejde-885	228	21	and	and	CCONJ
ejde-885	228	22	drug	drug	NOUN
ejde-885	228	23	administration	administration	NOUN
ejde-885	228	24	,	,	PUNCT
ejde-885	228	25	24	24	NUM
ejde-885	228	26	november	november	PROPN
ejde-885	228	27	2017	2017	NUM
ejde-885	228	28	,	,	PUNCT
ejde-885	228	29	www.fda.gov/drugs/information-consumers-andpatients-drugs/fdas-drug-review-process-ensuring-drugs-are-safe-and-effective	www.fda.gov/drugs/information-consumers-andpatients-drugs/fdas-drug-review-process-ensuring-drugs-are-safe-and-effective	ADJ
ejde-885	228	30	.	.	PUNCT
ejde-885	229	1	[	[	X
ejde-885	229	2	9	9	NUM
ejde-885	229	3	]	]	PUNCT
ejde-885	229	4	covid	covid	NOUN
ejde-885	229	5	vaccine	vaccine	NOUN
ejde-885	229	6	testing	testing	NOUN
ejde-885	229	7	and	and	CCONJ
ejde-885	229	8	approval	approval	NOUN
ejde-885	229	9	,	,	PUNCT
ejde-885	229	10	university	university	PROPN
ejde-885	229	11	of	of	ADP
ejde-885	229	12	maryland	maryland	PROPN
ejde-885	229	13	medical	medical	ADJ
ejde-885	229	14	system	system	NOUN
ejde-885	229	15	,	,	PUNCT
ejde-885	229	16	www.umms.org/coronavirus/covid-vaccine/testing	www.umms.org/coronavirus/covid-vaccine/teste	VERB
ejde-885	229	17	.	.	PUNCT
ejde-885	230	1	[	[	X
ejde-885	230	2	10	10	NUM
ejde-885	230	3	]	]	X
ejde-885	230	4	pfizer	pfizer	NOUN
ejde-885	230	5	and	and	CCONJ
ejde-885	230	6	biontech	biontech	NOUN
ejde-885	230	7	provide	provide	VERB
ejde-885	230	8	update	update	NOUN
ejde-885	230	9	on	on	ADP
ejde-885	230	10	ongoing	ongoing	ADJ
ejde-885	230	11	studies	study	NOUN
ejde-885	230	12	of	of	ADP
ejde-885	230	13	covid-19	covid-19	PROPN
ejde-885	230	14	vaccine	vaccine	NOUN
ejde-885	230	15	.	.	PUNCT
ejde-885	231	1	pfizer	pfizer	PROPN
ejde-885	231	2	,	,	PUNCT
ejde-885	231	3	www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provideupdate-ongoing-studies-covid-19	www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-provideupdate-ongoing-studies-covid-19	ADV
ejde-885	231	4	.	.	PUNCT
ejde-885	232	1	[	[	X
ejde-885	232	2	11	11	NUM
ejde-885	232	3	]	]	PUNCT
ejde-885	232	4	v.	v.	CCONJ
ejde-885	232	5	piechotta	piechotta	PROPN
ejde-885	232	6	,	,	PUNCT
ejde-885	232	7	s.	s.	PROPN
ejde-885	232	8	waldemar	waldemar	PROPN
ejde-885	232	9	,	,	PUNCT
ejde-885	232	10	t.	t.	NOUN
ejde-885	232	11	iris	iris	NOUN
ejde-885	232	12	,	,	PUNCT
ejde-885	232	13	et	et	PROPN
ejde-885	232	14	al	al	PROPN
ejde-885	232	15	.	.	PROPN
ejde-885	232	16	;	;	PUNCT
ejde-885	232	17	safety	safety	NOUN
ejde-885	232	18	and	and	CCONJ
ejde-885	232	19	effectiveness	effectiveness	NOUN
ejde-885	232	20	of	of	ADP
ejde-885	232	21	vaccines	vaccine	NOUN
ejde-885	232	22	against	against	ADP
ejde-885	232	23	covid-19	covid-19	PROPN
ejde-885	232	24	in	in	ADP
ejde-885	232	25	children	child	NOUN
ejde-885	232	26	aged	age	VERB
ejde-885	232	27	5	5	NUM
ejde-885	232	28	-	-	SYM
ejde-885	232	29	11	11	NUM
ejde-885	232	30	years	year	NOUN
ejde-885	232	31	:	:	PUNCT
ejde-885	232	32	a	a	DET
ejde-885	232	33	systematic	systematic	ADJ
ejde-885	232	34	review	review	NOUN
ejde-885	232	35	and	and	CCONJ
ejde-885	232	36	meta	meta	ADJ
ejde-885	232	37	-	-	PUNCT
ejde-885	232	38	analysis	analysis	NOUN
ejde-885	232	39	,	,	PUNCT
ejde-885	232	40	the	the	DET
ejde-885	232	41	lancet	lancet	PROPN
ejde-885	232	42	child	child	NOUN
ejde-885	232	43	&	&	CCONJ
ejde-885	232	44	adolescent	adolescent	ADJ
ejde-885	232	45	health	health	NOUN
ejde-885	232	46	volume	volume	NOUN
ejde-885	232	47	7	7	NUM
ejde-885	232	48	,	,	PUNCT
ejde-885	232	49	issue	issue	NOUN
ejde-885	232	50	6	6	NUM
ejde-885	232	51	,	,	PUNCT
ejde-885	232	52	june	june	PROPN
ejde-885	232	53	2023	2023	NUM
ejde-885	232	54	,	,	PUNCT
ejde-885	232	55	pages	page	NOUN
ejde-885	232	56	379	379	NUM
ejde-885	232	57	-	-	SYM
ejde-885	232	58	391	391	NUM
ejde-885	232	59	.	.	PUNCT
ejde-885	233	1	[	[	X
ejde-885	233	2	12	12	NUM
ejde-885	233	3	]	]	PUNCT
ejde-885	233	4	m.	m.	NOUN
ejde-885	233	5	thompson	thompson	PROPN
ejde-885	233	6	,	,	PUNCT
ejde-885	233	7	matthew	matthew	PROPN
ejde-885	233	8	,	,	PUNCT
ejde-885	233	9	v.	v.	PROPN
ejde-885	233	10	talley	talley	PROPN
ejde-885	233	11	,	,	PUNCT
ejde-885	233	12	p.	p.	PROPN
ejde-885	233	13	blair	blair	PROPN
ejde-885	233	14	,	,	PUNCT
ejde-885	233	15	et	et	PROPN
ejde-885	233	16	al	al	PROPN
ejde-885	233	17	.	.	PROPN
ejde-885	233	18	;	;	PUNCT
ejde-885	233	19	duration	duration	NOUN
ejde-885	233	20	of	of	ADP
ejde-885	233	21	symptoms	symptom	NOUN
ejde-885	233	22	of	of	ADP
ejde-885	233	23	respiratory	respiratory	ADJ
ejde-885	233	24	tract	tract	NOUN
ejde-885	233	25	infections	infection	NOUN
ejde-885	233	26	in	in	ADP
ejde-885	233	27	children	child	NOUN
ejde-885	233	28	:	:	PUNCT
ejde-885	233	29	systematic	systematic	ADJ
ejde-885	233	30	review.bmj	review.bmj	NOUN
ejde-885	233	31	2013	2013	NUM
ejde-885	233	32	;	;	PUNCT
ejde-885	233	33	347	347	NUM
ejde-885	233	34	:	:	PUNCT
ejde-885	233	35	f7027	f7027	NUM
ejde-885	233	36	doi	doi	NOUN
ejde-885	233	37	:	:	PUNCT
ejde-885	233	38	doi.org/10.1136/bmj.f7027	doi.org/10.1136/bmj.f7027	PRON
ejde-885	234	1	[	[	X
ejde-885	234	2	13	13	NUM
ejde-885	234	3	]	]	PUNCT
ejde-885	234	4	s.	s.	PROPN
ejde-885	234	5	del	del	PROPN
ejde-885	234	6	valle	valle	PROPN
ejde-885	234	7	,	,	PUNCT
ejde-885	234	8	j.	j.	PROPN
ejde-885	234	9	hyman	hyman	PROPN
ejde-885	234	10	,	,	PUNCT
ejde-885	234	11	h.	h.	PROPN
ejde-885	234	12	hethcote	hethcote	ADV
ejde-885	234	13	;	;	PUNCT
ejde-885	234	14	mixing	mix	VERB
ejde-885	234	15	patterns	pattern	NOUN
ejde-885	234	16	between	between	ADP
ejde-885	234	17	age	age	NOUN
ejde-885	234	18	groups	group	NOUN
ejde-885	234	19	in	in	ADP
ejde-885	234	20	social	social	ADJ
ejde-885	234	21	networks	network	NOUN
ejde-885	234	22	.	.	PUNCT
ejde-885	235	1	www.researchgate.net/publication/228649013-mixing-patterns-between-agegroups-in-social-networks	www.researchgate.net/publication/228649013-mixing-patterns-between-agegroups-in-social-network	NOUN
ejde-885	235	2	.	.	PUNCT
ejde-885	236	1	[	[	X
ejde-885	236	2	14	14	NUM
ejde-885	236	3	]	]	PUNCT
ejde-885	236	4	p.	p.	NOUN
ejde-885	236	5	van	van	PROPN
ejde-885	236	6	den	den	PROPN
ejde-885	236	7	driessche	driessche	PROPN
ejde-885	236	8	;	;	PUNCT
ejde-885	236	9	reproduction	reproduction	NOUN
ejde-885	236	10	numbers	number	NOUN
ejde-885	236	11	of	of	ADP
ejde-885	236	12	infectious	infectious	ADJ
ejde-885	236	13	disease	disease	NOUN
ejde-885	236	14	models	model	NOUN
ejde-885	236	15	.	.	PUNCT
ejde-885	237	1	infectious	infectious	ADJ
ejde-885	237	2	disease	disease	NOUN
ejde-885	237	3	modelling	modelling	NOUN
ejde-885	237	4	,	,	PUNCT
ejde-885	237	5	2017	2017	NUM
ejde-885	237	6	,	,	PUNCT
ejde-885	237	7	volume	volume	NOUN
ejde-885	237	8	2	2	NUM
ejde-885	237	9	,	,	PUNCT
ejde-885	237	10	issue	issue	NOUN
ejde-885	237	11	3	3	NUM
ejde-885	237	12	,	,	PUNCT
ejde-885	237	13	pages	page	NOUN
ejde-885	237	14	288	288	NUM
ejde-885	237	15	-	-	SYM
ejde-885	237	16	303	303	NUM
ejde-885	238	1	[	[	X
ejde-885	238	2	15	15	NUM
ejde-885	238	3	]	]	X
ejde-885	238	4	s.	s.	PROPN
ejde-885	238	5	dahlberg	dahlberg	PROPN
ejde-885	238	6	,	,	PUNCT
ejde-885	238	7	e.	e.	PROPN
ejde-885	238	8	korn	korn	PROPN
ejde-885	238	9	,	,	PUNCT
ejde-885	239	1	j.	j.	PROPN
ejde-885	239	2	le	le	PROPN
ejde-885	239	3	-	-	PROPN
ejde-885	239	4	rademacher	rademacher	PROPN
ejde-885	239	5	et	et	PROPN
ejde-885	239	6	al	al	PROPN
ejde-885	239	7	.	.	PROPN
ejde-885	239	8	;	;	PUNCT
ejde-885	240	1	clinical	clinical	ADJ
ejde-885	240	2	versus	versus	ADP
ejde-885	240	3	statistical	statistical	ADJ
ejde-885	240	4	significance	significance	NOUN
ejde-885	240	5	in	in	ADP
ejde-885	240	6	studies	study	NOUN
ejde-885	240	7	of	of	ADP
ejde-885	240	8	thoracic	thoracic	NOUN
ejde-885	240	9	malignancies	malignancy	NOUN
ejde-885	240	10	,	,	PUNCT
ejde-885	240	11	journal	journal	NOUN
ejde-885	240	12	of	of	ADP
ejde-885	240	13	thoracic	thoracic	NOUN
ejde-885	240	14	oncology	oncology	NOUN
ejde-885	240	15	,	,	PUNCT
ejde-885	240	16	vol	vol	NOUN
ejde-885	240	17	.	.	PROPN
ejde-885	240	18	15	15	NUM
ejde-885	241	1	no	no	NOUN
ejde-885	241	2	.	.	NOUN
ejde-885	242	1	9	9	NUM
ejde-885	242	2	:	:	PUNCT
ejde-885	242	3	1406–8	1406–8	X
ejde-885	242	4	.	.	PUNCT
ejde-885	243	1	[	[	X
ejde-885	243	2	16	16	NUM
ejde-885	243	3	]	]	X
ejde-885	243	4	guiding	guide	VERB
ejde-885	243	5	principles	principle	NOUN
ejde-885	243	6	for	for	ADP
ejde-885	243	7	ethical	ethical	ADJ
ejde-885	243	8	research	research	NOUN
ejde-885	243	9	.	.	PUNCT
ejde-885	244	1	national	national	PROPN
ejde-885	244	2	institutes	institutes	PROPN
ejde-885	244	3	of	of	ADP
ejde-885	244	4	health	health	NOUN
ejde-885	244	5	,	,	PUNCT
ejde-885	244	6	www.nih.gov/healthinformation/nih-clinical-research-trials-you/guiding-principles-ethical-research	www.nih.gov/healthinformation/nih-clinical-research-trials-you/guiding-principles-ethical-research	NOUN
ejde-885	244	7	.	.	PUNCT
ejde-885	245	1	[	[	X
ejde-885	245	2	17	17	NUM
ejde-885	245	3	]	]	PUNCT
ejde-885	245	4	a.	a.	NOUN
ejde-885	245	5	paturel	paturel	PROPN
ejde-885	245	6	.	.	PUNCT
ejde-885	246	1	understanding	understand	VERB
ejde-885	246	2	covid-19	covid-19	PROPN
ejde-885	246	3	vaccine	vaccine	NOUN
ejde-885	246	4	trials	trial	NOUN
ejde-885	246	5	in	in	ADP
ejde-885	246	6	children	child	NOUN
ejde-885	246	7	cedars	cedar	NOUN
ejde-885	246	8	-	-	PUNCT
ejde-885	246	9	sinai	sinai	PROPN
ejde-885	246	10	,	,	PUNCT
ejde-885	246	11	13	13	NUM
ejde-885	246	12	july	july	NOUN
ejde-885	246	13	2021	2021	NUM
ejde-885	246	14	,	,	PUNCT
ejde-885	246	15	www.cedars-sinai.org/blog/covid-19-vaccine-trials-children.html	www.cedars-sinai.org/blog/covid-19-vaccine-trials-children.html	PROPN
ejde-885	246	16	.	.	PUNCT
ejde-885	247	1	[	[	X
ejde-885	247	2	18	18	NUM
ejde-885	247	3	]	]	SYM
ejde-885	247	4	lasch	lasch	PROPN
ejde-885	247	5	,	,	PUNCT
ejde-885	247	6	florian	florian	PROPN
ejde-885	247	7	;	;	PUNCT
ejde-885	247	8	the	the	DET
ejde-885	247	9	impact	impact	NOUN
ejde-885	247	10	of	of	ADP
ejde-885	247	11	covid-19	covid-19	PROPN
ejde-885	247	12	on	on	ADP
ejde-885	247	13	the	the	DET
ejde-885	247	14	initiation	initiation	NOUN
ejde-885	247	15	of	of	ADP
ejde-885	247	16	clinical	clinical	ADJ
ejde-885	247	17	trials	trial	NOUN
ejde-885	247	18	in	in	ADP
ejde-885	247	19	europe	europe	PROPN
ejde-885	247	20	and	and	CCONJ
ejde-885	247	21	the	the	DET
ejde-885	247	22	united	united	PROPN
ejde-885	247	23	states	states	PROPN
ejde-885	247	24	.	.	PUNCT
ejde-885	248	1	ascpt	ascpt	NOUN
ejde-885	248	2	,	,	PUNCT
ejde-885	248	3	ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.2534	ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.2534	PROPN
ejde-885	248	4	.	.	PUNCT
ejde-885	249	1	28	28	NUM
ejde-885	249	2	jan	jan	PROPN
ejde-885	249	3	.	.	PROPN
ejde-885	249	4	2022	2022	NUM
ejde-885	249	5	.	.	PUNCT
ejde-885	250	1	12	12	NUM
ejde-885	250	2	d.	d.	PROPN
ejde-885	250	3	gerberry	gerberry	PROPN
ejde-885	250	4	,	,	PUNCT
ejde-885	250	5	h.	h.	PROPN
ejde-885	250	6	joshi	joshi	PROPN
ejde-885	250	7	,	,	PUNCT
ejde-885	250	8	m.	m.	NOUN
ejde-885	250	9	peloquin	peloquin	NOUN
ejde-885	250	10	,	,	PUNCT
ejde-885	250	11	s.	s.	PROPN
ejde-885	250	12	vargas	vargas	PROPN
ejde-885	250	13	ejde-2022	ejde-2022	NOUN
ejde-885	250	14	/	/	SYM
ejde-885	250	15	conf/26	conf/26	X
ejde-885	250	16	david	david	PROPN
ejde-885	250	17	gerberry	gerberry	PROPN
ejde-885	250	18	department	department	PROPN
ejde-885	250	19	of	of	ADP
ejde-885	250	20	mathematics	mathematics	PROPN
ejde-885	250	21	,	,	PUNCT
ejde-885	250	22	xavier	xavier	PROPN
ejde-885	250	23	university	university	PROPN
ejde-885	250	24	,	,	PUNCT
ejde-885	250	25	cincinnati	cincinnati	PROPN
ejde-885	250	26	,	,	PUNCT
ejde-885	250	27	oh	oh	NUM
ejde-885	250	28	45207	45207	NUM
ejde-885	250	29	,	,	PUNCT
ejde-885	250	30	usa	usa	PROPN
ejde-885	250	31	email	email	NOUN
ejde-885	250	32	address	address	NOUN
ejde-885	250	33	:	:	PUNCT
ejde-885	250	34	david.gerberry@xavier.edu	david.gerberry@xavier.edu	PROPN
ejde-885	250	35	hem	hem	PROPN
ejde-885	250	36	joshi	joshi	PROPN
ejde-885	250	37	department	department	PROPN
ejde-885	250	38	of	of	ADP
ejde-885	250	39	mathematics	mathematics	PROPN
ejde-885	250	40	,	,	PUNCT
ejde-885	250	41	xavier	xavier	PROPN
ejde-885	250	42	university	university	PROPN
ejde-885	250	43	,	,	PUNCT
ejde-885	250	44	cincinnati	cincinnati	PROPN
ejde-885	250	45	,	,	PUNCT
ejde-885	250	46	oh	oh	NUM
ejde-885	250	47	45207	45207	NUM
ejde-885	250	48	,	,	PUNCT
ejde-885	250	49	usa	usa	PROPN
ejde-885	250	50	email	email	NOUN
ejde-885	250	51	address	address	NOUN
ejde-885	250	52	:	:	PUNCT
ejde-885	250	53	joshi@xavier.edu	joshi@xavier.edu	PROPN
ejde-885	250	54	mac	mac	PROPN
ejde-885	250	55	peloquin	peloquin	PROPN
ejde-885	250	56	department	department	PROPN
ejde-885	250	57	of	of	ADP
ejde-885	250	58	mathematics	mathematics	PROPN
ejde-885	250	59	,	,	PUNCT
ejde-885	250	60	xavier	xavier	PROPN
ejde-885	250	61	university	university	PROPN
ejde-885	250	62	,	,	PUNCT
ejde-885	250	63	cincinnati	cincinnati	PROPN
ejde-885	250	64	,	,	PUNCT
ejde-885	250	65	oh	oh	NUM
ejde-885	250	66	45207	45207	NUM
ejde-885	250	67	,	,	PUNCT
ejde-885	250	68	usa	usa	PROPN
ejde-885	250	69	email	email	NOUN
ejde-885	250	70	address	address	NOUN
ejde-885	250	71	:	:	PUNCT
ejde-885	250	72	peloquinj@xavier.edu	peloquinj@xavier.edu	PROPN
ejde-885	250	73	sonia	sonia	PROPN
ejde-885	250	74	vargas	vargas	PROPN
ejde-885	250	75	department	department	PROPN
ejde-885	250	76	of	of	ADP
ejde-885	250	77	mathematics	mathematics	PROPN
ejde-885	250	78	,	,	PUNCT
ejde-885	250	79	xavier	xavier	PROPN
ejde-885	250	80	university	university	PROPN
ejde-885	250	81	,	,	PUNCT
ejde-885	250	82	cincinnati	cincinnati	PROPN
ejde-885	250	83	,	,	PUNCT
ejde-885	250	84	oh	oh	NUM
ejde-885	250	85	45207	45207	NUM
ejde-885	250	86	,	,	PUNCT
ejde-885	250	87	usa	usa	PROPN
ejde-885	250	88	email	email	NOUN
ejde-885	250	89	address	address	NOUN
ejde-885	250	90	:	:	PUNCT
ejde-885	250	91	vargass2@xavier.edu	vargass2@xavier.edu	PROPN
ejde-885	250	92	1	1	X
ejde-885	250	93	.	.	PUNCT
ejde-885	250	94	introduction	introduction	NOUN
ejde-885	250	95	2	2	NUM
ejde-885	250	96	.	.	PUNCT
ejde-885	250	97	epidemiological	epidemiological	ADJ
ejde-885	250	98	model	model	NOUN
ejde-885	250	99	2.1	2.1	NUM
ejde-885	250	100	.	.	PUNCT
ejde-885	250	101	basic	basic	ADJ
ejde-885	250	102	reproductive	reproductive	ADJ
ejde-885	250	103	number	number	NOUN
ejde-885	250	104	for	for	ADP
ejde-885	250	105	epidemiological	epidemiological	ADJ
ejde-885	250	106	model	model	NOUN
ejde-885	250	107	3	3	NUM
ejde-885	250	108	.	.	PUNCT
ejde-885	251	1	clinical	clinical	ADJ
ejde-885	251	2	trial	trial	NOUN
ejde-885	251	3	modeling	model	VERB
ejde-885	251	4	3.1	3.1	NUM
ejde-885	251	5	.	.	PUNCT
ejde-885	252	1	coupling	couple	VERB
ejde-885	252	2	the	the	DET
ejde-885	252	3	epidemiological	epidemiological	ADJ
ejde-885	252	4	and	and	CCONJ
ejde-885	252	5	clinical	clinical	ADJ
ejde-885	252	6	trial	trial	NOUN
ejde-885	252	7	models	model	NOUN
ejde-885	252	8	4	4	NUM
ejde-885	252	9	.	.	PUNCT
ejde-885	252	10	simulation	simulation	NOUN
ejde-885	252	11	results	result	VERB
ejde-885	252	12	4.1	4.1	NUM
ejde-885	252	13	.	.	PUNCT
ejde-885	253	1	results	result	NOUN
ejde-885	253	2	assuming	assume	VERB
ejde-885	253	3	homogeneous	homogeneous	ADJ
ejde-885	253	4	populations	population	NOUN
ejde-885	253	5	4.2	4.2	NUM
ejde-885	253	6	.	.	PUNCT
ejde-885	254	1	results	result	NOUN
ejde-885	254	2	assuming	assume	VERB
ejde-885	254	3	differences	difference	NOUN
ejde-885	254	4	between	between	ADP
ejde-885	254	5	adults	adult	NOUN
ejde-885	254	6	and	and	CCONJ
ejde-885	254	7	children	child	NOUN
ejde-885	254	8	5	5	NUM
ejde-885	254	9	.	.	PUNCT
ejde-885	254	10	conclusions	conclusion	NOUN
ejde-885	254	11	and	and	CCONJ
ejde-885	254	12	further	further	ADJ
ejde-885	254	13	research	research	NOUN
ejde-885	254	14	acknowledgements	acknowledgement	NOUN
ejde-885	254	15	references	reference	NOUN